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Abstract 
 
To enable assessment of recombinant BFDV capsid protein (recBFDVcap) for 
vaccination to protect against PBFD, commercially available lovebirds (Agapornis sp.) were 
tested for evidence of past and current BFDV infection using PCR, HI and HA to identify 
suitable BFDV-free birds in which to test the vaccine. During this attempt, it was found that 
lovebirds from commercial aviaries were endemically infected with BFDV with evidence of 
up to 100% prevalence of BFDV DNA in blood samples from individual birds over time. 
Such an approach was abandoned as unlikely to yield suitable numbers of naïve birds to 
conduct a BFDV vaccination trial.   
 
As commercially available lovebirds were considered to be a poor source of BFDV-
free birds, wild caught cockatoo nestlings and eggs (long-billed corella; Cacatua tenuirostris 
and galah; Eolophus roseicapillus) were used to assess the efficacy of BFDV vaccination 
using baculovirus recombinant BFDV capsid. Eggs were artificially incubated and 3 eggs 
successfully hatched and 1 was successfully hand-reared. All nestlings were screened for 
BFDV DNA in blood using PCR upon arrival then on days 11, 18 and 25 and tested for anti-
BFDV antibody on the day of arrival. All hatched birds were determined to be free of BFDV 
DNA and BFDV HI antibody in the peripheral blood throughout the hand rearing period and 
the flock was considered to be suitable for a BFDV vaccination trial. 
 
Corellas (n=13) were injected with 1 mL of vaccine containing 10 μg recBFDVcap on 
day 0 and 0.4 mL vaccine containing 66.8 μg recBFDVcap on day 11. All vaccinated corellas 
and 5 non-vaccinated control corellas were given 0.4 mL BFDV suspension (titre = log2 12 
HAU/50 μL) intramuscularly and 0.1 mL orally 16 days after booster vaccination. Blood was 
collected periodically during the vaccination period and blood and feathers collected before 
and after BFDV administration. Testing included BFDV DNA detection by PCR and qRT 
PCR (on blood) as well as serum antibody detection by haemagglutination inhibition (HI) and  
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BFDV DNA and antigen was detected by qRT PCR and haemagglutination (HA) (on 
feathers), respectively. Four of 97 blood samples collected from vaccinated birds post BFDV 
challenge tested positive by PCR, whereas 17 of 35 samples taken from non-vaccinated 
control corellas tested positive. Vaccinated birds did not develop feather lesions, had only 
transient PCR detectable viraemia and had no evidence of persistent infection 270 days post-
challenge using PCR, histopathology and immunohistochemistry (IHC). Non-vaccinated 
control corellas developed transient feather lesions and PCR, HI and HA test results 
consistent with PBFD. They were BFDV PCR positive for up to 41 days post-challenge and 
qRT PCR demonstrated reduced virus replication in vaccinated birds compared to non-
vaccinated control birds. Thus, administration of recBFDVcap vaccine alone was found to 
incite an adaptive immune response in BFDV-free corellas that subsequently conferred 
protection against inoculation with BFDV. 
 
A commonly utilized method for excising blood dried on filter paper was proven to be 
of high risk of carryover contamination facilitated by a hole punch used for processing 
several samples. Therefore a practical method of avoiding carryover contamination was 
developed and used in the DNA testing procedures of the vaccination trial. 
 
Finally, the haematological characteristics of the above mentioned cockatoos were 
studied before and for 97 days after experimental infection with BFDV. It was found that the 
pre-challenge haematological values were similar between the vaccinated and non-vaccinated 
corellas. Most pre-challenge parameters were comparable to previously reported values of 
other cockatoos and psittacine birds. Significant differences were seen in both groups when 
comparing pre-challenge values with post challenge values for total and differential leukocyte 
concentrations, but PCV and TSP were not significantly affected by BFDV challenge. 
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Chapter 1 : Review of the Literature 
 
1.1 Introduction 
 
Psittacine beak and feather disease (PBFD) is the most common viral disease of 
psittacine birds in Australia and is endemic in wild and captive populations. The disease 
affects both old and new world Psittaciformes and is caused by the virus beak and feather 
disease virus (BFDV) (McOrist et al. 1984; Raidal et al. 1993b). BFDV is listed as a key 
threatening process for endangered psittacine species in Australia
*, New Zealand and South 
Africa and causes significant problems with breeding of Psittaciformes worldwide. The 
present literature review will consider current knowledge of PBFD, its associated aetiological 
agent beak and feather disease virus (BFDV) and other relevant literature. 
 
1.2 BFDV Taxonomy 
 
The BFDV is a single stranded DNA virus that belongs to a family of viruses known 
as the Circoviridae, which infect vertebrate hosts. The Circoviridae currently encompasses 
two genera; the Circoviruses and the Gyroviruses. Within the Circovirus genus are six 
species; beak and feather disease virus (BFDV), canary circovirus (CaCV), goose circovirus 
(GoCV), pigeon circovirus (PiCV), porcine circovirus – 1 (PCV1) and porcine circovirus – 2 
(PCV2). In addition duck circovirus, finch circovirus, gull circovirus and raven circovirus 
(RaCV) have been suggested as tentative members of the genus (Fauquet et al. 2005; Stewart 
et al. 2006). Gyrovirus contains only one member, the chicken anaemia virus (CAV) 
(Fauquet et al. 2005). Early findings suggested little relation of CAV to the other members of 
the  Circoviridae (Bassami et al. 1998). Although the CAV genome is a circular single 
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stranded DNA, it encodes a single polycistronic message (as apposed to the other circoviruses 
which encode separate messages from separate strands) and has been placed in the 
Circoviridae by the ICTV, probably due to the circular nature of the genome and the highly 
similar nonanucleotide motif of the origin of replication to the circoviruses (Fauquet et al. 
2005). 
 
1.3 Clinical presentation and pathology of PBFD 
 
Young captive psittacine birds under the age of three years are presumed most 
susceptible to PBFD. The condition is chronic and progressive and affected birds can survive 
from several months to years or more and no reports have indicated any reversibility of 
disease progression (Pass and Perry 1984; Jacobson et al. 1986). PBFD occurs as two forms, 
chronic (also referred to as classical) and acute. Chronic PBFD is characterised by 
symmetrical loss and dystrophy of contour, crest, tail and down feathers (Figure 1.1). Wing 
feathers may also be affected, however this is less common. Abnormally developed feathers 
may display a number of lesions, including retained feather sheaths, blood-filled sheaths, 
short and clubbed presentation, curling and deformity, circumferential indentation and stress 
lines in the vane (McOrist et al. 1984; Pass and Perry 1984; Jacobson et al. 1986; Jergens et 
al. 1988). The development of feather lesions is dependent on moulting; i.e. old feathers are 
not affected, only feathers growing during infection (Wylie 1991).  
 
Abnormalities of the beak are commonly observed. Typically, the beak will exhibit 
colour changes, progressive elongation, palatine necrosis and longitudinal and transverse 
fractures (Figure 1.2) (McOrist et al. 1984; Pass and Perry 1984; Jergens et al. 1988). 
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BFDV particles are icosahedral, non-enveloped and 14-22 nm in diameter (Pass and 
Perry 1984; Ritchie et al. 1989b). Virus induced intranuclear inclusion bodies have been 
reported within affected feather epithelial cells and macrophages (Latimer et al. 1991) and 
intracytoplasmic inclusions in macrophages, epithelial cells and keratinocytes in the feather 
epithelium in the form of paracrystalline arrays have also been reported (Trinkaus et al. 
1998). The pulp cavity may also contain BFDV (Latimer et al. 1991; Trinkaus et al. 1998). 
 
Feather follicles with normal development consist of two components; an epithelial 
layer that grows from a collar of cells at the base of the follicle and a dermal papilla (in the 
germinative stage) or pulp (in the growing stage). The epithelial cells differentiate into a 
basal layer, intermediate layer and an outer keratinised layer. Further cell division causes 
these cells to move upwards forming the rachis, barbs and barbules and finally the mature 
feather calamus. The feather sheath is in general thin and breaks soon after the feather 
emerges from the follicle allowing the barbs to spread out. Further development of the 
growing feather consists of re-absorption of the vascularised pulp from the tip of the feather 
and the epithelium covering the feather tip (termed pulp cap) becomes cornified. This process 
results in cross bars in the feather shaft. During the pulp cap re-absorption there may be 
notable oedema and haemorrhage, heterophil infiltration into the pulp and vacuole formation 
(Lucas and Stettenheim 1972; Pass and Perry 1984). 
 
A combination of dystrophy and hyperplasia in the epidermis of the feather follicle, 
beak and claws is the cause of the clinical signs seen in chronic PBFD. Necrosis and 
hyperplasia of epidermal cells cause dystrophy and the hyperplasia results in hyperkeratosis 
of the beak and claws outer layers and the feather sheath. The dystrophy further causes 
abnormally shaped feathers (Pass and Perry 1984). Chapter 1. Literature Review 
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Figure  1.1 Two chronically infected sulphur-crested cockatoos (Cacatua galerita) presenting typical 
chronic lesions of PBFD. Pictures courtesy of Dr David Pass. 
 
 
Figure  1.2 A galah (Eolophus roseicapilla) chronically infected with BFDV presenting gross clinical 
signs of beak fracture. Picture courtesy of Dr David Pass. 
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Feather sheath hyperkeratosis produces a sheath that does not break. Thus the 
growing feather retains its feather sheath. Feathers emerging from the follicle have more 
haemorrhage, inflammation and necrosis in the region of the pulp cap than normal and it is 
retained within this sheath (Pass and Perry 1984).  
 
In BFDV affected feathers inflamed, necrotic pulp causes distal swelling, exacerbated 
by vascular proliferation and oedema in the pulp resulting in short club-shaped feathers (Pass 
and Perry 1984). Bacterial and fungal infections may aggravate the inflammation (Pass and 
Perry 1984; Trinkaus et al. 1998). Distal keratinising feather shaft that curls up within the 
feather sheath also generate clubbed feathers (Pass and Perry 1984). 
 
Circumferential indentation of feathers is instigated in the developing rachis. This 
indentation is caused by reduction of the rachis epidermis, possibly because of a period of 
slow growth or excessive necrosis at this point (Pass and Perry 1984). Beak elongation is 
caused by hyperkeratosis and the keratinised layers not sloughing. Epidermal layers are 
predisposed to splitting because of the degenerative changes within. Secondary infections 
occur in these splits (Pass and Perry 1984).  
 
BFDV-infected cells typically show condensation of the cytoplasm and nuclear 
chromatin condensation (Trinkaus et al. 1998). Such changes are common events in apoptosis 
(Trinkaus et al. 1998). Vesicle formation that buds from the cell surface and associated 
zeiosis, both events associated with apoptosis have been observed in BFDV-infected 
macrophages. The disruption in keratin production is due to the apoptosis. It is likely that this 
apoptosis also facilitates dissemination of the virus between cells (Trinkaus et al. 1998). 
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The acute presentation of PBFD is most commonly observed in fledgling and 
immature birds. Its presentation is characterised by lethargy, depression, vomiting, diarrhoea 
and feather lesions but does not normally present with beak lesions. This condition 
commonly results in death (Ritchie et al. 1989a; Raidal 1994; Doneley 2003).  
 
A peracute condition involving: severe leukopenia, anaemia, or pancytopenia and 
liver necrosis has been reported in young African grey parrots (Psittacus erithacus erithacus) 
(Schoemaker et al. 2000). These peracutely infected birds lacked beak and feather disorders. 
 
The tropism of BFDV appears to be the epithelium and the primary virus replication 
organ being the bursa of Fabricius although BFDV antigen has been demonstrated in a 
number of internal organs including liver, kidneys, thymus, bone marrow (Pass and Perry 
1984). The liver has been suggested as an important site for BFDV replication in both acute 
and chronic infections (Raidal et al. 1993a). Necrotizing hepatitis has been observed in 
experimental infections of nestling sulphur-crested cockatoos (Raidal and Cross 1995) and in 
studies on African grey parrots (Schoemaker et al. 2000). The latter publication also report 
observations of severe leukopenia in naturally infected African grey parrot.  
 
Thus it is fair to assume that the lesions observed in acute and peracute PBFD are 
mediated by the lytic activity of the virus causing trauma to the: thymus, bursa of Fabricius 
and bone marrow causing pancytopenia (leukopaenia, anaemia) and associated lethargy and 
depression. Diarrhoea may be associated with necrotising hepatitis as seen in other viral 
infections like dengue fever (Mourao et al. 2004) as well as BFDV and secondary infections 
of the gastro intestinal tract. 
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1.4 Immunology associated with PBFD 
 
CAV is known to damage lymphoid tissue, destroying both precursor helper (CD4
+) 
and cytotoxic (CD8
+) T cells (Adair 2000). BFDV is thought to cause similar lymphoid 
depletion in psittacine birds, although this has not been studied thoroughly. Birds affected by 
BFDV commonly die due to secondary infections and is therefore believed to be immune-
suppressive (Latimer et al. 1990; Latimer et al. 1992; Schoemaker et al. 2000). Bursal and 
thymic lesions are commonly observed in BFDV infected birds and this supports this notion 
(Latimer et al. 1990). Cytoplasmic inclusions are also frequently found in macrophages 
present in affected epidermis, in the feather pulp cavity and in lymphoid tissue which also 
strengths the hypothesis of immune-suppression caused by BFDV (Latimer et al. 1991). 
Consequently, infected birds are predisposed to secondary bacterial and fungal infections, 
which may result in death (Latimer et al. 1992; Schoemaker et al. 2000). Wylie and Pass 
(1987) reported infiltration of heterophils and lymphocytes into the pulp of feathers during 
experimental infection of budgerigars with BFDV. These findings are supported by Jacobson 
et al. (1986), indicating that feather lesions and abnormalities are associated with the immune 
response.  
 
1.5 Transmission of BFDV 
 
The major postulated vehicle of transmission is feather dust as the follicular and 
feather epithelium of actively infected birds have a high number of BFDV inclusion bodies 
(McOrist et al. 1984; Pass and Perry 1984; Ritchie et al. 1991a). The theory of feather dust as 
the major vehicle for transmission is supported by necrotic epithelial cells in the outer layers 
of hyperkeratotic feather sheaths also containing intracytoplasmic viral inclusion bodies (Pass Chapter 1. Literature Review 
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and Perry 1984). The transmission of feather dust is likely completed by ingestion during 
normal preening activity (Ritchie et al. 1991a).  
 
The faecal-oral route is another likely mode of BFDV transmission. Findings of viral-
induced inclusion bodies in several locations of the gastro-intestinal tract support this 
suggestion and explain the observation of BFDV in the faeces of infected birds. Transmission 
via the faecal-oral route is thus likely to occur (Ritchie et al. 1991a; Raidal and Cross 1995). 
Feeding activities involving regurgitation of food and crop epithelium may cause 
transmission from adult to neonate as crop washings have been found to contain BFDV, 
although at low levels (Gerlach 1994).  
 
Vertical transmission has yet to be proven but a study has shown that chicks hatched 
from artificially incubated eggs from an infected hen consistently developed PBFD (Gerlach 
1994) and Rahaus et al. (2008) detected BFDV DNA in both embryonated and non-
embryonated psittacine eggs.  
 
The final proposed mode of transmission is direct imbibing of contaminated material 
into the cloaca of nestling birds (Raidal 1994). Due to weakness of legs and poor balance, 
nestling birds are forced to sit tripod like on their legs and abdomen. During defecation, these 
birds will slide their cloaca over nesting material and may therefore contract infections in this 
way (Raidal 1994). 
 
1.6 Epidemiology of BFDV  
 
In 1887/88 a decline of Psephotus parrots in the Adelaide hills population was 
observed (Ashby 1907). These birds had “feathering abnormalities” that impaired flight and Chapter 1. Literature Review 
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was most likely caused by BFDV (Raidal et al. 1993b). A second report in 1903 describes a 
near naked sulphur crested cockatoo with the “feather stumps breaking off close to the skin” 
and wild cockatoos in similar conditions near Cooma, NSW (Powell 1903). 
 
BFDV is endemic in wild and captive psittacine populations (Raidal et al. 1993b; 
Raidal 1994). There have been reports of BFDV infection of both old and new world captive 
psittacine birds (Ritchie et al. 1991a; Kock et al. 1993; Raidal 1995). PBFD has been 
reported, based on clinical and histological observations, in 42 psittacine species (Gerlach 
1994). In Australia it is recognised that 30 and possibly all 50 psittacine species are 
susceptible, whether they be captive or wild (Studdert 1993).  
 
The sulphur-crested cockatoo (Cacatua galerita) is the most commonly observed 
species with BFDV infection. In 1984, McOrist et al. (1984) found that several Victorian 
flocks of sulphur-crested cockatoo had a 10-20% incidence of PBFD, based on histological 
and gross pathological observations. Seroprevalence in wild populations of up to 94% has 
been reported, although exact numbers of affected individuals are hard to determine, due to 
an unknown number dying in the nest (Raidal et al. 1993b). A number of other species have 
been reported to be susceptible to BFDV, including; galahs (Eolophus roseicapilla), little 
corella (Cacatua sanguinea), Major Mitchell’s cockatoo (Cacatua leadbeateri), lovebirds 
(Agapornis  spp.), budgerigars (Melopsittacus undulatus), African grey parrot (Psittacus 
erithacus erithacus), short-billed corella (Cacatua sanguinea), eastern long-billed corella 
(Cacatua tenuirostris), blue bonnet (Psephotus haematogaster), rainbow lorikeet 
(Trichogolossus haematodus), horned parakeets (Eunymphicus cornutus)  eastern rosellas 
(Platycercus eximius) cockatiel (Nymphicus hollandicus) and other psittacine species (Raidal 
et al. 1993b; Schoemaker et al. 2000; Ritchie et al. 2003; Ha et al. 2007; Tomasek and Tukac Chapter 1. Literature Review 
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2007; Shearer et al. 2008a). PBFD is the most common viral disease of Australian 
Psittaciformes and is currently listed as a key threatening process for endangered psittacine 
species in Australia, New Zealand and South Africa and causes significant problems with 
breeding of Psittaciformes worldwide (Khalesi et al. 2005). 
 
1.7 Diagnosis of PBFD 
 
Clinical examination and observation of gross pathological lesions are primary tools 
for PBFD diagnosis. However, clinical presentation is in it self not adequate for accurate 
diagnosis as many clinicians fall short of detecting pathognomonic feather lesions in early 
cases (Raidal et al. 1993c) and because feather lesions caused by other aetiologies can appear 
similar. In addition, clinical signs are often confused with lesions of polyoma virus infection 
and other epidermal lesions [reviewed in Riddoch (1996)]. Observation of hyperplasia of the 
epidermis and feather follicle hyperkeratosis using histopathology (Pass and Perry 1984) is a 
useful diagnostic method but requires a follicular biopsy, causing trauma to the bird and has 
limited usefulness when testing flocks (Raidal et al. 1993c).  
 
Polymerase chain reaction (PCR) (Ypelaar et al. 1999) and haemagglutination (Raidal 
and Cross 1994b) are the best methods for detecting BFDV DNA and antigen, respectively. 
The haemagglutination inhibition assay (HI) (Raidal et al. 1993c) has become the standard 
for anti-BFDV antibody detection. Other techniques including immunohistochemistry, 
transmission electron microscopy, DNA dot-blot hybridization (Raidal et al. 1993c), in situ 
hybridisation (Ramis et al. 1994) and a feather enzyme immunoassay (Raidal 1994) have 
been described. 
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Recently, monoclonal antibody to recombinant BFDV capsid protein has been 
produced and found very useful in ELISA, western-immuno blotting and 
immunohistochemistry (Shearer et al. 2008b). 
 
1.8 Vaccination and control of PBFD 
 
Vaccines may be synthesized by several different methods. These include 
amplification of virus using various cell cultures and eggs and delivery of live vaccine (i.e. 
Polio) or delivery of inactivated/killed virus (i.e. Influenza), DNA facilitated immunisation 
(naked DNA, facilitated DNA, virus delivered DNA vector), monoclonal antibodies (passive 
immunity) and finally peptides expressed in bacterial, baculovirus and yeast systems (Plotkin 
and Orenstein 2004).  
 
There have been attempts at culturing BFDV in numerous cell culture systems, 
however there have been no reports of successful virus amplification using cell cultures (Pass 
and Perry 1985). DNA vaccination is a currently unexplored venue for control of BFDV. 
Adult and nestling cockatoos have been shown to be protected against BFDV challenge when 
vaccinated with an inactivated BFDV, double-oil emulsion vaccine (Raidal et al. 1993a). 
Using an aviary flock of 77 Agapornis spp which had a history of endemic PBFD and vaccine 
produced from the feathers of BFDV infected sulphur-crested cockatoo, (Raidal and Cross 
1994a) demonstrated that vaccination may be an effective means of controlling PBFD by 
decreasing the potential for active infection in susceptible birds. The progeny of the 
vaccinated birds did not develop clinical signs either. These findings are indicative of the 
potential for vaccination being an effective means for protecting individual birds as well as 
flocks against BFDV. Therefore, a recombinant protein vaccine may be useful in the control 
of this endemic disease in wild and aviary psittacine birds. Chapter 1. Literature Review 
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More recently, preliminary findings have indicated that β-(1,3/1,6)-D-glucan from 
oyster mushroom (Pleurotus ostreatus) may be a useful treatment option for BFDV-infected 
psittacine birds (Tomasek and Tukac 2007). In this study captive-bred horned parakeets 
(Eunymphicus cornutus) and captive-bred Major Mitchell cockatoos (Cacatua leadbeateri) that had 
tested positive for BFDV DNA in whole blood, were treated with β-(1,3/1,6)-D-glucan and became 
negative for BFDV DNA 7-9 months after commencing treatment. However, this does not 
exclude BFDV from the whole bird and further investigation would be necessary to 
determine the actual value of this treatmen. 
 
1.9 General BFDV genetics 
 
This section will be based on the first reported BFDV sequence by (Bassami et al. 
1998) (the isolate later characterized as BFDV-AUS). The subsequent section will consider 
variation in BFDV genetic aspects. The nomenclature for numbering nucleotides is according 
to the convention used in Geminiviruses and was first adopted for BFDV by Bassami et al. 
(1998).  
 
1.9.1  The BFDV genome 
 
The BFDV genome is a covalently closed, ambisense, single stranded DNA molecule 
first determined to be 1993 nucleotides in length (Bassami et al. 1998; Niagro et al. 1998). 
Bassami et al. (1998) predicted seven potential open reading frames (ORFs), three on the 
viral strand and four on the complimentary strand of the double stranded replicative form of 
the genome (Figure 1.3). All the tentative ORFs were predicted to potentially encode proteins 
of >8.7kDa. However, only two ORFs have provoked further interest on their structure and 
function. These are ORFs “C1” and “V1”. The former is located on the complementary strand Chapter 1. Literature Review 
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of the double stranded replicative genome form and though to encode the virus capsid 
protein. ORF V1 is located on the viral strand and thought to encode a protein involved in 
rolling circle replication (RCR) (Bassami et al. 1998).  
 
Between ORFs C1 and V1 (positions 1976-1993 and 1-12, respectively) is a 
nucleotide motif that has the capacity to form a stem loop structure (Figure 1.4). The apex of 
the stem loop structure has the nonanucleotide motif 5’-TAGTATTAC-3’, a sequence highly 
conserved amongst members of the Circoviridae and other single stranded DNA viruses 
(Table 1.1). In Geminiviruses this motif is a required cis-acting element for DNA replication 
(Lararowits et al. 1992; Revington et al. 1989). Extending from the 3’ end of the stemloop 
structure is the octanucleotide repeat sequence 5’-GGGCACCG-3’ (Figure 1.4) (Bassami et 
al. 1998). 
 
 
 
Figure  1.3 Schematic representation of BFDV double stranded replicative form. The Figure displays 
location and orientation of predicted ORFs and their size in nucleotides [adapted from Bassami et al. 
(1998)]. ORF C1 and V1 are the only ORFs that have been proven to have transcription. Chapter 1. Literature Review 
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Figure  1.4 The predicted stem-loop structure of the BFDV genome. The nonanucleotide motif (bold) 
and the octanucleotide repeat sequence (underlined) are highlighted. Figure adopted from Bassami et 
al. (1998). 
 
 
 
 
 
 
Table 1.1 Sequence alignment of nonanucleotide motif of BFDV (accession No. AF080560) 
(Bassami et al. 1998), PCV (accession No. U49186) (Meehan et al. 1997), CAV (accession No. 
D10068) and the geminiviruses: Tomato golden mosaic virus (TGMV), squash leaf curl virus (SLCV) 
and dicot-infecting geminiviruses (DIG) (Arguello-Astorga et al. 1994). * indicates conserved 
nucleotides (CN) between the motifs. 
Virus Species  Nonanucleotide motif sequence 
BFDV TAGTATTAC 
CAV TACTATTCC 
PCV TAGTATTAC 
TGMV TAATATTAC 
SLCV TAATATTAC 
DIG TAATATTAC 
CN  * *    ** **   * Chapter 1. Literature Review 
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Two potential TATA boxes are present on the viral strand, namely; TATA at 
nucleotide 86-89 and TATAAAA at nucleotide 680-686, were reported by Bassami et al. 
(1998). TATA boxes are part of the core promoter in eukaryotic transcription systems. They 
are usually found approximately 30 nucleotides upstream of the transcription initiation start 
site and are reliant on cis-acting promoter proximal elements to mediate transcription 
(Griffiths et al. 1999). Such elements may be found within 100 to 200 nucleotides of the 
transcription initiation site and often entails a CCAAT box and GC rich segment (Griffiths et 
al. 1999).  A GC rich region (Figure 1.4) has been reported for the BFDV and is found within 
200 nucleotides of the start codon for ORF V1 and one of the reported TATA boxes was 
approximately 40 nucleotides upstream of ORF V1. Thus it seems likely that these two 
elements (GGGCACCG and TATA) are the constituents of the promoter for the BFDV ORF 
V1. Bassami et al. (2001) also reported two possible polyadenylation signals on the virion 
strand at nucleotides 1019-1024 (CATAAA) and at nucleotides 1196-1201 (AATAAA), 
downstream of the stop codon for ORF V1.  Additionally, a polyadenylation signal 
(AATAAA) was found only one nucleotide downstream from the ORF C1 on the 
complementary strand of the replicative form (Bassami et al. 1998).  
 
1.10 ORFs and their protein products 
 
1.10.1 ORF CI 
 
The ORF C1 is 741 nucleotides long and located on the strand complimentary to the 
genome (Figure 1.3), corresponding to nucleotides 1978-1238 of the genome. This ORF Chapter 1. Literature Review 
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potentially encodes a 28.9 kDa protein product; most likely the viral capsid protein (Bassami 
et al. 1998).  
 
The equivalent ORF in PCV is also located on the complimentary strand and reported 
that the predicted protein product of the equivalent ORFs in PCV and BFDV shared 29.1% 
amino acid sequence identity. Additionally, the ORFs start close to the stem-loop structure of 
both the respective viruses, giving further evidence for BFDV ORF C1 encoding the capsid 
protein (Bassami et al. 1998).  
 
For both BFDV and PCV, the predicted ORF C1 protein has a highly conserved 14 
amino acid sequence close to the C-terminus with an adjacent myristylation site (Niagro et al. 
1998). The highly conserved nature of these features, suggests that they are necessary for 
protein function. When the PCV2 ORF C1 was cloned into baculovirus expression vector by 
Nawagitgul et al. (2000) a 30 kDa protein was produced. Similar results were achieved with 
purified virus particles. Electron microscopy viewing of the recombinant protein detected 
capsid-like particles. Similar results have been reported by Liu et al. (2001). These reports 
are experimental proof for PCV2 ORF C1 encoding a capsid protein, and further strengthen 
the assumptions by Bassami et al. (1998) that BFDV ORF C1 also encodes the capsid 
protein. The number of individual capsid proteins that comprises the complete BFDV capsid 
is not clear. However, for PCV2 a structural model that comprises 60 subunits (T=1) arranged 
in 12 flat pentameric morphological units has been suggested and it is likely that BFDV is 
similar (Fauquet et al. 2005). 
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1.10.2 ORF VI 
 
The 867 nucleotide ORF V1 is located on the viral strand (Figure 1.3) and was 
predicted to encode a 33.3 kDa protein product (rep) (Bassami et al. 1998). This putative 
protein has all the sequence motifs found in proteins involved in RCR. P-loop motifs and 
ATP/GTP binding motifs are typically found in proteins with helicase activity. A P-loop 
motif has been identified in the BFDV ORF V1 (Niagro et al. 1998; Hodgeman 1988). A 
potential pyrophosphatase domain is found in the predicted amino acid sequence of this 
protein (Niagro et al. 1998). Bassami et al. (1998) demonstrated a high amino acid sequence 
similarity (45.6%) between the product of BFDV ORF V1 and the replication-associated 
protein of PCV, subterranean clover stunt virus and faba bean necrotic yellows virus. 
Therefore it has been predicted that BFDV ORF V1 also encodes a replication-associated 
protein. 
 
1.10.3 BFDV replication 
 
Replication of the BFDV must be heavily dependent on the host cell’s machinery as 
the BFDV has a very small genome with limited protein expressing capacity (Todd 2000). 
The exact mechanism by which BFDV replicates is not known. However, other circular 
single stranded DNA viruses are known to replicate using a mechanism known as RCR and 
the predicted Rep protein of BFDV possesses all motifs involved in RCR (Niagro et al. 1998; 
Gronenborn 2004; Gutierrez et al. 2004). Thus replication of BFDV is also likely to be by 
RCR. The stem loop structure and nonanucleotide motif previously described, are common 
features of single stranded DNA viruses that replicate via RCR. For example, Geminiviruses 
have been proven to replicate via RCR. Their nonanucleotide motifs have high sequence 
homology to BFDV and PCV (Table 1.1) and have a short inverted repeat sequence flanking 
the nonanucleotide motif, similar to BFDV (Arguello-Astorga et al. 1994; Bassami et al. Chapter 1. Literature Review 
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1998). The closely related PCV ORF V1 encodes a putative replication-associated protein 
(rep). The BFDV Rep protein carries all the sequence motifs commonly found in RCR 
proteins and required for RCR, and additionally a P-loop motif (Niagro et al. 1998). These 
findings in BFDV with its similarities to other circular single stranded DNA viruses, suggests 
that BFDV also replicates via RCR.  
 
Newer research (Heath et al. 2006) has revealed that recombinant BFDV capsid 
protein has a nuclear localisation site. This site is responsible for binding and transporting 
BFDV DNA into the nucleus allowing for viral replication to occur. Viral karyophilic 
proteins are believed to play a central role in the active delivery of many DNA virus genomes 
into the nucleus of target cells (Yamada and Kasamatsu 1993; Liu et al. 1997; Liu et al. 
1999; Hiscox 2002). However the BFDV capsid protein is also likely to facilitate the 
movement of Rep into the nucleus as well. This is because recombinant BFDV Rep protein 
has been found to remain in the cytoplasm when it is expressed on its own in insect cells but 
can move to the nucleus only if it is co-expressed with BFDV capsid protein (Heath et al. 
2006). If this takes place naturally in susceptible avian cells, then BFDV capsid must be co-
expressed with BFDV Rep in the early viral replication stages to facilitate the delivery of Rep 
into the nucleus for the initiation of rolling circle replication. Many viral replication strategies 
do not require the synthesis of capsid proteins until late in replication but for others at least a 
small number of molecules of capsid protein are required to initiate replication of the genome 
(De Graaff et al. 1995; Jaspars 1999; Bol 2005) and BFDV is likely to replicate in a similar 
manner. 
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1.11 Genetic variation amongst BFDV isolates 
 
1.11.1 Observations in the current literature 
 
Ritchie et al. (1989b) initially determined that the BFDV genome was single stranded 
DNA, estimated to be 1.7 to 1.9 kb in size. Later, Bassami et al. (1998) determined a more 
accurate size of 1993 nucleotides (isolate termed BFDV-AUS, Genbank accession number: 
AF080560). Bassami et al. (2001) further compared eight novel isolates of BFDV (from blue 
bonnet, rainbow lorikeet, Major Mitchell’s cockatoo, sulphur-crested cockatoos, peach-faced 
lovebird, galah and Eastern long-billed corella) in Australia , to the BFDV-AUS isolate and a 
BFDV-USA isolate derived from pooled BFDV in the USA reported by Niagro et al. (1998). 
The eight isolates had genomes ranging between 1992 and 2018 nt and had an overall 
nucleotide similarity between 84 and 97% compared to the BFDV-AUS isolate. There was an 
80 to 90% nucleotide sequence identity of the ORF C1 between the eight Australian isolates 
studied by Bassami et al. (2001) and the earlier BFDV-AUS isolate. Seven ORFs were 
detected in the BFDV-AUS isolate. Of these, only three (ORF V1, ORF C1 and ORF 5) were 
consistently detected in all 10 isolates compared. The variations in these isolates were 
accounted for as point mutations and several deletions and insertions from 1 to 17 nucleotides 
in size which occurred in both coding and non-coding regions. The isolates were homologous 
in respects to location of; ORFs, hairpin structure, nonanucleotide motif, the three motifs in 
the Rep protein required for rolling circle replication (RCR), the P-loop motif and 
polyadenylation signal downstream of ORF V1 and ORF C1, and the octanucleotide motif 
downstream of the hairpin structure. One single bird however, a blue bonnet sampled in 
Western Australia, had a base substitution in the second octanucleotide motif (Bassami et al. 
2001).  
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The conclusions of this investigation were that the isolates could be clustered into 
four genetic clusters. However, the authors could not determine the significance of this 
finding. No evidence was found to suggest a relationship between regional distribution of 
isolates and genetic variation, nor did there seem to be any difference in pathogenicity, 
antigenicity or other physicochemical characteristics of PBFD and the genetic variance. 
Similarly, Ritchie et al. (1990) also described lack of antigenic variation amongst BFDV 
isolates from different genera of psittacine birds [sulphur-crested cockatoo, black palm 
cockatoo (Probosciger aterrimus), red-lored Amazon parrot (a.k.a yellow cheek Amazon, 
Amazona autumnalus) and peach-faced lovebird (Agapornis roseicollis)] in their early 
research.  
 
 Ritchie et al. (2003) conducted a study on BFDV isolates with samples obtained from 
25 psittacine birds of varying species from various locations in New Zealand. The species 
included rainbow lorikeet (Tricholglossus haematodus), red collared lorikeet (Trichoglossus 
haematodus rubritorquis), yellow-bib lorikeet  (Lorius chlorocercus), Goldie’s lorikeet 
(Trichoglossus goldiei), blue-streak lorikeet (Eos reticulata), Eastern long-billed corella, 
sulphur-crested cockatoo, turquoise parrot  (Neophema pulchella), Senegal parrot 
(Poicephalus senegalus) and budgerigar (Melopsittacus undulatus). Of the 25 birds, 21 were 
found positive for BFDV DNA. Within these positives, 17 new sequences (Genbank 
accession numbers AY148285 to AY148301) were detected and further aligned with 10 
BFDV reference sequences and 7 outgroup sequences. The sequences were aligned to the 
ORF V1, comprising 184 amino acid codons. No insertions or deletions were required to 
align the 27 BFDV sequences, but they did have unequal base frequencies and nucleotide 
substitutions biased towards transitions rather than transversions (A ↔ C = 0.65, A ↔ G = 
1.98, A ↔T = 0.54, C ↔ G = 0.64, C ↔ T = 3.58, relative to G → T = 1.0). Eighty four of 
the third positions and 20 of the first and second positions were polymorphic. The ratio of Chapter 1. Literature Review 
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non-synonymous changes per non-synonymous site to synonymous changes per synonymous 
site was estimated to 0.13. With the assumption that all synonymous substitutions are 
selectively neutral the investigators could not see any evidence for strong positive selection 
on this viral protein.  
 
The analysis by Ritchie et al. (2003) revealed that the New Zealand sequences formed 
3 distinct clades, each being associated with a group of psittacine species. One of these has 
close relationship (Figure 1.5) to the sulphur-crested cockatoo isolate described by Bassami 
et al. (1998) (referred to as the ‘cockatoo lineage’). Six of the New Zealand sequences, 
comprising four different sequences from sulphur-crested cockatoo and Eastern long-billed 
corella, could also be assigned to this lineage. Another lineage was identified from a single 
budgerigar sequence (referred to as the ‘budgerigar lineage’), and was found to be unique 
with closest ties to the galah-WA sequence (d = 0.0420 ± 0.0090) described by Bassami et al. 
(2001) (Accession number AF311298). The last lineage was identified from several species 
of lorikeet (rainbow lorikeets, red collared lorikeet, blue-streaked lorikeet and yellow-bib 
lorikeets). This lineage (‘lorikeet lineage’) was most closely related to the rainbow lorikeet 
sequence from Victoria described by Bassami et al. (2001). Among the 11 lorikeet lineage 
sequences found by Ritchie et al. (2003), there were eight different sequences, defined by 20 
polymorphic sites. The cockatoo and lorikeet reciprocal monophyly had a 100% bootstrap 
support for the basal node of the lorikeet lineage. 
 
Raue et al. (2004) conducted a nucleotide sequence analysis of 202 nucleotides of the 
ORF C1 of BFDV isolates from many different species of psittacine birds from different 
countries, including both new world and old world species. The sample set comprised 40 
newly determined sequences and 10 identical to published sequences. In the 40 new cases, 
classical clinical signs of PBFD had been reported in 12 cases, immune-suppression without Chapter 1. Literature Review 
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feather loss was reported in nine cases, 16 samples were from clinically healthy birds and the 
remaining three had no clinical report. There was an overall nucleotide similarity of 84.1 to 
100% and an 83.3 to 100% similarity of the inferred amino acid sequence between the 40 
novel sequences. No particular nucleotide sequence could be assigned to distinct bird species.  
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Figure 1.5 The neighbor-joining tree showing the phylogenetic relationships among circovirus 
sequences according to Ritchie et al. (2003). Grey areas indicate the clusters of sequences used to 
define the three BFDV lineages. Their names according to the group’s host species: CT = cockatoos; 
BG = budgerigar; and LK = lorikeets.  
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The compiled phylogenetic tree showed nine major branches and a number of minor 
branches. No particular nucleotide sequences could be allocated to particular avian species. A 
sequence from a budgerigar in Germany with severe clinical signs formed a separate branch. 
However, a viral DNA sequence originating from another budgerigar (also from Germany), 
clustered with sequences from a Forsten’s rainbow lorikeet (Trichoglosus haematodus 
forsteni) kept in Spain. These two sequences had 89.7% nucleotide identity and 92.9% 
deduced amino acid identity. The deduced amino acid sequence alignment showed that the 
amino acid changes were not distributed randomly. Of 42 amino acid positions, five showed 
high heterogeneity, with only four or five different amino acid at these five positions. None 
of these amino acid differences can be assigned to a single bird species (Raue et al. 2004).  
 
Six viral DNA sequences; two from African grey parrots (one from Germany and one 
from Hong Kong), one blue-headed rainbow lorikeet (Trichoglossus haematodus 
caeruleiceps, Spain), one red-breasted parakeet (Psittacula alexandri, Spain), one peach-
faced lovebird (Australia) and a rainbow lorikeet (Australia) were reported to have amino 
acid substitutions not found in the other sequences. Both African grey parrots had atypical 
clinical signs, whereas the blue-headed rainbow lorikeet and red-breasted parakeet showed no 
clinical signs of infection as apposed to the peach-faced lovebird and rainbow lorikeet which 
had classical lesions.  
 
Three Forsten’s rainbow lorikeets (Trichoglossus haematodus forsteni) from a single 
aviary flock in Spain grouped together in a separate branch of the phylogenetic tree. All three 
had classical clinical signs of infection, but all three survived with full regeneration of 
feathers and were free of virus after one year. In contrast a clinically healthy blue-headed Chapter 1. Literature Review 
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rainbow lorikeet, housed in the same aviary, had a isolate that clustered elsewhere. Further, 
the three isolates from Forsten’s rainbow lorikeets all showed the same amino acid 
substitution at positions 175 (T→N) and 186 (N→S). This feature was not found in any other 
isolate examined. The authors believe this could mean that an individual BFDV genotype 
may cause a distinct clinical picture in lories and that these species are also susceptible to 
other BFDV isolates/genotypes. 
 
Seven of 10 African grey parrots included in this study, had an ‘atypical’ disease 
progression, characterised by severe immune-suppression and died without classical clinical 
signs of PBFD. Two of the remaining three had severe feather abnormalities and the final 
bird had an unknown history. The seven immune-suppressed individuals clustered in different 
branches of the compiled phylogenetic tree. The three other birds however, clustered together 
on a minor branch and had been obtained from different aviaries in different years. Raue et 
al. (2004) believe this disease progression could be associated with the BFDV isolate found 
in these birds. 
 
Later, de Kloet and de Kloet (2004) conducted a study on the phylogenetic 
relationship of 15 complete BFDV nucleotide sequences and 43 putative capsid protein 
encoding DNA sequences. The material stemmed from 39 individuals of 16 species, 
including cockatoos, African grey parrots and peach-faced lovebirds. The samples came from 
birds infected in different geographical regions from Australia and other countries. The 
investigators found that the predicted amino acid sequences of the ORF C1 encoded capsid 
protein were highly diverse with up to 50 of the 250 amino acids different between isolates 
from a rainbow lorikeet and a Major Mitchell’s cockatoo. Their phylogenetic analysis (Figure 
1.6) revealed six clusters and a varying degree of host species specificity; isolates from Chapter 1. Literature Review 
26 
 
African grey parrots all clustered together and likewise did the isolates infecting cockatoo 
species. In respect to species specificity, the peach-faced lovebird isolates showed the 
opposite characteristic, clustering with isolates infecting Australasian species like eclectus 
parrot (Eclectus roratus), ring-necked parakeet (Psittacula kramerii) and blue bonnet.  
 
Further, de Kloet and de Kloet (2004) determined the complete genome sequence of 
five novel isolates from the following species and locations: Ring-necked parakeet (Texas), 
African grey parrot (Germany, Portugal and UK), and peach-faced lovebird (UK). These 
were further aligned with complete sequences reported by Bassami et al. (2001). The 
resulting phylogenetic distribution can be viewed in Figure 1.7. 
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Figure 1.6 Neighbour joining tree illustrating the phylogenetic distribution of 43 BFDV isolates 
based on the ORF C1 sequence by de Kloet and de Kloet (2004). 0 = no clinical signs, 1 = 
chronic/classical signs with feather loss, 2 = acute clinical presentation (no feather loss), U = 
unknown clinical history, a resp b indicates that the sequences were obtained from the same bird, c 
resp d = birds were from same aviary. Roman numerals denote the six clusters. UK = United 
Kingdom, GE = Germany, JAP = Japan, PR: Puerto Rico, ISR = Israel, TX = Texas (USA), US = 
USA, AUS = Australia, FL = Florida (USA), POR = Portugal, SAU = Saudi Arabia, NZ = New 
Zealand, IND = India. 
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Figure  1.7  Neighbour joining tree illustrating the phylogenetic distribution of 15 BFDV isolates 
based on the complete genome sequence by de Kloet and de Kloet (2004). The tree is adopted from de 
Kloet and de Kloet (2004).  
 
Their genome sizes were within the ranges previously reported (from 1989 nucleotides in 
African grey parrot from Portugal to 2019 nucleotides in peach-faced lovebird from the UK) 
and sequence elements found to be conserved in other isolates, for example the previously 
mentioned nonanucleotide motif, were conserved in the five new sequences. Another 
interesting element is a stretch of 31 nucleotides starting at approximately nucleotide 1150, 
with a 97% GC content, was also found to be conserved in the new isolates as well as 
previously described isolates. An exception however, was the sequence PK01-1TX from a 
Ring-necked parakeet in Texas. This isolate had a unique deletion of the 22 nucleotides long Chapter 1. Literature Review 
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segment:  ACC GCA GCC ATT GGC TGC ATT G, found between nucleotides 22 and 44 of 
the PEG07-1GE sequence.  This sequence was predicted by de Kloet and de Kloet (2004) to 
form the majority of a second variable hairpin structure adjacent to the previous hairpin. 
 
The authors also reported frequent trinucleotide indels (insertions or deletions). These 
were prominent between nucleotide 1850 and 2000. Tentative protein coding sequence 
analysis revealed that the ORF V1 was conserved in all isolates. ATG was used as initiation 
codon by all and TGA as termination in most cases. The African grey parrot isolate PEP01-
1POR showed an amino acid deletion at position 259. This position showed little 
conservation between the other isolates.  
 
The capsid protein encoding ORF C1 was in almost all sequences described by de 
Kloet and de Kloet (2004) terminated by two adjacent TAA codons. However, a reoccurring 
problem with the ORF C1 sequence is the frequent absence of the most commonly observed 
start codon (ATG), and thus ORF C1 is normally identified by the flanking termination 
codons. These occur in different locations, often the result of small indels causing open 
reading frame-shifts in this element. Alternative start codons (e.g. CTG, TTG, GTG) have 
been documented (de Kloet and de Kloet 2004)  and occur upstream of the N-terminal. 
Additionally, initiation close to this site is implicated by the highly conserved sequence 
element ACC GCC GCC, which carries a strong Kozak content. Kozak elements are thought 
to play an important role in initiation of translation in eukaryotes (Griffiths et al. 1999). 
 
No other ORFs reported in BFDV were entirely conserved among the analysed 
isolates. ORF 4 (Figure 1.3) overlaps with the ORF 6 and is found in many isolates (de Kloet 
and de Kloet 2004).  In a isolate (PEP01-1POR) from an African grey parrot (Portugal), ORF Chapter 1. Literature Review 
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4 contains three termination codons. ORF3 on the complimentary strand was detected in the 
five isolates sequenced for this study. In one isolate (A. roseicollis AUS) from a peach-faced 
lovebird the termination codon for this element was located in a different position than in the 
other isolates. These two latter ORFs did not show any relationship to any other entries in the 
database. 
 
A phylogenetic analysis was conducted of 15 complete sequences (Figure 1.7). The 
analysis showed that the ring-necked parakeet isolate from Texas (PK01-TX) and lovebird 
isolate from the UK (AR02-1UK) clustered with blue bonnet and peach-faced lovebird from 
Australia (bootstrap support 100) and separately from cockatoos and a rainbow lorikeet from 
Australia. These four isolates were the only ones to possess an indel between nucleotides 
1195 and 1196 as compared to the PE07-1GE sequence from a African grey parrot in 
Germany. 
 
In their analysis, all cockatoos clustered together and within the cluster were two 
secondary clusters (Figure 1.7). One consisted of Australian isolates from sulphur-crested 
cockatoo and Major Mitchell’s cockatoo (C. galerita 2 AUS and C. leadbeaterii AUS, 
respectively), the other consisted of the Australian isolates from sulphur-crested cockatoo (C. 
galerita 1 AUS and C. galerita 3 AUS), Eastern long-billed corella (C. tenuirostris AUS), 
galah (E. roseicapillus AUS) and an unidentified Psittaciforme from the USA (psittacine X). 
A sequence determined from a blue-headed rainbow lorikeet was according to the authors, 
remotely related to the other isolates examined. Isolate sequences from African grey parrot 
(PEG07-1GE and PEU01-1UK) aligned with a bootstrap support of 85% with the sequences 
from ring-necked parakeet, blue bonnet and peach-face lovebird and with a 76% bootstrap 
support with the cockatoos. Chapter 1. Literature Review 
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The analysis by de Kloet and de Kloet (2004) also showed average distance of the 
ORF V1 was lower than the sequence of ORF C1. Strongly suggesting selection as a 
evolutionary pressure of these elements, the average non-synonymous/synonymous mutation 
ratio was 0.37 for ORF C1 and 0.17 for ORF V1. 
 
de Kloet and de Kloet (2004) determined the sequence of the ORF C1 from isolates of 
27 different birds representing 16 species. Amongst these; 10 were from African grey parrots 
and five from peach-faced lovebirds, infected at different geographical locations across the 
globe. The phylogenetic relationship between the new and previously published sequences, in 
all 43 sequences derived from 39 infected individuals belonging to 19 psittacine species, was 
further examined.  
 
Up to 115 nucleotides interspecific differences were found between for example the 
sequences derived from rainbow lorikeet and Major Mitchell’s cockatoo. A neighbour joining 
tree of the compared sequences showed six clusters (97% minimum bootstrap support). 
Figure 1.6 shows the isolates belonging to each cluster based on ORF C1 according to de 
Kloet and de Kloet (2004) and the clinical signs observed in each infection.  
 
In the study by de Kloet and de Kloet (2004), several sequences of clones were 
determined from an individual bird and used as a measure of intra-individual sequence 
variation. An African grey parrot from Germany provided three sequences: P. erithacus 7GE, 
73GE and 74GE. However, these sequences were virtually identical (max dist = 
0.014±0.0014, using the Tajima-Nei model). According to the authors, this corresponds to 
one or two different nucleotides, or at most one amino acid. These three sequences also had Chapter 1. Literature Review 
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high sequence identity (data were not given) with sequences obtained from blue-fronted 
amazon parrot (A. aestiva) (sequences A. aestiva GE and 102GE) housed together with an 
African grey parrot (sequence Psittacus erithacus7GE) and with African grey sequences from 
other aviaries in Germany (Psittacus erithacus2GE and Psittacus erithacus1GE) and with the 
African grey parrots from India and Japan. Clones selected at random from African grey 
parrot in Portugal (POR, 11POR, 16POR) were found to be much more divergent with a 
(max dist = 0.0480±0.0081), corresponding to 30 nucleotides (equivalent to 10 amino acids). 
 
The most recent investigation into genetic diversity of BFDV (Shearer et al. 2008a) 
found that BFDV isolated from a cockatiel was serologically and genetically different to 
other BFDV isolates. This is the first paper to report evidence of an antigenically distinct 
BFDV in psittacine birds. 
 
1.11.2 Discussions of the observations on BFDV genetic variation 
 
PBFD has been described in more than 40 psittacine species (Gerlach 1994). In early 
BFDV research, Ritchie et al. (1990) demonstrated the ultrastructural, protein composition 
and antigenic similarity of BFDV isolated from four genera of psittacine birds. Bassami et al. 
(2001) could not demonstrate any evidence to suggest a relationship between genetic 
variation and regional isolate distribution. Neither did they find any differences in 
pathogenicity, antigenicity or other physiochemical characteristics between isolates.  
 
However, the conclusions drawn by Ritchie et al. (2003) indicate a possibility of 
specificity of BFDV isolates among avian hosts. No evidence of adaptive selection was found 
using the McDonal-Kreitman test and there was no variation in the substitution rate (using 
likelihood ratio test) which might be expected if different selective pressures were exerted on Chapter 1. Literature Review 
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different isolates (Ritchie et al. 2003). Subdivision of BFDV and a genotypic association with 
psittacine species were however evident in their phylogenetic analysis. Inter-lineage 
substitution rate was invariant and believed to indicate possible different selective pressures 
exerted on different isolates.  
 
The host immune system and the effects of random genetic drift after isolation on 
different host species were cited as possible selective pressures. Random genetic drift refers 
to the statistical drift over time of allele frequencies in a finite population due to the effects of 
random sampling in the formation of following generations. Natural selection on the other 
hand causes a higher representation of beneficial alleles and lower representation of 
detrimental ones in the population. The stochastic process of ‘random genetic drift’ is the 
tendency of the frequency of any allele to vary over time. This is purely caused by statistical 
variation, which has no preferred direction as long as it does not comprise the entire or none 
of the distribution (Griffiths et al. 1999). In regards to virus populations, such “drift” may 
occur by two mechanisms; the random sampling of wild-type and mutant virions per infected 
cell generation and random sampling of virions transmitted to the next host (Ritchie et al. 
2003). 
 
Single stranded DNA viruses exhibit large amounts of intraspecific sequence 
variation, as seen in the population of the human infecting circovirus ‘TT virus’. A study on 
this virus showed three lineages spread throughout the human population (Desai et al. 1999). 
If a large population size is maintained over a long period of time and/or if there is a high 
mutation rate, a high level of genetic diversity can occur (Ritchie et al. 2003). Thus such 
changes are likely to occur due to the large population size of BFDV. 
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Additionally, single stranded DNA does not form a double helix structure (as double 
stranded DNA does) and therefore lack the protection conferred by such a helix. Thus 
nucleotides of single stranded DNA molecules are more prone to deamination (especially 
cytosine resulting in a uracil nucleotide causing a C→T transition, adenine deamination 
causes a A→G transition) by factors of the environment in which the DNA is located 
(Lindahl and Nyberg 1974). Thus it may be inferred that single stranded DNA genomes, like 
the BFDV genome may have a high mutation rate relative to double stranded DNA genomes 
because of lacking double helix [reviewed in Ritchie et al. (2003)]. On the other hand, DNA 
repair mechanisms such as ‘base excision repair’, ‘nucleotide excision repair’ and ‘mismatch 
repair’ may counteract these forces. 
 
Raue et al. (2004) conducted their analysis using 202 nucleotides of the ORF C1. This 
ORF codes for the capsid protein, and should be of particular interest, as variation of this 
sequence amongst species may indicate virus-host interactions and selective pressures exerted 
by the host immune system. Such an assumption is supported by the high variability of this 
sequence demonstrated between isolates and the lower variability of the ORF V1 (Raue et al. 
2004). Their phylogenetic analysis disagreed with that of Bassami et al. (2001), who 
proposed four genetic clusters. This disagreement could be expected, as the sample set used 
by Raue et al. (2004) was much larger, had a more diverse species selection and also 
comprised samples from many geographic locations. In contrast Bassami et al. (2001) only 
had nine sequences from Australia and a sequence compiled from a pooled virus isolates 
from unknown species in the USA by Niagro et al. (1998). Further differences may have 
arisen as Bassami et al. (2001) used the entire virus genome for their analysis, whereas Raue 
et al. (2004) only utilised a fragment of the ORF C1. 
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de Kloet and de Kloet (2004) conducted phylogenetic analysis of 15 complete 
nucleotide sequences and 43 ORF C1 sequences. Like earlier reports, several different 
isolates of BFDV were found. Complete genome sequences studied showed little difference 
in size (1989-2019 nucleotides). On the other hand, the length of sequence between the ORF 
C1 and ORF V1 between isolates did vary significantly. One isolate (PK01-1TX) from a 
ring-necked parakeet (Texas) was found to have a 22 nucleotide deletion in this region (ACC 
GCA GCC ATT GGC TGC ATT G) corresponding to nucleotides 22 to 44 of Psittacus 
erithacus PEG07-1GE.  This element is involved in the formation of a hairpin structure, seen 
as different forms in many BFDV isolates. This deletion has not been reported for any other 
isolate. However, the sequence element TGA CCA CTT GTA AAG GAA is found in several 
isolates. It is found as an insert between nucleotides 1195 and 1196 of the Psittacus erithacus 
PEG07-1GE isolate in the isolate PK01-1TX (ring-necked parakeet, Texas) and with small 
modifications in the isolate P. haemogaster AUS and in both peach-faced lovebird isolates. 
Sequences from cockatoos, African grey parrot and the loriids on the other hand did not have 
this element, an observation also made in the study by Bassami et al. (2001). The frequent 
insertion of this element in the isolates from the former species suggests that the loss or gain 
of this element may have occurred after the BFDV isolates infecting the former species and 
the isolates infecting the cockatoo, rainbow lorikeet and African grey parrot diverged and that 
the exceptional deletion in the ring-necked parakeet isolate occurred at a more recent time. 
 
Phylogenetic analysis based on the ORF C1 (de Kloet and de Kloet 2004) resulted in 
six clusters and suggests the existence of some psittacine species or subfamily specificity. 
Phylogenetics based on the capsid protein encoding ORF is interesting as it could be expected 
that possible species specificity could be mediated by this structure. The ability of non-
enveloped viruses to enter cells is mediated by viral capsid epitopes binding to cell surface Chapter 1. Literature Review 
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receptors (Flint et al. 2000). Thus it is reasonable to expect that some viral adaptations to 
species differences could lie within this structure; if the cell receptor required for virus entry 
is significantly different between species, which is a justifiable assumption. Similarly, clinical 
manifestations could also be associated with this structural protein by allowing or not 
allowing virus entry to specific tissue cell types. 
 
Previous reports using a segment of ORF V1 (Ritchie et al. 2003) and reports utilizing 
the entire genome (Bassami et al. 2001) for analysis agree with the findings of  de Kloet and 
de Kloet (2004). Raue et al. (2004) on the other hand did not find a distinct pattern of 
sequence diversity, most likely due to only utilizing a fragment of the ORF C1. 
 
In almost all cases studied by de Kloet and de Kloet (2004), isolates clustering 
together on the basis of ORF C1 were from birds with the same types of lesions and birds of 
the same species generally clustered together, but not always (Figure 1.6). The remaining 
either had an unknown clinical history or had no clinical signs at all. In this study and in an 
earlier study (Bassami et al. 2001) isolates from cockatoos formed two clusters (clusters III 
and V, Figure 1.6). There was notable divergence (up to 50 amino acid differences) between 
the two clusters and to isolates infecting other species. Interestingly all isolates in the two 
clusters were associated with chronic lesions. The only two rainbow lorikeet samples 
included in this study clustered together and separately from isolates of other species, In 
agreement with earlier reports (Ritchie et al. 2003; Raue et al. 2004). The investigators found 
that most of the African grey parrot isolates clustered together (Figure 1.6, cluster VI) with 
little sequence variation even though many samples were from geographical locations remote 
to each other. In this cluster seven of 10 African grey parrot isolates were associated with 
acute clinical signs. The remaining three had unknown history. Differences between these Chapter 1. Literature Review 
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African grey parrot isolates, although from widespread geographical locations, were only a 
few amino acids in the capsid protein sequence as apposed to 50 amino acids in the 
cockatoos. Such small changes can according to the authors reflect the recent origin of this 
isolate in this species and the global trade of these birds (de Kloet and de Kloet 2004). 
 
One African grey parrot was infected with an isolate in cluster I and had no clinical 
signs. The final three African grey parrot samples used in this study were from Portugal. 
They formed a cluster with a Sun conure (Aratinga solstitialis) isolate and were from birds 
with acute disease signs (Figure 1.6, cluster II). These isolates were highly diverse with little 
relation to other isolates. Thus, like the cockatoos the African grey parrots appear to be 
susceptible to more than one isolate of BFDV (de Kloet and de Kloet 2004). 
 
Disease progression seems to be associated, at least in the cockatoos and African grey 
parrots, with the species of infected psittacine rather than the BFDV isolate infecting the 
species. This is because regardless of the isolate infecting individuals of the two species, 
cockatoos always had classical signs of infection and the African grey parrots always had 
acute signs (de Kloet and de Kloet 2004). 
 
Cluster I (Figure 1.6) consisted of all isolates isolated from peach-faced lovebird 
(Australia, UK and USA), ring-necked parakeet (from Texas), blue bonnet (from Australia), 
A. militaris (Florida) and E. roratus (Florida). This cluster also included isolates E. 
roseicapillus ISR (Israel) and an African grey parrot (Puerto Rico), species that seem to be 
more commonly infected with isolates clustering in cluster VI. Thus it seems that at least the 
cockatoos and African grey parrots are not limited to infections by one isolate of BFDV. Chapter 1. Literature Review 
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Similarly, the major African grey parrot isolates appear to be able to infect other species as 
well (Figure 1.6) (de Kloet and de Kloet 2004). 
 
de Kloet and de Kloet (2004) also conducted phylogenetics on the entire genome of 
BFDV isolates (Figure 1.7). As in the ORF C1 analysis, it was found that cockatoo, blue 
bonnet, ring-necked parakeet, peach-faced lovebird isolates and a lorie isolate had unique 
genotypes forming their own branches (Figure 1.7). Although African grey parrot infecting 
isolates appear to be relatively unique (Figure 1.6), these isolates seem to have some 
relationship to the isolates infecting either the cockatoos or those infecting blue bonnet, ring-
necked parakeet, and peach-faced lovebird (Figure 1.7).  
 
The species peach-faced lovebird is phylogenetically likely to be closer to blue bonnet 
and ring-necked parakeet than to cockatoos as the Cacatuidae is a monophyletic group in the 
Psittaciformes. Therefore it could be expected that the peach-faced lovebird is susceptible to 
isolates infecting these related species. The phylogenetic characterization of African grey 
parrots is on the other hand unclear due to limited research on the species. However, the 
evidence that is available, suggests a remote relationship to the other psittaciformes, thus 
African grey parrots are likely to be susceptible to different isolates of BFDV (de Kloet and 
de Kloet 2004).  
 
In a recent report on BFDV genetic variation (Khalesi et al. 2005), the ORF V1 
sequence of BFDV isolates from seven lorikeets of the species rainbow lorikeet, musk 
lorikeet (Glossopsitta concinna) and red-collared lorikeet (T. haematodus rubritorquis), and 
two swift parrots (Lathamus discolor) was determined. The data were compared with 36 
previously published ORF V1 sequences from psittacine birds across the globe including Chapter 1. Literature Review 
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Australia, USA, UK, Germany, South Africa, Portugal, Austria and New Zealand. The 
determined nucleotide sequence identity was high (86-97%) and phylogenetic analysis 
favoured the theory of clustering of BFDV isolates from lorikeets and lories into a loriid 
genotype as first proposed by Ritchie et al. (2003). Khalesi et al. (2005) also showed for the 
first time that lorikeet derived BFDV isolates may be able to infect other psittacine species. 
 
In recent years there has been much debate in the literature over the existence of 
BFDV isolates genetically adapted to lorikeets and parrots (Ritchie et al. 2003; de Kloet and 
de Kloet 2004; Heath et al. 2004; Raue et al. 2004) and the emergence of species-specific 
BFDV genotypes in cockatoos, budgerigars, lorikeets and lovebirds. Findings by Khalesi et 
al. (2005) give further support for BFDV isolates adapted to lorikeets and lories, but also 
showed that BFDV isolates may not be entirely confined to the species they are adapted to 
and possibly transmit to other psittacine species. Raue et al. (2004) found evidence to support 
that the BFDV lineage infecting a psittacine bird may influences the disease progression. 
 
1.12 Aims of this PhD thesis 
 
The primary aim of this thesis was to investigate whether vaccination with recombinant 
BFDV capsid protein could protect psittacine birds against PBFD in experimental infection 
with BFDV. This aim was achieved as follows: 
1)  Acquisition of BFDV-free psittacine birds used as a study population, described in 
Chapter 3. 
2)  Identification and resolvement of issues associated with sample preparation for PCR 
testing in commonly utilized laboratory methodology that affects the outcome of test 
results (Chapter 4). In this Chapter, improved methodology that eliminates the Chapter 1. Literature Review 
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potential for false-positive PCR results was developed. This was necessary in order to 
obtain true PCR test results, thereby aiding correct PCR diagnosis of the study flock. 
3)  Testing for BFDV DNA and HI antibody in peripheral blood and HA antigen 
excretion in feathers before and after vaccination and challenge (Chapter 5). 
4)   Investigation of haematological values in vaccinated and non-vaccinated birds before 
and after challenge with live BFDV (Chapter 6).  
 
Chapter 2 describes an initial attempt to obtain a suitable flock of birds for this investigation. 
 Chapter 2. BFDV-free Agapornis 
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Chapter 2 : Attempts to obtain a BFDV-free 
flock of Agapornis 
 
 
2.1 Summary 
 
A major obstacle to the development of a vaccine to protect against PBFD is the 
acquisition of adequate numbers of BFDV-free psittacine birds to assess a candidate vaccine. 
The purpose of this experiment was to obtain a flock of psittacine birds without previous 
exposure to BFDV. Peach faced lovebirds (Agapornis  roseicollis) were identified as a 
commercially available psittacine bird that could be acquired in sufficient numbers. Samples 
of blood and feather were obtained from commercially available lovebirds and tested for 
BFDV DNA by PCR, antibodies to BFDV using HI assay and virus excretion in feathers 
using HA assay. Over an 8 month period, a total of 128 lovebirds were tested either one or 
more times, resulting in 244 blood samples and 76 feather samples that were PCR tested, 76 
feathers samples that were tested for BFDV excretion using HA and 222 blood samples that 
were tested for BFDV antibody using HI, to find birds that consistently tested negative. Birds 
that tested negative were purchased and housed in an indoors aviary or cages, where 
psittacine birds had not been kept previously and tested again. Of the 128 lovebirds, 67 had 
initial test that were negative in all three assays. However, all originally negative birds 
subsequently yielded positive PCR and/or HI results. These individuals may have been 
infected all along with viraemia induced by the stress of handling and relocation. In 
conclusion, purchasing birds from commercial sources is unlikely to result in a BFDV-free 
flock of Agapornis, due to the high prevalence of BFDV in such aviary flocks. Chapter 2. BFDV-free Agapornis 
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2.2 Introduction 
 
Currently, there is no commercially available vaccine to protect against infection with 
BFDV and subsequent development of clinical PBFD. Vaccination with inactivated BFDV 
isolated from the feathers of chronically infected sulphur-crested cockatoos, has been proven 
to induce production of antibodies that can be detected with HI assay and protect against 
development of PBFD in experimental BFDV infection (Raidal et al. 1993a; Raidal and 
Cross 1994a). However, a major hurdle to the development of a vaccine for BFDV is the 
availability of susceptible psittacine birds proven free of previous exposure to BFDV. This 
Chapter describes an approach to obtain a flock of BFDV-free psittacine birds that could be 
used to assess the immunogenic and protective properties of a candidate vaccine to protect 
against PBFD.  
 
Birds belonging to the genus Agapornis (“lovebirds”) were selected as they are known 
to be readily susceptible to PBFD infection (Kock et al. 1993; Trinkaus et al. 1998; Bert et al. 
2005) and are widely available from commercial outlets. Additionally, lovebirds reach sexual 
maturity in 8 to 12 months, a relatively early age for psittacine birds (Foster and Smith 2008). 
This would allow the study of vertical transmission of disease and the effect of vaccination in 
immature birds within a reasonable time period.  Chapter 2. BFDV-free Agapornis 
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2.3 Materials and methods 
2.3.1 Birds, samples and housing of purchased birds 
2.3.1.1 Birds and samples 
 
Samples of blood from peach faced lovebirds (Agapornis roseicollis) in a single large 
retail outlet were obtained by jugular venepuncture and samples of feather by plucking 
pinfeathers. The blood samples were spotted onto Whatman filter paper (No 3), dried at room 
temperature and then stored in individual zip lock bags at 4°C until use. The sampling took 
place from the 21
st of March to the 7
th of November 2005. The birds in the commercial outlet 
were kept in several medium large aviaries that had common fencing, containing 
approximately 30 individuals each, in a single shed with several other species of bird (quail 
(Coturnix spp.), finch (Erythrura spp.), budgerigar (Melopsittacus undulatus) and others). 
 
Sampled birds were placed temporarily in designated aviaries (up to 31 lovebirds in 
the aviary) or small cages (maximum three per cage). The birds were marked with a 
permanent marker (Staedtler, Lumocolor permanent marker) or ring tagged to distinguish 
individuals.   
 
The aviaries were in the previously mentioned shed and the cages were in the 
commercial outlet main building approximately 30-40 metres from other birds in well-
ventilated conditions. The other birds included species such as sulphur crested cockatoo 
(Cacatua galerita), eclectus parrot (Eclectus roratus), cockatiel (Nymphicus hollandicus), 
budgerigar, red-tailed black cockatoo (Calyptorhynchus banksii), princess parrot (Polytelis 
alexandrae). 
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2.3.1.2 Housing of purchased birds 
 
Birds, whose samples tested negative, were purchased and kept in an aviary, in an air-
conditioned room at Murdoch University. This room had not previously contained psittacine 
birds. Here the birds were tested again up to 8 times. Birds that became positive after 
purchase were removed from the room containing the other birds and to limit transmission to 
the aviary mates, the aviary and contents were disinfected with Bleach (42 g/L sodium 
hypochlorite, White King, SaraLee Household and Body Care, Pymble, NSW, Australia). 
Birds that incurred injuries were placed in a “sick room” and treated or euthanized by lethal 
overdose of barbiturate.  
 
2.3.2 DNA extraction and PCR 
 
PCR was performed on DNA isolated from dried blood spots (Khalesi 2007) and/or 
on DNA isolated from plucked feathers as follows: Dried blood spots were excised from the 
filter paper using a stationary hole puncher (One hole punch, Officeworks Superstores Pty 
Ltd, Box Hill, Vic, Australia), deposited into 1.5mL Eppendorf tubes and DNA extracted 
using the QIAamp DNA Blood Mini kit (QIAGEN, Australia) exactly according to the 
directions provided by the manufacturer.  
 
DNA was isolated from feathers by firstly cutting approximately 5 mm of feather 
calamus using a sterile scalpel blade, then washing the piece of feather in firstly 70% ethanol, 
then in sterile water. Subsequently, the feather was transferred to a microcentrifuge tube 
containing 500 mL of lysis solution (50 mM KCl, 10 mM tris-HCL (pH 8.0), 2.5 mM MgCl2, 
0.6% Tween 20, 0.5% Nonidet P4 and 250 μg/mL proteinase K) and incubated at 37°C for 1-
2 hr. The proteinase K was then heat inactivated at 95°C for 10 min and particulate mater Chapter 2. BFDV-free Agapornis 
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removed by centrifugation. DNA was then isolated from the supernatant fluid using a 
QIAamp spin column (QIAGEN, Australia) and elution conducted as with DNA isolated 
from dried blood. 
 
PCR was conducted according to previously described methodology (Ypelaar et al. 
1999) using forward primer ‘Pr2’ (5’-AACCCTACAGACGGCGAG-3’) and reverse primer 
‘Pr4’ (5’-GTCACAGTCCTCCTTGTACC-3’). Reactions consisted of: 2 μL of 25 mM 
MgCl2, 5 μL of 5×polymerase buffer, 0.12 μL of Tth polymerase (all Fisher Biotech, Western 
Australia), 12.8 ρmol of each primer, 2 μL of DNA extract and water-for-injection
 
(AstraZeneca, NSW, Australia)  added to a final volume of 25.12 μL. Reactions were 
subjected to the following conditions: 95°C for 5 min, then 32 cycles of 95°C × 30 sec, 60°C 
× 30 sec, 72°C × 1.5 min and finally 72°C for 10 min. PCR products were electrophoresed in 
a 1% agarose gel at 90V for 30 min and results visualized by UV transillumination.  
 
2.3.3 HI 
 
Anti-BFDV  HI antibody detection was performed on blood recovered from filter 
paper as described by Riddoch et al. (1996). Briefly, a dried blood spot was excised using a 
hole punch and deposited into 100μL of 5% acid washed kaolin in a 1.5mL micro centrifuge 
tube (Eppendorf). The blood was eluted for 1hr at room temp or overnight at 4°C. The tubes 
were then centrifuged briefly to pellet the kaolin and paper. Fifty microlitres of the 
supernatant was then transferred to 50μL of 10% galah erythrocytes and then allowed to 
hemadsorb at 4°C overnight. Then, 50μL of PBS was added to all wells of a 96 well U-
bottom microtitre plate. Chicken anti-BFDV serum was added to the first well of the second 
row (positive control) and 50 μL of each sample added to the first well of each subsequent 
row and serially diluted 1:2 across the row. Thereafter, 50 μL of BFDV solution was added to Chapter 2. BFDV-free Agapornis 
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all wells except the first row and 50μL BFDV to the last well of the first row and then titrated 
1:2 back to the first row (negative control). The plate was then incubated at 37°C for 1 hour. 
After incubation, 50μL of galah erythrocytes was added to all wells and the microtitre plate 
incubated at 37°C for 45-60mins. 
2.3.4 HA 
 
 HA testing was conducted on feather extracts according to the protocol developed by 
Raidal et al. (1993c). The feather extract was prepared by cutting approximately 5mm of 
feather stem using a sterile scalpel and dropped into 100 μL PBS in a 1.5 mL Eppendorf tube. 
Tubes were incubated for 60 min in a 60°C water bath and centrifuged for approx 5 s to 
clarify and 50 μL of the supernatant used as the feather extract. The HA was then carried out 
by first adding 50 μL of PBS to all wells of the U-bottomed micro titre plate. Then, 50 micro 
litres of stock BFDV solution was added to the first well of the second row of the micro titre 
plate (positive control row) and 50 μL of each feather extract transferred to the first well of 
the subsequent rows. The positive control and feather extracts were further diluted 1:2 across 
the plate and then, 50 μL of 10% galah erythrocytes added to all wells of the plate and finally 
the plate was incubated for 60 min at 37°C. The first row was the negative control row and 
only received PBS and galah erythrocytes. Chapter 2. BFDV-free Agapornis 
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2.4 Results 
2.4.1 PCR, HI and HA 
 
All PCR, HI and HA results are presented in Tables 1-7. In the first batch of 31 
lovebirds that were tested (Table 1), 5 birds tested negative for BFDV DNA, BFDV-antigen 
and BFDV-antibody. These birds were purchased and housed at Murdoch University. 
Subsequently, these 5 birds were tested again (Table 1). Four of 5 birds tested PCR positive 
for BFDV DNA in peripheral blood and 4 of 5 were PCR positive for BFDV DNA in 
feathers. One of 5 had detectable BFDV antibody using the HI assay.  
 
Twenty new birds that were sampled all tested positive for BFDV DNA in peripheral 
blood (Table 2). Four of these birds where HI positive, 3 were HA positive and 1 tested 
positive for BFDV DNA in feather extract (Table 2). 
 
Another batch of 22 lovebirds tested entirely negative for BFDV antibody, DNA and 
antigen. On return, only 12 had retained their ring tags. These 12 were purchased and tested 
again (Table 3) but subsequently all tested positive for BFDV DNA in peripheral circulation.  
 
Twenty-two more lovebirds were tested for BFDV DNA in circulation and they all 
tested negative (Table 4). However, on return to purchase the birds, several had been sold, 
remaining birds had lost their ring tags and non-tested birds had been added to the aviary. 
Therefore, none of these were purchased. 
 
Several more birds initially tested negative for BFDV infection (Tables 5 and 6). 
However, further testing of these birds after purchase (Table 7) only found 1 bird that had 
consistently negative test results.  Chapter 2. BFDV-free Agapornis 
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In all, 244 blood samples and 76 feather samples from 128 lovebirds were tested for 
BFDV DNA using PCR, 76 feathers were tested for BFDV excretion using HA and 222 
blood samples were tested for BFDV HI antibody using HI, to find birds that consistently 
tested negative. Of the 128 lovebirds, 67 had initial test results that were negative in all three 
assays. However, retesting of birds with previously negative results inevitably yielded 
positive results in either PCR or HI or both after purchase. 
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Table 2.1  The results of HI, HA and PCR testing of samples collected from 31 lovebirds sampled at 
the commercial retail outlet and retesting of 5 birds that were purchased. As can be seen in the table, 6 
birds tested negative in HI, HA, PCR on feather DNA extract when sampled in the outlet.  One of 
these birds (no 28) had died on return and the 5 remaining birds were purchased. All 5 purchased 
birds had laboratory results indicating BFDV exposure at the second sample date and were discarded. 
Bird 
ID 
Sample 
date 
HI 
blood 
HA 
feather 
PCR 
feather 
PCR 
blood 
Test 
no 
Sample 
date 
HI 
blood 
HA 
feather 
PCR 
feather 
PCR 
blood 
Test 
no 
1 21.03.05 −  −  − +  1 
2 21.03.05 −  − + +  1 
3 21.03.05 +  −  − +  1 
4 21.03.05 −  −  − +  1 
5 21.03.05 −  −  − +  1 
6 21.03.05 −  −  − +  1 
7 21.03.05 −  −  − +  1 
8 21.03.05 − +  +  +  1 
9 21.03.05 −  − + +  1 
10 21.03.05  −  −  − +  1 
11 21.03.05  −  −  − +  1 
12 21.03.05  −  −  − +  1 
13 21.03.05  −  −  − +  1 
14 21.03.05  −  n/a n/a  −  1* 26.04.05  −  − + +  2
+ 
15 21.03.05  −  −  − +  1 
16 21.03.05  −  −  − +  1 
17 21.03.05  −  n/a n/a  −  1* 26.04.05  −  −  − +  2
+ 
18 21.03.05 n/a  −  −  n/a 1 
19 21.03.05  −  −  − +  1 
20 21.03.05  −  −  − +  1 
21 21.03.05  −  −  − +  1 
22 21.03.05  −  −  − +  1 
23 21.03.05  −  −  − +  1 
24 21.03.05  +  −  − +  1 
25 21.03.05  −  −  −  −  1* 26.04.05  −  − + +  2
+ 
26 21.03.05  −  −  −  −  1* 26.04.05 n/a  − + +  2
+ 
27 21.03.05  −  −  − +  1 
28 21.03.05  −  −  −  −  1† 
29 21.03.05  −  −  −  −  1* 26.04.05  +  −  −  −  2
+ 
30 21.03.05  + +  −  −  1 
31 21.03.05  −  −  − +  1 
−    negative (no PCR amplification or <20 HI or HA U/50μL).   
+    positive (PCR positive or >20 HI or HA U/50μL).  
n/a    not available  
*    purchased  
†    dead on return 
+  
   removed from flock 
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Table 2.2 HI, HA and PCR testing of 20 lovebirds sampled at the commercial retail outlet. All these 
birds were positive for BFDV DNA in blood and some positive in HI, HA and PCR on feather extract. 
None of these birds were considered appropriate for a vaccination. 
Bird ID  Sample 
date 
HI 
blood 
HA 
feather 
PCR 
feather 
PCR 
blood  Test no 
32 04.04.05 − + − + 1 
33 04.04.05 −  −  − + 1 
34 04.04.05 −  −  − + 1 
35 04.04.05 +  −  − + 1 
36 04.04.05 +  −  − + 1 
37 04.04.05 −  −  − + 1 
38 04.04.05 −  −  − + 1 
39 04.04.05 −  −  − + 1 
40 04.04.05 −  −  − + 1 
41 04.04.05 −  −  − + 1 
42 04.04.05 +  −  − + 1 
43 04.04.05 −  −  − + 1 
44 04.04.05 −  −  − + 1 
45 04.04.05 − + + + 1 
46 04.04.05 −  −  − + 1 
47 04.04.05 − + + + 1 
48 04.04.05 −  −  − + 1 
49 04.04.05 −  −  − + 1 
50 04.04.05 −  −  − + 1 
51 04.04.05 +  −  − + 1 
 
−  negative (no PCR amplification or <20 HI or HA U/50μL)  
+  positive (PCR positive or >20 HI or HA U/50μL)  
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Table 2.3 HI, HA and PCR testing of feather and blood collected from 22 lovebirds at the commercial 
outlet (09.05.05) and PCR testing for BFDV DNA in peripheral circulation in lovebirds that 
previously tested negative and had retained ring tags (23.05.05, 07.06.05 and 19.07.05, overleaf). 
Bird 
no 
Sample 
date 
HI 
blood 
HA 
feather 
PCR 
feather 
PCR 
blood  Test no  Sample 
date 
PCR 
blood  Test no 
52 09.05.05  n/a  −  −  −  1* 23.05.05  −  2 
53 09.05.05  n/a  −  −  −  1* 23.05.05  −  2 
54 09.05.05  −  −  −  −  1* 23.05.05  −  2 
55 09.05.05  −  −  −  −  1" 
56 09.05.05  −  −  −  −  1" 
57 09.05.05  n/a  −  −  −  1" 
58 09.05.05  n/a  −  −  −  1" 
59 09.05.05  −  −  −  −  1* 23.05.05  −  2 
60 09.05.05  −  −  −  −  1* 23.05.05  −  2
† 
61 09.05.05  n/a  −  −  −  1" 
62 09.05.05  n/a  −  −  −  1* 23.05.05  −  2 
63 09.05.05  −  −  −  −  1" 
64 09.05.05  n/a  −  −  −  1" 
65 09.05.05  −  −  −  −  1" 
66 09.05.05  n/a  −  −  −  1" 
67 09.05.05  n/a  −  −  −  1* 23.05.05  −  2 
68 09.05.05  n/a  −  −  −  1* 23.05.05  −  2 
69 09.05.05  n/a  −  −  −  1* 23.05.05  +  2
+ 
70 09.05.05  −  −  −  −  1" 
71 09.05.05  n/a  −  −  −  1* 23.05.05  −  2 
72 09.05.05  n/a  −  −  −  1* 23.05.05  −  2 
73 09.05.05  n/a  −  −  −  1* 23.05.05  −  2 
−   negative (no PCR amplification or <20 HI or HA U/50μL) 
+  positive (PCR positive or >20 HI or HA U/50μL 
n/a not  available 
* purchased   
† died   
+ 
 removed from flock 
“ lost  ID 
 
 
 
Table 2.3 continued. 
Bird no  Sample 
date 
HI 
blood 
PCR 
blood  Test no  Sample 
date 
HI 
blood 
PCR 
blood  Test no  Bird no  Sample 
date 
HI 
blood 
PCR 
blood  Test no 
52 07.06.05  -  −  3 19.07.05 + + 4
+ 52  01.08.05  + + 5 
53 07.06.05 n/a  −  3 19.07.05  n/a  +  4
+ n/a  01.08.05  + + 5 
54 07.06.05 n/a  −  3 n/a  n/a  n/a  n/a  54 01.08.05 − + 4 
n/a 01.08.05  − +  2 or 3 
n/a 01.08.05  + +  2 or 3 
n/a 01.08.05  −  −  2 or 3 
n/a 01.08.05  − +  2 or 3 
59 07.06.05 n/a  −  n/a  n/a  n/a  n/a  n/a  59 01.08.05 + + 4 
     n/a 01.08.05  − +  2 or 3 
n/a 01.08.05  − +  2 or 3 
62 07.06.05 n/a  −  3 19.07.05  n/a  −  4 62  01.08.05  − + 5 
n/a 01.08.05  − +  2 or 3 
n/a 01.08.05  + +  2 or 3 
n/a 01.08.05  − +  2 or 3 
n/a 01.08.05  − +  2 or 3 
67 07.06.05 n/a  +  3" 19.07.05 n/a  −  4 67  01.08.05  − + 5 
68 07.06.05 n/a  +  3" 19.07.05 n/a  −  4" 68  01.08.05  + + 5 
69 07.06.05 n/a  +  3" 19.07.05 n/a  +  4
+ n/a  01.08.05  − + 5 
n/a 01.08.05  − +  2 or 3 
71 07.06.05 n/a  −  3 19.07.05  n/a  +  4
+ n/a  01.08.05  − +  2 or 3 
72 07.06.05 n/a  −  3 19.07.05  n/a  −  4" n/a  01.08.05  − + 5 
73 07.06.05 n/a  −  3 19.07.05 +  −  4
+ n/a  01.08.05  − + 5 
−; negative (no PCR amplification or <20 HI U/50μL).  +; positive (PCR positive or >20 HI or HA U/50μL. n/a; not available. *; purchased. 
+;
 
removed from flock. “; the bird had lost it’ ring-tag. 
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Table 2.4. PCR testing for BFDV DNA on peripheral blood collected from 22 lovebirds at the 
commercial outlet. All these birds tested negative, however on return to purchase the birds, several 
had been sold, remaining birds had lost their tags and non-tested birds had been added to the aviary. 
Therefore, none of these were purchased and new sampling was conducted (Table 6). 
Bird no  Date  PCR blood  Test no 
74 23.05.05  −  1 
75 23.05.05  −  1 
76 23.05.05  −  1 
77 23.05.05  −  1 
78 23.05.05  −  1 
79 23.05.05  −  1 
80 23.05.05  −  1 
81 23.05.05  −  1 
82 23.05.05  −  1 
83 23.05.05  −  1 
84 23.05.05  −  1 
85 23.05.05  −  1 
86 23.05.05  −  1 
87 23.05.05  −  1 
88 23.05.05  −  1 
89 23.05.05  −  1 
90 23.05.05  −  1 
91 23.05.05  −  1 
92 23.05.05  −  1 
93 23.05.05  −  1 
94 23.05.05  −  1 
95 23.05.05  −  1 
−; negative (no PCR amplification). 
  Chapter 2. BFDV-free Agapornis 
54 
 
 
 
 
Table 2.5 HI and PCR testing of blood collected from 16 lovebirds at the commercial outlet and 
retesting of 4 lovebirds that had tested negative. 
Bird No  Sample 
date 
HI 
blood 
PCR 
blood  Test no  Sample 
date 
HI 
blood 
PCR 
blood  Test no 
96 09.06.05 − + 1
+ 
97 09.06.05 − + 1
+ 
98 09.06.05 − + 1
+ 
99 09.06.05 −  −  1* 18.07.05 n/a  −  2
t 
100 09.06.05  −  −  1* 18.07.05 n/a  −  2
t 
101 09.06.05  − + 1
+ 
102 09.06.05  − + 1
+ 
103 09.06.05  −  −  1* 18.07.05 n/a  −  2
t 
104 09.06.05  −  −  1* 
105 09.06.05  − +  1* 
106 09.06.05  − + 1
+ 
107 09.06.05  − + 1
+ 
108 09.06.05  −  −  1* 18.07.05 n/a  −  2
t 
109 09.06.05  − + 1
+ 
110 09.06.05  − + 1
+ 
111 09.06.05  − + 1
+ 
 
−  negative (no PCR amplification or <20 HI U/50μL) 
+  positive (PCR positive or >20 HI or HA U/50μL 
n/a not  available   
* purchased 
+  removed from flock 
t   further test result in Table 7Chapter 2. BFDV-free Agapornis 
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Table 2.6 PCR and HI results of samples collected from 17 lovebirds at the commercial 
outlet. Thirteen of these birds were purchased and further tested. 
Bird No  Sample 
date  HI  PCR 
blood  Test No 
112 18.07.05  n/a  −  1*
t 
113 18.07.05  +  −  1 
114 18.07.05  n/a  −  1*
t 
115 18.07.05  n/a  −  1*
t 
116 18.07.05  n/a  −  1*
t 
117 18.07.05  n/a  −  1*
t 
118 18.07.05  n/a  −  1*
t 
119 18.07.05  n/a  −  1*
t 
120 18.07.05  n/a  −  1*
t 
121 18.07.05  +  −  1 
122 18.07.05  n/a  −  1*
t 
123 18.07.05  n/a  −  1*
t 
124 18.07.05  −  −  1*
t 
125 18.07.05  +  −  1 
126 18.07.05  n/a  −  1*
t 
127 18.07.05  +  −  1 
128 18.07.05  −  −  1*
t 
 
−  negative (no PCR amplification or <20 HI U/50μL) 
+  positive (PCR positive or >20 HI or HA U/50μL 
n/a not  available 
* purchased   
t  further test result in Table 7  
 
 
Table 2.7  PCR and HI testing of 24 lovebirds that had been acquired from the commercial outlet because they had previously tested BFDV negative. 
As can be seen in the table, only 5 lovebirds (67301B6, 682F205, 682C317, 682E902 and 682DF42) tested negative for BFDV DNA and BFDV-
antibody in circulation. However, only one of the birds (682F205) tested consistently negative. 
Microchip  Old bird ID  Sample date  HI  PCR blood  Test no  Sample date  HI  PCR blood  Test no  Sample date  HI  PCR blood  Test no 
682DABA 52  05.09.05  +  −  6 10.10.05  +  −  7 07.11.05  + +  8
‡ 
682EE1F 53  05.09.05  + +  6 10.10.05  + +  7 07.11.05  +  −  8 
67301B6 54  05.09.05  −  −  5 10.10.05  − +  6 07.11.05  −  −  7 
682BF0B n/a  05.09.05  − + 3 or 4  10.10.05  − + 4 or 5  07.11.05  − + 5 or 6 
6730646 n/a  05.09.05  + + 3 or 4  10.10.05  + + 4 or 5  07.11.05  +  −  5 or 6 
682F546 n/a  05.09.05  +  −  3 or 4  10.10.05  +  −  4 or 5  07.11.05  +  −  5 or 6 
6730172 n/a  05.09.05  − + 3 or 4  10.10.05  − + 4 or 5  07.11.05  − + 5 or 6 
6739B77 59  05.09.05  +  −  5 10.10.05  + +  6 07.11.05  + +  7 
672F9C7 n/a  05.09.05  − + 3 or 4  10.10.05  − + 4 or 5  07.11.05  − + 5 or 6 
673248E n/a  05.09.05  + + 3 or 4  10.10.05  + + 4 or 5  07.11.05  + + 5 or 6 
682F205 62  05.09.05  −  −  6 10.10.05  −  −  7 07.11.05  −  −  8 
6739FDD n/a  05.09.05  + + 3 or 4  10.10.05  + + 4 or 5  07.11.05  + + 5 or 6 
67398DC n/a  05.09.05  +  −  3 or 4  10.10.05  +  −  4 or 5  07.11.05  + + 5 or 6 
682F04B n/a  05.09.05  + + 3 or 4  10.10.05  +  −  4 or 5  07.11.05  + + 5 or 6 
682C317 n/a  05.09.05  −  −  3 or 4  10.10.05  − + 4 or 5  07.11.05  −  −  5 or 6 
672F1D7 67  05.09.05  +  −  6 10.10.05  +  −  7 07.11.05  +  −  8 
672F048 n/a  05.09.05  − +  6 10.10.05  + +  7 07.11.05  +  −  8 
682F099 n/a  05.09.05  −  n/a 6  10.10.05  + +  7 07.11.05  + +  8 
682C440 n/a  05.09.05  − + 3 or 4  10.10.05  − + 4 or 5  07.11.05  − + 5 or 6 
67379DF n/a  05.09.05  − + 3 or 4  10.10.05  + + 4 or 5  07.11.05  + + 5 or 6 
682E902 n/a  05.09.05  −  −  6 10.10.05  +  −  7 07.11.05  +  −  8
† 
682E872 n/a  05.09.05  + +  6 10.10.05  +  −  7 07.11.05  +  −  8 
682E2DA n/a  05.09.05  + + 3 or 4  10.10.05  n/a  n/a  4 or 5  07.11.05  +  −  5 or 6 
682DF42 n/a  05.09.05  −  −  n/a 10.10.05  − +  n/a 07.11.05  −  −  n/a 
−; negative (no PCR amplification or <20 HI U/50μL).  +; positive (PCR positive or >20 HI U/50μL).  †; The bird was found dead. ‡; euthanized. n/a; not available. 
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2.5 Discussion 
 
This study pursued an approach to acquire a small flock of lovebirds that were free 
from BFDV infection. Samples of blood and feather were collected from commercially 
available lovebirds and tested for BFDV infection using PCR, HI and HA in the hope to 
develop a nucleus flock that was BFDV-free.  
 
Over an 8 month period, a total of 128 lovebirds were tested either one or more times, 
resulting in 244 blood samples and 76 feather samples that were PCR tested, 76 feathers 
samples that were tested for BFDV excretion using HA and 222 blood samples that were 
tested for BFDV antibody using HI, to find birds that consistently tested negative. Of the 128 
lovebirds, 67 had initial tests that were negative in all three assays. However, retesting of 
birds with previously negative results yielded positive results in all birds except one in either 
PCR or HI or both after purchase. 
 
Unsatisfactory control of birds during the period from sampling in commercial 
aviaries to purchasing caused complications for a number of reasons.  Loss of identity was a 
problem for many individual birds. Firstly, permanent markers and ring tags did not prove to 
be good ways of identifying individual lovebirds. Frequently, the birds would pull the tag off 
with their beak or would inflict damage to themselves while attempting to pull the ring off. 
Permanent marker labels on feet and beaks quickly rubbed of and became illegible. The birds 
were initially maintained in a single aviary at the commercial outlet and therefore loss of tags 
made it impossible to identify many individuals upon return to purchase selected birds. 
Secondly, outlet staff occasionally removed or added birds to aviaries containing the samples 
birds without providing information of this. Thus, the identity of tested birds was not always 
reliable. Microchips may be a more suitable method of keeping track of individual birds. Chapter 2. BFDV-free Agapornis 
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However, this was not feasible due to the large number of birds that were tested and as they 
were owned by the outlet when they were initially tested. 
 
Many birds tested negative for exposure to BFDV when sampled at the commercial 
outlet and were purchased. However, these birds later had test results positive for BFDV 
infection. This may have been due to a number of reasons including exposure or infection 
immediately after sample collection.  Alternatively, the birds may have already been infected 
at the initial time of sampling but with low viral replication or at least insufficient to be not 
detectable by PCR or HA. Further to this, it may have been that handling for sample 
collection, tagging, isolation and the establishment of new pecking orders may have caused 
stress and associated immune-suppression to carrier birds with subsequent recrudescence of 
replication. It seems unlikely that the birds had been free of exposure before sampling and 
then became infected after sampling, considering the magnitude of psittacine birds kept in the 
outlet and the lack of suitable management to limit transmission of aerosol. In all other cases, 
the birds that had tested positive in their first sample by at least one assay were excluded.  
 
None of the lovebirds had any clinical signs consistent with PBFD, but frequently 
tested positive for BFDV DNA in blood and feathers as well as BFDV antibody. This may 
indicate that lovebirds are less susceptible to developing chronic progressive PBFD than 
other psittacine species, but are more likely to develop a chronic persistent BFDV carrier 
status. Others have shown that lovebirds may recover from acute infections relatively easily, 
with some individuals affected to a varying degree (Kock et al. 1993). 
 
Feather dander is easily aerosilized both during sample collection and within the 
laboratory and this can pose as a source of potential false positive PCR results due to the Chapter 2. BFDV-free Agapornis 
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inherent amplification factors that are the basis of the PCR. Given the large number of 
samples that were processed by PCR, considerable care was taken to avoid carryover 
contamination of BFDV DNA in sample preparations. Experiments designed to analyse this 
are described in Chapter 4. With respect to laboratory contamination, HI and HA assays, with 
minimum detection limits of 20 HI or HAU/50μL, are less sensitive than PCR and also less 
likely to provide false positive results.  
 
The results obtained in this study indicate the importance of multiple testing when 
attempting to obtain SPF (specific pathogen free) animals. An individual with negative test 
results may not actually be free from infection. Similarly, positive test results may be false, 
due to contamination, and the investigator misses opportunities to obtain suitable individuals.  
The results also indicate that BFDV may be endemically infected in commercially available 
lovebird populations and that using a commercial outlet for obtaining a flock of psittacine 
birds has a high risk of failure. This study also found that PCR testing for BFDV DNA in 
blood is more likely to identify infected birds than PCR testing of feather extract or HA and 
HI testing.  Chapter 3. BFDV-free Cockatoos 
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Chapter 3 : Raising a BFDV-Free Flock of 
Cacatua tenuirostris and Eolophus roseicapillus 
 
3.1 Summary 
 
Studies into the pathogenesis of BFDV or vaccination to protect against PBFD require 
the use of susceptible birds that are free from BFDV infection and BFDV-antibody. In this 
Chapter, a flock of BFDV-free fledgling psittacine birds was created from long-billed corella 
(Cacatua tenuirostris) eggs (n=8), galah (Eolophus roseicapillus) eggs (n=6) and corella and 
galah nestlings (n= 19 and n=2, respectively) collected by DEC (Department of 
Environmental Conservation) officers from a site in which DEC wanted to ensure was 
available for endangered white tailed black cockatoo (Calyptorhynchus latirostris) nesting. 
Eggs were artificially incubated and 3 eggs successfully hatched and 1 was successfully 
hand-reared. Nestling birds were hand-raised using a commercial hand rearing formula. All 
nestlings were screened for BFDV DNA by PCR upon arrival then on days 11, 18 and 25 and 
tested for anti-BFDV antibody on the day of arrival. All hatched birds were determined to be 
free of BFDV DNA and BFDV HI antibody in the peripheral blood throughout the hand 
rearing period and the flock was considered to be suitable for a BFDV vaccination trial. Chapter 3. BFDV-free Cockatoos 
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3.2 Introduction 
 
In a study to assess a vaccine’s usefulness  in preventing or reducing severity of 
clinical disease or controlling spread of disease, it is necessary to obtain test subjects of 
appropriate species that are susceptible to infection. In this case, the appropriate species 
needs to be known to be readily susceptible to BFDV infection and susceptible to developing 
clinically apparent disease. Experimental birds should also be antibody free and not have 
been exposed to the pathogen prior to the study. 
 
Easily obtainable species that are known to become infected with BFDV include 
lovebirds (Agapornis  spp.) and various species of cockatoo including sulphur-crested 
cockatoo (Cacatua galerita), corella (Cacatua tenuirostris) and galah (Eolophus 
roseicapillus) (Kock et al. 1993; Raidal and Cross 1995; Trinkaus et al. 1998; 
Kiatipattanasakul-Banlunara et al. 2002; Bert et al. 2005; Khalesi et al. 2005). 
 
Initially, lovebirds where investigated as to their suitability for a vaccination study 
(Chapter 2) because they are readily available from commercial retailers, can easily be bred 
to obtain large numbers; also allowing for studying vertical transmission. However,  as 
described in Chapter 2, obtaining birds not previously exposed to BFDV from commercial 
sources was not possible. Therefore a different approach of obtaining birds had to be 
investigated in order to obtain a suitable flock of birds to perform this vaccine trial. With 
support from the Department of Environmental Conservation (DEC), eggs and nestlings from 
“pest” species were removed from a region where white tailed black cockatoos 
(Calyptorhynchus latirostris) are encouraged to nest and tested for BFDV periodically and 
form the flock from birds that consistently test negative for BFDV.  
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  Nesting sites for endangered white tailed black cockatoos in WA are considered to be 
overpopulated by pest species. In WA, the DEC has initiatives to decrease the burden of pest 
birds that interfere with black cockatoo nesting activity. Some of these “pest” species are 
long-billed corella and galah. These species are suitable because they are known to become 
infected with BFDV and develop PBFD and collecting them as part of initiatives to decrease 
pest numbers is ethical. This provided a good opportunity to obtain an experimental BFDV-
free flock of psittacine birds for vaccination studies (Chapter 4). The aim of the work 
presented in this Chapter was to produce a flock of BFDV/PBFD susceptible psittacine birds 
that had not had previous exposure to BFDV.  
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3.3 Materials and Methods 
 
3.3.1 Preparation of a clean environment  
 
The floors and walls of the rooms allocated for incubating eggs and raising birds were 
tested for contamination with BFDV both before and after disinfection by swabbing and 
testing for BFDV DNA with PCR as described below. DNA extracted using the QIAamp 
DNA Blood Mini kit (QIAGEN, Australia). PCR was performed using 2μL of sample extract 
with the protocol described under section DNA extraction and PCR (pg 59). The rooms were 
then disinfected by spraying all walls, floors, ceilings and any other objects in the room with 
Virkon S (Antec, Janos-Hoey, NSW) according to the manufacturer’s recommendations. The 
Virkon S was left for a minimum of 1hr and then removed by rinsing with tap water. All 
other equipment was disinfected before placing in the room by wiping down with Virkon S, 
leaving for 1 to 24 h then wiping down with moist cloth to remove disinfectant residue. 
 
3.3.2 Acquisition of eggs and nestling birds 
 
Nestling long-billed corellas (Cacatua tenurostris) (n=19), nestling galahs (Eolophus 
roseicapillus) (n=2), long-billed corella eggs (n=8) and galah eggs (n=6) were collected from 
a nesting site near Perth, Western Australia, by officers of the DEC and transported to 
Murdoch University. The eggs and nestlings were provided as part of a DEC initiative to 
decrease the population of “pest” species in the area that inhibit white tailed black cockatoo 
(Calyptorhynchus latirostris) nesting. The eggs were transported in portable incubators at 36-
37.5°C and nestlings in partitioned cardboard boxes. 
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3.3.3 Artificial incubation of corella and galah eggs 
 
Eggs were placed in Octagon 20 egg incubators (Brinsea, UK) at 36-38.4°C and 35-
45% humidity. These incubators automatically rotate eggs along the long axis to mimic the 
natural egg rotation performed by the parents. 
 
The development of the foetus was monitored by candling, initially after transport to 
the raising facilities to estimate the time to hatching and thereafter twice every week. Once 
pipping had started, the hatching bird was moved to a TLC-4 brooder (Brinsea, UK) 
preheated to 37°C and humidified. The temperature was gradually decreased as the bird aged 
and became more feathered. 
 
3.3.4 Hand raising nestling corellas and galahs 
 
Nestlings that had not yet fully developed contour feathers when arriving at the 
university were placed, as singularly or as pairs, into TLC-4 brooder at maintained 25-30°C 
in a temperature controlled room (21-22°C). Older nestlings that had more plumage were 
kept in cardboard boxes in groups of 3-5. Every 2 hours, each bird was fed approximately 7-
60 mL of 30% Roudybush formula 3 (Kimani, WA). After each feed, the incubators were 
wiped down with chlorhexidine (2% v/v) and the nesting material (shredded paper towels) 
was changed to maintain sanitation.  
 
As the birds approached fledgling age, feeding was gradually decreased to every 3 
hours, then every 4 hours and so forth. When the birds reached fledging age, syringe feeding 
was decreased to twice a day (morning and evening) and solid food including parrot pellets 
(Roudybush pellets, Kimani, WA) and fresh fruit and vegetables incorporated into the diet. In Chapter 3. BFDV-free Cockatoos 
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the latter part of the weaning stage, birds were placed in suspended wire cages (n= 7 corellas, 
2 galahs) with low perches or an indoor aviary (n= 13 corellas). 
 
3.3.5 Sampling 
 
Blood was taken from each bird by jugular venepuncture on the day of arrival and the 
surfaces of eggs were swabbed (sterile swab-sticks from Copan, Italy). Thereafter, blood 
samples were collected on days 11, 18 and 25 after arrival. A nestling that resulted from 
artificially egg incubation was sampled on day 27, 33 and 40 after hatching. The blood 
samples were spotted onto Whatman filter paper (No. 3) and dried at room temperature for 1 
hour or over night, then placed in zip lock bags and stored at 4°C until use. Birds were micro-
chipped (Trovan, UK) on day 11 to allow accurate identification of each bird. 
 
3.3.6 PCR and HI testing 
 
The birds were tested for current BFDV infection by PCR. Dried blood spots were 
excised from the filter paper using a stationary hole puncher (OfficeWorks, Australia) 
according to methods previously described (Bonne et al. 2008) deposited into 1.5mL 
Eppendorf tubes and DNA extracted using the QIAamp DNA Blood Mini kit (QIAGEN, 
Australia). PCR for detection of BFDV DNA was performed as described by others (Ypelaar 
et al. 1999) and accounted for in Chapter 2. Detection of serum HI antibody to BFDV was 
performed on dried blood spots as described by Riddoch et al. (1996) and accounted for in 
Chapter 2. 
 
3.3.7 Clinical examination 
 
All collected birds were regularly examined for clinical signs of BFDV infection and 
other medical concerns. Chapter 3. BFDV-free Cockatoos 
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3.4 Results 
 
3.4.1 Artificial egg incubation 
 
Only one corella was successfully hatched and raised, the other eggs died for 
unknown reason, but probably due to excessive variations in incubation temperature or 
humidity at various stages of development. Two galah eggs were hatched, but both died 
within 5 days of hatching due to hypothermia caused by an accidental sudden and extended 
drop in incubator temperature (to 27°C) over night.  
 
3.4.2 Hand-rearing nestlings 
 
The nestlings acquired from the nesting site and one hatched corella were all 
successfully hand-reared. 
 
3.4.3 PCR and HI 
 
All birds were, upon arrival, PCR negative for BFDV DNA and remained PCR 
negative throughout the rearing period (Figures 3.1 - 3.4).
† HI testing on samples collected 
during the hand-rearing period did not detect any antibody against BFDV in the peripheral 
circulation (Figure 3.5). Clinical examinations did not reveal any concerns regarding the 
health of the birds. 
 
  
                                                 
† Blood samples from day 11 became contaminated by the positive control paper during DNA 
extraction and could not be tested. The problem of this carry-over contamination (caused by 
inadequacy of the DNA extraction technique) was identified and resolved (see Chapter 4). Chapter 3. BFDV-free Cockatoos 
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Figure  3.1  PCR results of the BFDV-free nestling birds on the day of arrival from the wild. As can 
be seen in the gel; all the birds were free of BFDV DNA in their peripheral blood when they arrived. 
None-utilized primers can be seen at the bottom of each lane. 
Lanes; 
M: Promega 100bp molecular weight ladder. 
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird 89A0.  
9: Bird B009.  
10: Bird EF7E (galah). 
11: Bird C852.  
12: Bird C548.  
13: Bird F357.  
14: Bird D6F7.  
15: Bird C8AE.  
16: Bird 52A5.  
17: Bird F7DD (galah). 
18: Bird 1245.  
19: Bird FEF8.  
20: Bird 07E4. 
21: Bird F0A8. 
P: PCR positive control reaction. 
N: PCR negative control reaction. 
 Chapter 3. BFDV-free Cockatoos 
68 
 
 
 
Figure  3.2  PCR results of the BFDV-free nestling birds 18 days after arrival from the wild. 
As can be seen in the gel; all the birds were free of BFDV DNA in their peripheral blood. 
 
Lanes; 
M: Promega 100bp molecular weight ladder. 
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird 89A0.  
9: Bird B009.  
10: Bird EF7E (galah). 
11: Bird C852.  
12: Bird C548.  
13: Bird F357.  
14: Bird D6F7.  
15: Bird C8AE.  
16: Bird 52A5.  
17: Bird F7DD (galah). 
18: Bird 1245.  
19: Bird FEF8.  
20: Bird 07E4. 
21: Bird F0A8. 
DP: DNA extraction positive control.  
DN: DNA extraction negative control. 
P: PCR positive control reaction. 
N: PCR negative control reaction. 
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Figure  3.3  PCR results of the BFDV-free nestling birds 25 days after arrival from the wild. 
As can be seen in the gel; all the birds were free of BFDV DNA in their peripheral blood. 
 
Lanes; 
M: Promega 100bp molecular weight ladder. 
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird 89A0.  
9: Bird B009.  
10: Bird EF7E (galah). 
11: Bird C852.  
12: Bird C548.  
13: Bird F357.  
14: Bird D6F7.  
15: Bird C8AE.  
16: Bird 52A5.  
17: Bird F7DD (galah). 
18: Bird 1245.  
19: Bird FEF8.  
20: Bird 07E4. 
21: Bird F0A8. 
DP: DNA extraction positive control.  
DN: DNA extraction negative control. 
P: PCR positive control reaction. 
N: PCR negative control reaction. 
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Figure  3.4  PCR results of samples collected from the successfully hatched and hand-reared 
corella during the hand-rearing period. As can be seen in the gel; the bird was free of BFDV 
DNA in its peripheral blood after hatching and trough out the hand-rearing period 
Lanes; 
M: Promega 100bp molecular weight ladder. 
1: Bird BF10; 27 days after hatch. 
2: Bird BF10; 33 days after hatch. 
3: Bird BF10; 40 days after hatch. 
 
DP: DNA extraction positive control.  
DN: DNA extraction negative control. 
P: PCR positive control. 
N: PCR negative control. 
  
 
 
 
 
Figure  3.5 Haemagglutination inhibition assay results of blood samples taken from the flock on the day of arrival (rows 3-20), and day 11 (rows 21-41) and 
18 (rows 42-62) after arrival. 
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3.5 Discussion 
 
Long-billed corellas and galahs are both considered “pest” species in Western 
Australia (DEC 2007a; DEC 2007b) and limit the opportunities of black cockatoos to 
reproduce through occupying as well as overtaking nesting hollows. It is not uncommon for 
corellas to push eggs of other species out of nesting hollows in order to use the hollow for 
their own eggs. As mentioned, these eggs and nestlings were removed from the site as part of 
DEC initiative to decrease the burden of pest species in the area, thereby producing more 
favourable conditions for the endangered white tailed black cockatoo.  
 
Wild populations of cockatoos (including long-billed corella and galah) have been 
found previously to have a high incidence (up to 94%) of BFDV infection (Raidal et al. 
1993b; Ha et al. 2007). However in this study, no evidence for current BFDV infection or 
past and overcome BFDV infection could be found using PCR and HI in corellas and galahs 
captured near Perth. This may reflect the difference in geographic location between studies 
but also that the number of birds tested may have been to low to detect any positive birds. 
 
Nestling corellas (n=19), galahs (n=2) and eggs from each species [n(corella)=6 and 
n(galah)=4] were taken from nests at a wild nesting site near Perth, Western Australia. All 
nestlings taken were successfully hand-reared and stayed very healthy. Three eggs (2 galahs 
and 1 corella) were successfully hatched, however the galahs died after 5 days due to an 
accidental drop in brooder temperature. The remaining eggs that were collected died at 
various stages of development during artificial incubation or were found not viable at the first 
candling. The non-viability of eggs at first candling may have been the result of transport 
from the nest site to the laboratory with associated shaking and vibrations, killing the embryo 
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The practicality of wild caught eggs for obtaining SPF birds is questionable, as many 
eggs may not hatch, probably due to disruptions to the animal during  transport. Considering 
such complications, the method would require collection of many eggs, to obtain a few birds,  
or extremely gentle transport from the nest site.  Additionally, eggs are not guaranteed to be 
free of BFDV (Gerlach 1994; Rahaus et al. 2008) and therefore has no advantage over 
collecting nestlings.   
 
This study was successful in obtaining a flock of psittacine birds, which had not 
previously been exposed to BFDV and therefore suitable for trial of a vaccine to protect 
against BFDV. Chapter 4. Elimination of false positive PCR 
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Chapter 4 : Elimination of False Positive 
Polymerase Chain Reaction Results Resulting 
From Hole-Punch Carryover Contamination 
 
4.1 Prelude 
 
As mentioned in Chapter 3, samples collected from the corella flock 11 days after the 
birds had been collected from the wild, were believed to have become contaminated by the 
positive control filter paper during the DNA extraction process. Therefore, PCR testing of 
these samples yielded false positive results. As reviewed below, laboratories routinely use a 
single hole-puncher for excising circles of blood dried on filter paper to test using PCR. 
Considering the high sensitivity and specificity of the PCR, it seemed most likely that false 
positive results had been caused by the hole-puncher carrying enough biological material 
from one sample to another to yield a (false) positive result. 
 
The following material was published in Journal of Veterinary Diagnostic 
Investigation (Bonne et al. 2008).  
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4.2 Summary 
 
The collection of biological material, such as blood, directly onto filter paper for 
subsequent use in laboratory assays such as PCR, has become a common practice. Dried cells 
or fluid on the paper can be readily rehydrated and retrieved into a standard volume of an 
appropriate elution buffer but introduces a dilution factor to the sample. The use of a common 
cutting instrument for excising a standard sized piece of paper containing the material also 
introduces the potential for transferring biological material from one sample to subsequent 
samples causing false positive results by PCR. In the present study, filter paper-collected 
blood containing beak and feather disease virus (BFDV) was used to determine if viral DNA 
could be transferred between samples by a hole-punch used to excise sequential filter papers. 
It was determined that false positive results could be obtained for up to 13 times after a 
positive sample. Subsequently the efficacy of 4 methods of hole-punch disinfection using 
flaming, VirkonS, bleach, and a bleach-ethanol combination was assessed. The only effective 
and practical method to destroy DNA was a method where the hole-punch was agitated in 
commercial bleach, rinsed in water, the water displaced with 100% ethanol and air dried. 
This method was simple, cheap and relatively rapid and allowed for the use of a single hole-
punch for a series of samples, without carryover contamination and consequent false positive 
results.  
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4.3 Introduction 
 
Molecular diagnostic methods, such as the polymerase chain reaction (PCR), are 
widely used for the detection of aetiological agents including viruses, bacteria, and parasites, 
as well as for genotyping of both fauna and flora and in forensic investigations. PCR allows 
the detection of DNA from samples that originally contain a very few copies of the DNA of 
interest (Arnheim and Erlich 1992). However, the fidelity of the PCR reaction relies on 
avoiding contamination of true negative samples by carryover of target material from other 
samples. 
 
Recently, it has become common practice to apply biological material to filter paper 
(Whatman filter paper or FTA cards, Whatman international, UK) for subsequent use in PCR. 
The material dried on filter paper is easily stored and transported without the need for 
refrigeration (Noda et al. 1993; Panteleeff et al. 1999; Campino et al. 2000; Khalesi et al. 
2005; Huang et al. 2006; Mbogori et al. 2006). Typically, such samples are eluted from the 
sample paper, and nucleic acid is subsequently isolated from the eluate for use in PCR. 
Furthermore, some filter paper products include reagents that lyse cell membranes and 
stabilize nucleic acids, allowing material to be easily washed and deposited directly into the 
PCR reaction (Borman et al. 2006; Mbogori et al. 2006). To access the biological material for 
PCR, the material dried on filter paper is commonly excised using a hole-punch (Panteleeff et 
al. 1999; Campino et al. 2000; Drescher and Graner 2002; Kuboki et al. 2003; Huang et al. 
2006; Mbogori et al. 2006; Jefferies et al. 2007; Patton et al. 2007). This method allows for 
expedient processing of samples and provides a standard volume of filter paper. However, the 
use of a single piece of equipment for multiple samples makes the method vulnerable to 
carryover of nucleic acid between samples. 
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The aim of this experiment was to investigate the potential for contamination of true 
negative samples by carryover of DNA caused by using a hole-punch to excise material from 
filter paper. Subsequently a method to minimise the potential of DNA transfer from a positive 
sample to the other samples was developed. 
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4.4 Materials and methods 
4.4.1 Sample blood 
 
The sample blood originated from a long-billed corella (Cacatua tenuirostris) that had 
been submitted to our laboratory for BFDV testing. This bird had lesions consistent with 
chronic beak and feather disease virus (BFDV) infection and diagnosed BFDV-positive by 
PCR by the Murdoch University veterinary diagnostic service. EDTA-preserved blood 
collected from the bird, was spotted onto Whatman filter paper
  No. 3, (Whatman 
International Ltd., UK) and dried at room temperature over night. 
 
4.4.2 Sample processing and DNA extraction without a step to disinfect the hole-punch 
 
A new, unused hole-punch
 (Officeworks Superstores Pty Ltd, Australia) was used to 
excise filter paper. In accordance to the DNA extraction kit
 (QIAamp DNA blood mini kit, 
Qiagen Pty Ltd., Doncaster, Vic, Australia) specifications, 3 circles were excised from each 
filter paper. Sequentially, “material” was excised from an unused filter paper (pre-cut control) 
from a previously unopened pack, from filter paper with blood from the infected corella 
sample (known positive sample), and from 5 unused filter papers (contamination controls 1–
5). Figure 4.1 illustrates the sequence of filter paper excisions. The excised circles were 
placed into 1.5 mL microcentrifuge tubes and DNA was extracted according to the kit 
manufacturer’s instructions. 
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Figure  4.1 Method used to assess carryover of biological material by a hole-punch used to excise a 
standard sized hole from filter paper. 
 
 
4.4.3 Sample processing and DNA extraction with a step to disinfect the hole-punch 
 
The following 4 methods of disinfecting the hole-punch were assessed: 1) flaming the 
hole-punch with a Bunsen burner; 2) soaking the hole-punch in 0.5% (w/v) VirkonS (ANTEC 
VirkonS, Janos-Hoey Pty Ltd, Forbes, NSW, Australia) for 30 min with subsequent washing 
in running tap water for 1 hr; 3) soaking the hole-punch in bleach  (42 g/L sodium 
hypochlorite, White King, SaraLee Household and Body Care, Pymble, NSW, Australia) for 
20 min with subsequent washing in running tap water for 20 min (after the washing step in 
methods 2 and 3, the hole-punch was dried by removing excess water with tissue paper and 
by drying at 50°C in a heated cabinet); and 4) agitating the hole-punch in 100% bleach 
(approx. 5 sec), rinsing in water (approx. 5 sec), immersing and agitating in 100% ethanol (5–
10 sec) to displace the water, and finally air drying. 
 
The dryness of the hole-punch after each method of liquid disinfection was assessed 
by flicking the instrument against a clean dry surface and observing for drops. In methods 2 
and 3, the hole-punch was dry after approximately 60 min at 50°C. In method 4 the ethanol 
evaporated, leaving the hole-punch dry within seconds. 
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For each of the disinfection methods, a new, unused hole-punch was used to excise 
filter paper. In accordance with the instructions in the DNA extraction kit, 3 circles were 
excised from each filter paper. Sequentially, “material” was excised from an unused filter 
paper (precut control) from a previously unopened pack, from filter paper with blood from 
the infected corella sample (known positive sample), then from an unused filter paper 
(carryover positive control), to positively control carryover of a non-disinfected hole-punch. 
Further, the known positive sample was excised (without retaining circles) to contaminate the 
hole-punch before disinfection. After disinfection, unused filter paper was excised 
(disinfection control). Finally, to control for significant disinfectant residue retention (and 
associated interference in subsequent applications), a single circle was excised from the 
known positive sample (post-disinfection positive control). Figure 4.2 illustrates the sequence 
of sample paper excisions. The excised circles were placed into 1.5 mL microcentrifuge tubes 
and the DNA (if any) extracted according to the kit manufacturer’s instructions. 
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Figure  4.2  Method used to assess disinfection procedures of a hole-punch. For assessing methods of 
decontamination, the points where the hole-punch was disinfected using Method 1 (flaming), Method 
2 (VirkonS), Method 3 (bleach), or Method 4 (rapid bleach and ethanol combination) are shown as an 
asterisk. A post-disinfection positive sample was used to assess the effects of any carryover of 
disinfectant that might have interfered with the assay (causing a false negative result). 
 
 
4.4.4 Polymerase chain reaction 
 
PCR for detecting a fragment of BFDV ORF V1 and visualization of amplified DNA 
was conducted according to the method described in Chapter 2. 
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4.5 Results 
 
4.5.1 Sample processing and DNA extraction without a step to disinfect the hole-punch 
 
PCR of pre-cut control did not yield any detectable amplification (Figure 4.3, lane 1). 
The known positive control (lane 2) yielded the expected strong signal. Contamination 
controls 1–5 (lanes 3–7) yielded progressively weaker signals at the same molecular weight 
as the positive control. 
 
 
 
Figure  4.3 Agarose gel illustrating the effect of using a nondisinfected hole-punch to excise filter 
paper for DNA extraction and subsequent PCR analysis. Lane MW: Promega 100bp molecular weight 
marker. The sample sources for lanes 1–7 are shown diagrammatically in Figure 1. Lane 1: Precut 
control. Lane 2: Known positive sample. Lanes 3–7: Contamination controls 1–5. Lane 8: PCR 
negative control. 
 
4.5.2 Sample processing and DNA extraction with a step to disinfect the hole-punch 
 
Method 1 (Bunsen burner) 
 
PCR of the pre-cut control did not yield any detectable amplification. The known 
positive sample yielded a strong product at the expected molecular weight. The carryover 
positive control yielded a weaker product at the expected molecular weight for this fragment. 
PCR of the disinfection control sample yielded a product at the molecular weight of the Chapter 4. Elimination of false positive PCR 
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known positive sample, but was significantly weaker than the known positive. Finally, the 
post-disinfection positive control yielded the expected product (data not shown). 
 
Methods 2 (VirkonS and tap water) and 3 (bleach and tap water) 
 
The precut control did not yield any detectable amplification from PCR. The expected 
positive result was obtained with the known positive sample. PCR of the carryover positive 
control resulted in a positive signal, weaker than that of the known positive. The disinfection 
control did not yield detectable amplification. Finally, the post-disinfection positive control 
yielded a strong signal at the same molecular weight of the known positive sample. Methods 
2 and 3 both caused corrosion of the hole-punch (data not shown). 
 
Method 4 (Bleach, tap water, ethanol) 
 
No detectable amplification was obtained with PCR of the precut control (Figure 4.4, 
lane 1). The known positive sample yielded the expected positive result (lane 2). PCR of the 
carryover positive control obtained a product at the molecular weight of the known positive 
sample, however significantly weaker than the known positive (lane 3). The disinfection 
control sample did not yield a detectable signal (lane 4). Finally, the post-disinfection 
positive control resulted in a strong positive signal (lane 5). This method did not cause visible 
corrosion of the hole-punch. 
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Figure  4.4 Agarose gel of PCR products yielded from filter paper cut with a disinfected hole-punch. 
Lane MW: Promega 100 bp molecular weight marker. The sample sources for lanes 1–5 are shown 
diagrammatically in Figure 4.2. Lane 1: Precut control. Lane 2: Known positive sample. Lane 3: 
Carryover positive control. Lane 4: Post-disinfection result (Method 4). Lane 5: Post-disinfection 
positive control. Lane 6: PCR negative control. 
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4.6 Discussion 
 
Many studies have used hole-punches to excise material dried on filter paper 
(Panteleeff et al. 1999; Campino et al. 2000; Drescher and Graner 2002; Kuboki et al. 2003; 
Borman et al. 2006; Mbogori et al. 2006; Milne et al. 2006; Pezzoli et al. 2006; Suematsu 
and Isohashi 2006; Inoue et al. 2007; Jefferies et al. 2007). However, only a few reports 
mention any protocols for detecting possible carryover or detection of false positives in filter 
paper-based PCR methods (Khalesi et al. 2005; Jefferies et al. 2007). Furthermore, many 
published studies overlook any consideration for the possibility of such contamination 
(Campino et al. 2000; Kuboki et al. 2003; Borman et al. 2006; Milne et al. 2006; Pezzoli et 
al. 2006; Inoue et al. 2007). 
 
Quality assurance methods to avoid such contamination have been reported by some 
authors (Panteleeff et al. 1999; Drescher and Graner 2002; Mbogori et al. 2006; Suematsu 
and Isohashi 2006; Jefferies et al. 2007; Patton et al. 2007).  Some laboratories report 
punching holes in blank paper between samples to remove possible contaminants (Patton et 
al. 2007). One study reported ethanol-flaming the hole-punch before making an excision 
(Panteleeff et al. 1999) and other studies report wiping or pressing the hole-punch against 
ethanol wetted paper towel (Drescher and Graner 2002; Mbogori et al. 2006), or a 
combination of wiping the hole-punch with ethanol and excising blank papers (Jefferies et al. 
2007). 
 
The present study shows that there may be significant carryover even 13 excisions 
after the first excision of a positive sample. It was concluded that sequential cutting of fresh 
blank paper alone is inadequate for cleaning or removing contaminating material from the 
hole-punch. Furthermore, the data obtained in the present experiment shows that exposing a Chapter 4. Elimination of false positive PCR 
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contaminated hole-punch to a high temperature Bunsen flame may not result in elimination of 
all residual DNA. 
 
Studies on the effects of ethanol for disinfection have shown that although various 
concentrations of ethanol may be in some cases effective at reducing infectivity, it does not 
destroy nucleic acid effectively (Ito et al. 2002; Duizer et al. 2004). Thus it can be concluded 
that a hole-punch disinfection procedure that depends on alcohol will not be sufficient to 
avoid nucleic acid carryover contamination. 
 
The likely possibility of a hole-punch carrying contamination to consecutive samples 
and associated false positive results may have been overlooked by many laboratories and 
some may be utilizing methods that are insufficient to ensure decontamination. In the present 
study, a virgin hole-punch was used to determine whether hardware used for processing dried 
blood samples on filter paper could serve as a vessel for carryover. The results obtained in 
this experiment give support for this hypothesis, as clean filter paper processed subsequently 
to the known positive control resulted in progressively weaker positive results for as many as 
13 punches afterward. This result is not surprising in light of the ability of the PCR to detect 
few copies of the target DNA. 
 
The present study demonstrates that the simple, cheap and relatively rapid disinfection 
technique involving bleach, tap water, and ethanol was the most successful. This method 
allows for the use of a single hole-punch for a series of samples, without carryover and 
consequent false positive results. 
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Forensic scientists and scientists that study ancient DNA commonly use bleach to 
eliminate contaminating DNA on bone samples (Kemp and Smith 2005). Furthermore, 
studies have determined the effectiveness of bleach for eliminating DNA in PCR reactions 
(Prince and Andrus 1992) but the present study is the first to demonstrate its use to 
decontaminate hole-punches used for filter paper excision. 
 
The results presented in the present study provide evidence for the potential of a hole-
punch to transfer material between filter paper dried samples. The possibility of carryover of 
material between samples by using a piece of hardware should be considered by all 
researchers that employ PCR analysis of biological material and appropriate methods used to 
minimise its occurrence. Chapter 5. Vaccination  
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Chapter 5 : Vaccination and Challenge of 
Cockatoos 
 
5.1 Summary  
 
The following study investigated the immunogenicity of recombinant BFDV capsid 
(recBFDVcap) to protect against the development of psittacine beak and feather disease 
(PBFD). Long-billed corellas (Cacatua tenuirostris) (n=13) were injected with 1 mL of 
vaccine containing 10 μg recBFDVcap on day 0 and 0.4 mL vaccine containing 66.8 μg 
recBFDVcap on day 11. All vaccinated corellas and 5 non-vaccinated control corellas were 
given 0.4 mL BFDV suspension (titre = log2 12 HAU/50 μL) intramuscularly and 0.1 mL 
orally 16 days after booster vaccination. Blood was collected during the vaccination period 
and blood and feathers collected after BFDV administration. Testing of blood samples 
included BFDV DNA detection by PCR and qRT PCR as well as antibody detection by 
haemagglutination inhibition (HI) and on feather samples, BFDV DNA and antigen was 
detected by qRT PCR and haemagglutination (HA). Four of 97 blood samples collected from 
vaccinated birds after virus challenge tested positive by PCR, whereas 17 of 35 samples taken 
from non-vaccinated control corellas tested positive. Vaccinated birds did not develop feather 
lesions, had only transient PCR detectable viraemia and had no evidence of persistent 
infection 270 days post-challenge using PCR, histopathology and immunohistochemistry 
(IHC). Non-vaccinated control corellas developed transient feather lesions and PCR, HI and 
HA test results consistent with PBFD. They were BFDV PCR positive for up to 41 days post-
challenge and qRT PCR demonstrated reduced virus replication in vaccinated birds compared 
to non-vaccinated control birds. Thus, administration of recBFDVcap vaccine alone incited 
an adaptive immune response in wild-caught, BFDV-free, long-billed corellas that 
subsequently conferred protection against challenge with live BFDV. 
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5.2 Introduction 
 
Psittacine beak and feather disease (PBFD) is a significant disease of both wild and 
captive psittacine birds across the globe and consequently has serious implications for the pet 
trade as well as for the conservation of threatened species (McOrist et al. 1984; Raidal et al. 
1993b; Rahaus and Wolff 2003; Albertyn et al. 2004; Bert et al. 2005). Vaccination to protect 
against BFDV using inactivated virus, purified from the feathers of chronically infected 
cockatoos has been shown to protect psittacine birds from clinical PBFD (Raidal et al. 1993a; 
Raidal and Cross 1994a). However, husbandry of BFDV infected birds for the production of 
vaccine is impractical, expensive and the maintenance of birds infected with BFDV is 
ethically questionable, thus researchers have strived to find alternative methods for vaccine 
production. Many traditional culture systems have been tried for amplification of BFDV, 
however these attempts have been unsuccessful [reviewed in Pass and Perry (1985)]. Stewart 
et al. (2007) described the use of recombinant baculovirus for production of the BFDV capsid 
protein and showed that it had similar properties to native virus. The assessment of this 
recombinant protein for vaccination against BFDV has been inhibited by the lack of suitable 
BFDV-free psittacine birds that are highly susceptible to BFDV.  
 
In this Chapter the vaccination and subsequent BFDV challenge of hand-raised long-
billed corellas (Cacatua tenurostris) and galahs (Eolophus roseicapillus) are described. The 
aim of this experiment was to determine whether recombinant BFDV capsid protein, 
expressed using a baculovirus system, could cause seroconversion and protect selected 
species of psittacine birds from developing clinical PBFD after infection with BFDV. 
 
 Chapter 5. Vaccination  
  90
5.3 Materials and Methods 
 
5.3.1 Birds  
 
The birds used for this experiment are as described in Chapter 3. Briefly, long-billed 
corella (Cacatua tenurostris) nestlings and eggs and galah (Eolophus roseicapillus) nestlings 
were collected from a wild nesting site by DEC officers and transported to Murdoch 
University. The birds were immediately screened for evidence of BFDV exposure, by PCR 
and HI, as described in detail in Chapter 3. The birds were hand reared using a hand rearing 
formula and temperature controlled incubators and tested periodically for BFDV DNA by 
PCR on the blood. Once the birds reached weaning age, they were moved to suspended wire 
cages or an aviary, all in a single air conditioned room. Here the birds were maintained on 
parrot pellets (Passwell, South Australia), fresh fruit, vegetables and peanuts for the duration 
of the experiment. 
 
5.3.2 Production of recombinant BFDV capsid protein  
 
The recombinant BFDV capsid protein expressing Baculovirus system was developed 
by Stewart et al. (2007) using the Bac to Bac® (Invitrogen) baculovirus expression system. 
Briefly, the PCR amplified BFDV ORFC1 (which encodes the capsid protein) was excised 
from a pCR2.1 BFDV ORFC1 construct using an EcoR1/Sal1 double digest, ligated into the 
EcoR1/Sal1 site of the pFastBAC HTa (Invitrogen) baculovirus transfer vector and 
transformed into TOP10F’ chemically competent E. coli (Invitrogen). The orientation of the 
gene in pFASTBAC was verified by restriction digest with BamH1 and sequence analysis. 
The recombinant bacmid was generated according to the manufacturer’s protocol (Bacto 
Bac® Baculovirus Expression System; Invitrogen). The pFASTBAC HTa BFDV ORFC1 
construct was transformed into the chemically competent E. coli DH10Bac (Invitrogen) 
containing the bacmid and helper vector, where the BFDV ORFC1 was transposed into the Chapter 5. Vaccination  
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bacmid. The recombinant bacmid containing the BFDV ORFC1 was purified and transfected 
using cellfectin (Invitrogen) into SF9 insect cells to produce recombinant baculovirus 
(AcMNPV) containing the BFDV ORFC1 gene under the control of the polyhedrin promoter. 
The recombinant baculovirus was amplified until the titre was sufficient for high-level 
expression of the protein. For the production of recombinant BFDV capsid protein, SF9 
insect cells were cultured to a density of 2 × 10
6 cells/mL and infected with the recombinant 
baculovirus at an MOI of 0.2 and harvested 72 h post infection. 
 
5.3.3 Recombinant protein purification 
 
Purification was performed according to methods described by Stewart et al. (2007). 
Cell cultures that had expressed the recombinant BFDV capsid protein were transferred from 
the Erlenmeyer cell culture flasks (0.2 μm vent cap, Corning Inc.) to 50 mL “V bottom” 
centrifuge tubes (Sarstedt). The tubes were then centrifuged at 4000×g for 10 min in a pre-
cooled (4°C) centrifuge with “swing–out” rotor, to pellet the cells. The supernatant was 
discarded and the cell pellets stored at -80°C until used. The cell pellets were resuspended in 
3mL cell lysis buffer (50 mM Tris-HCl pH 8.5, 100 mM KCl, 1 mM PMSF, 1% w/v Nonidet 
P-40 and 0.5% v/v β-mercaptoethanol) by vortexing and then mixed on a vertical rotor (2 h at 
4°C). Resuspended cells were then sonicated on ice with microtip at 4 with 25% pulse cycle 
for 1 min 6 times. Examination of the lysate with a haemocytometer estimated the lysis 
efficiency to be approximately 75% of cells. A sucrose cushion was then used to purify the 
recombinant BFDV capsid protein from the cell lysate. Ten mL of the lysate was layered onto 
a 10% (1° vaccine preparation) or 40% (2° vaccine preparation) (w/v) sucrose cushion (PBS 
with sucrose) in tubes suitable for the Beckman Ti40 ultracentrifuge rotor. Both the rotor and 
centrifuge had been pre-cooled to 4°C and the tubes were centrifuged at 28000 rpm for 2 h at Chapter 5. Vaccination  
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4°C. Each of the fractions that resulted, were further isolated by pipetting and dispensing into 
separate tubes using sterile single use pipettes.  
 
The fractions containing the recombinant BFDV capsid protein, prepared for the 1° 
vaccination, were found to have a low concentration of recombinant BFDV capsid protein by 
initial SDS-page and quantitative analysis. Therefore, two of these fractions were combined 
in 10000 MWCO snakeskin dialysis tubing (Pierce) and dialysed first over night in 2 L of 
PBS at 4°C, then in 5% polyetheleneglycol over night at 4°C to concentrate the protein 
preparation. This was not necessary for the protein preparation intended for 2° vaccination, as 
these baculovirus infected cell cultures produced much higher protein amounts. 
 
5.3.4 Western immuno-blot detection of recombinant protein 
 
Aliquots of the recombinant protein fractions obtained from sucrose cushion 
centrifugation were mixed with equal volume of SDS-page loading dye (62.5 mM Tris-HCl, 
10% v/v glycerol, 2% w/v sodium dodecyl sulphate, 5% v/v mercaptoethanol, 0.5% w/v 
bromophenol blue) and electrophoresed in a 12.5% polyacrylamide SDS-PAGE gel at 200V 
for 1 h. The separated protein in the gel was transferred to a nitrocellulose membrane using 
the BioRad mini transblot cell (both BioRad, Australia) over night a t  3 5 V  a t  4 ° C .  T h e  
membrane was transferred to a container with blocking solution [tris buffered saline  (pH 7.4) 
containing 0.05% v/v Tween-20 and 2% w/v skim milk powder (Diploma, instant skim milk 
powder)] for 1.5 h at room temperature. The blocking solution was then removed and fresh 
blocking solution that contained mouse anti-histidine IgG (Serotec, diluted 1:5000) was 
added and incubated at room temperature with agitation for 1 h. Subsequently, the membrane 
was washed twice for 5 min in TBST (tris buffered saline (pH 7.4) containing 0.05% v/v 
Tween-20). The membrane was then incubated for 1.5 h at room temperature in alkaline Chapter 5. Vaccination  
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phosphatase conjugated goat-anti-mouse IgG (Sigma Aldrich) diluted 1:30000 in blocking 
solution, with agitation. Finally, the membrane was washed three times for 5 min each in tris 
buffered saline and then the membrane developed using Western blue (BioRad, Australia). 
 
5.3.5 Quantification of expressed recombinant BFDV capsid protein for primary vaccination 
 
The recombinant protein preparation intended for primary vaccination was quantified 
by densitometry (Proteomics International, Perth) and the recombinant protein preparation for 
secondary vaccination was quantified in our laboratory by the same method. Briefly, Samples 
were mixed with SDS loading solution without reducing agent and boiled for 5 min. 
Subsequently, the samples were loaded onto NuPAGE 4-12% polyacrylamide midi-gels 
(Invitrogen) with MES electrophoresis buffer and electrophoresed at 200V for 1 h. The gels 
were stained using colloidal Coomassie G250 (PI-Blue method). The gels were then scanned 
using a ProEXPRESS 2D Proteomic Imaging System (Perkin-Elmer). Quantitative band 
analysis was carried out using Totallab TL120 (NonlinearDynamics). The total stained 
material in each gel lane was determined and the quantity of the recombinant BFDV capsid 
protein in the sample was determined from the graph of known ovalbumin quantities (chicken 
lysozyme standard). The percentage of the recombinant protein was performed using volume 
ratios from the recombinant BFDV capsid bands, where it was calculated as = Rec/ REC 
BEDV CAPSID (total). 
 
5.3.6 Vaccine preparation  
 
Vaccine doses were prepared immediately before injection by homogenizing the 
recombinant proteins with Freund’s incomplete adjuvant (Sigma Aldrich) using 2 sterile glass 
syringes connected to each other by a short piece of sterile steel 16 gauge needle. A volume 
of recombinant protein solution was drawn up into one syringe and an equal volume of Chapter 5. Vaccination  
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adjuvant was drawn up into the other syringe. The 2 syringes were then connected with the 
steel tube and the content of one syringe plunged into the other syringe and then the mixture 
was plunged from syringe to syringe until a primary suspension was obtained. 
 
5.3.7 Vaccination  
 
Thirteen vaccinated corellas and 2 vaccinated galahs were injected with 1 mL vaccine 
containing 10 μg recombinant BFDV capsid protein on day 0 and 0.4 mL vaccine containing 
66.8  μg recombinant BFDV capsid protein on day 11 post primary vaccination. Two 
vaccinated corellas received 0.45 mL vaccine containing 66.8 µg recombinant BFDV capsid 
protein on day 0 and 0.23 mL vaccine containing 38.4 µg recombinant BFDV capsid protein 
on day 16 post primary vaccination. The vaccine was delivered IM in the pectoral 
musculature. Non-vaccinated control birds (all corellas, n=5) did not receive any injection. 
The birds ranged in age from 65-89 days on the day of primary vaccination. 
 
5.3.8 BFDV inoculum  
 
The live BFDV inoculum, was produced by Raidal et al. (1993a) and had been stored 
at -80ºC until its use in this experiment. Briefly, BFDV was purified from the feathers of a 
PBFD-affected sulphur-crested cockatoo (Cacatua galerita). Feathers were made to 10% 
(w/v) suspension in phosphate buffered saline (PBS), containing sodium dodecyl sulphate 
(0.5%). The suspension was then homogenized at 4ºC for 10 min (Sorvall Omnimixer). 
Sterile gauze was used to filter the homogenate and then the homogenate was centrifuged at 
5,000 g for 10 min. Following centrifugation, sodium chloride (NaCl) and polyethylene 
glycol (PEG, MW 6,000) were added to the supernatant (final concentrations: 1M NaCl and 
10% PEG). The mixture was then stirred at 4 ºC for 1 h and then centrifuged at 11,000 g for 
20 min (Sorvall RC5 centrifuge). After centrifugation, the supernatant fluid was discarded Chapter 5. Vaccination  
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and the pellet resuspended in a minimal volume of PBS. Then, caesium chloride was added to 
a final concentration of 1.4 g/mL and the suspension centrifuged to isopycnic equilibrium 
(Beckman rotor SW 41Ti, 200,000 g at 4 ºC for 20 h). Virus containing fractions were then 
identified using HA and measured a log2 HA titre of 14 HAU/50 µL. 
 
5.3.9 Titration of BFDV inoculum after long term (~15 years) storage at -80ºC 
 
HA as described by Raidal et al. (1993c), was used to determine the titre of the above 
mentioned virus stocks after long term storage. Briefly, stock virus suspension was diluted 
1:2 or 1:10 in PBS. Then 50 µL of diluted stock was added to the first well of a U-bottom 96 
well microtitre plate and then diluted 1:2 across the plate. Fifty µL of 0.75% galah 
erythrocytes was then added to each well and the plate incubated at 37ºC for 45 min. The 
highest dilution that caused complete haemagglutination was determined to be the titre.  
 
5.3.10 BFDV challenge 
 
Vaccinated birds and non-vaccinated controls were challenged 16 days after the 
secondary injection (27 days post primary injection) with 0.5 mL BFDV, 0.4 mL 
administered intramuscularly in the pectoral musculature and 0.1 mL administered orally. 
 
5.3.11 Sampling 
 
Feathers and blood collected by jugular venepuncture, were taken from each of 13 
vaccinated corellas and each of the 5 non-vaccinated control birds on days 0, 11, 27, 40, 47, 
53, 68 and 124 post primary vaccination. Two vaccinated corellas were sampled for blood 
and feathers on days 0, 16, 32, 42, 50, 57, 64 and 92 post primary vaccination. One 
vaccinated galah was sampled for blood and feathers on days 0, 11, 27, 40, 47, 53 post Chapter 5. Vaccination  
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primary vaccination and the other galah was sampled on days 0, 11, 27, 40, 47, 53, 68 and 71 
post primary vaccination All corellas were sampled prior to euthanasia 270 days after BFDV 
challenge. The blood samples were spotted onto Whatman filter paper No. 3, allowed to dry 
for at least 1 h at room temperature and stored at 4°C until used. 
 
5.3.12 PCR, HI and HA 
 
Dried blood spots were excised from the filter paper using a stationary hole puncher 
(OfficeWorks, Australia) according to methods described by Bonne et al. (2008), deposited 
into 1.5mL Eppendorf tubes and DNA extracted using the QIAamp DNA Blood Mini kit 
(QIAGEN, Australia). PCR for detection of BFDV DNA was performed as described by 
(Ypelaar et al. 1999). Anti-BFDV HI antibody detection was performed on dried blood spots 
as described by Riddoch et al. (1996) and HA testing was performed on feather extracts 
according to the protocol developed by Raidal et al. (1993c) and as accounted for previously. 
 
5.3.13 Statistical analysis 
 
  One-way ANOVA with Tukey’s multiple comparison post test was performed using 
GraphPad Prism version 4.02 for Windows (GraphPad Software, San Diego California USA, 
www.graphpad.com) to test for significant difference in mean HI titres between the two 
groups (vaccinated vs. non-vaccinated) and between time-points within each group. 
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5.3.14 Quantitative real time polymerase chain reaction (qRT PCR) 
 
This work was performed by Dr Patrick Shearer. Briefly; qRT PCR was performed on 
the above mentioned DNA extracts and DNA extracts of feather samples (prepared as 
described in Chapter 2, pg 59). Briefly, Primers were designed based on conserved regions of 
known BFDV sequences (Wishart and Fortin 2001; Kumar et al. 2004; Wishart et al. 2000). 
Primers P5 (5’-GGA CGC AAA ATG AAG GAA G-3’) and P6 (5’-TAG CGA GAG GTT 
ATG CAA GC-3’) (Geneworks) were designed to amplify an 81bp fragment of ORF V1. 
Magnesium chloride concentrations and annealing temperatures were optimised using an 
Eppendorf Mastercycler Gradient thermocycler. The optimised PCR reactions consisted of 2 
mM MgCl2, 5 µL of 5x polymerisation buffer containing dNTPs, 3.34 µM SYTO9 
fluorescent dye (Invitrogen), 12.8 pmol of each primer and 0.1U of Tth Plus DNA 
polymerase, ultrapure water in a total volume of 23 µL (all reagents Fischer Biotec, except 
SYTO9), plus 2 µL of extracted DNA. Reactions were carried out in a Corbett Rotor-gene 
3000 (Corbett Research) real-time thermocycler. Cycling conditions consisted of an initial 
denaturation at 95ºC for 5 minutes, then 40 cycles of 95ºC for 20 seconds, 58ºC for 30 
seconds and 72ºC for 20 seconds, followed by a final extension step at 72ºC for 10 minutes. 
Known-copy-number DNA standards were included in each run for quantitation of viral load. 
The CT values obtained for these standards were graphed against time to construct a standard 
curve using the software supplied with the Rotor-Gene. The CT of each of the samples was 
then compared against the graph to estimate the viral load. Melt curve analysis was 
performed after each run. 
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5.3.15 Necropsy and pathological examinations 
 
All birds were euthanized and necropsied 270 days post BFDV-challenge. At this 
time blood and tissue samples were collected for serology, virus detection and 
histopathology. Feather samples were collected for HA and PCR assay. Liver was collected 
and stored at -20ºC for PCR (DNA extracted using the QIAamp DNA Mini kit (QIAGEN, 
Australia) and blood was collected for HI antibody and PCR as described above.  
 
Tissue samples collected at post mortem included skin and coelomic visceral organs 
which were fixed in buffered formalin for 24 hours and then processed by routine histology 
methods, stained with haematoxylin and eosin and examined by light microscopy. IHC using 
primary monoclonal antibody to recombinant BFDV capsid protein and a horseradish 
peroxidase (HRP) conjugated secondary antibody were performed on tissue sections as 
described previously (Shearer et al. 2008b).  Chapter 5. Vaccination  
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5.4 Results 
5.4.1 Western immuno-blot analysis of sucrose gradient purified recombinant protein 
 
All fractions isolated from the sucrose gradient that were analysed with western 
immuno-blot, were found to contain the histidine-tagged recombinant BFDV capsid protein 
as seen in Figure 5.1. The molecular weight of the recombinant protein was approximately 32 
kDa (Figure 5.1). This result is consistent with the results obtained by Stewart et al. (2007) 
using the same method. The protein in lane 2 and 6 were used for primary and secondary 
vaccination, respectively. 
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Figure  5.1 Western immuno-blot using mouse-anti-his tag (1° Ab) and goat-anti mouse alkaline 
phosphatase conjugate (2° Ab). Red box indicates the location of the recombinant protein. 
 
Lane 1: Biorad Precision Plus Protein 
Standard.  
Lane 2: Baculovirus expressed rec-BFDV 
capsid protein expressed for primary 
vaccination (10μL of 50% protein and 50% 
loading-dye loaded), purified in a 10% sucrose 
gradient column from infected Sf9 cells.  
Lanes 3-7: baculovirus expressed rec-BFDV 
capsid protein dialysed sucrose fractions (5μL 
of 50% protein/fraction loaded).  
Lane 3: Fraction 1. 
Lane 4: Fraction 2.  
Lane 5: Fraction 3.  
Lane 6: Fraction 4 (used for secondary 
vaccination). 
Lane 7: Fraction 5.  
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5.4.2 Quantification of recombinant protein for primary vaccination 
 
Proteomics international determined that the protein solution to be used for primary 
vaccination had a recombinant BFDV capsid protein concentration of 0.02 μg/μL (Figure 5.2, 
lane 1). 
 
 
 
 
 
Figure  5.2 SDS-PAGE gel used for quantification of Baculovirus expressed recombinant BFDV 
capsid protein produced for primary vaccination. Red box indicates the location of the recombinant 
protein. The image was kindly supplied by Proteomics International. 
 
Lanes: 
Mr: molecular weight marker  
1: Baculovirus expressed recombinant BFDV capsid protein 
2-7: Dilutions of BSA 
8-12: Dilutions of chicken serum albumin 
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5.4.3  Quantification of recombinant protein used for secondary vaccination 
 
Quantification of sucrose gradient fractions determined the following values for 
fractions 1-5 (Figure 5.3, lanes 7-10): 469.4 μg/μL, 405.4 μg/μL, 360.6 μg/μL and 812.9 
μg/μL, respectively. 
 
 
Figure  5.3 SDS-PAGE gel used for quantification of Baculovirus expressed recombinant BFDV 
capsid protein expressed for secondary vaccination. 
Lanes; 
1: Biorad Precision Plus Protein Standard.  
2-5: lysozyme and BSA standards (125μg, 
250μg, 500μg and 1000μg, respectively).  
6-10: protein fractions 1-5 obtained from 
sucrose gradient purification of protein 
expressed for secondary vaccination. 
Lane 6: this fraction had too high background 
to obtain a value. Chapter 5. Vaccination  
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5.4.4 Titration of BFDV for challenge of vaccinated and non- vaccinated birds 
 
The HA titre of the BFDV measured log2 12 HAU/50 μL (Figure 5.4). 
 
 
 
Figure  5.4 Results of HA titration of live BFDV stock used for live virus challenge of vaccinated and 
non-vaccinated birds. 
Rows;  
A; negative control (PBS and galah erythrocytes).  
B; 1:2 diluted virus titrated 1:2 across plate.  
C; 1:10 diluted virus titrated 1:2 across plate. 
 
 
 
 
Table 5.1  Summary of PCR results for vaccinated and non-vaccinated control birds from 0 days post 
challenge to 97 days post challenge. 
   Vaccinated birds  Non-vaccinated control birds 
Days post 
challenge 
Number of 
positive birds 
Number of 
negative birds 
Number of 
positive birds 
Number of 
negative birds 
0  0 13 0  5 
13  0 13 5  0 
20  0 13 5  0 
26  1 12 4  1 
41  3 10 3  2 
97  0 13 1  4 
270  0 13 0  5 
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5.4.5 PCR 
 
PCR results are summarized in Table 5.1, overleaf. Samples from all corellas were 
negative by PCR at the start of the vaccination/challenge study (results in Chapter 3). From 
the day of primary vaccination (day 0) to the day of challenge (day 27), all birds were PCR 
negative (Figures 5.5-5.7). Thirteen days post challenge with BFDV (Figure 5.8), all 5 non-
vaccinated controls (lanes 8, 9, 13, 15, 18) had become PCR positive for BFDV DNA and 
none of the vaccinated birds (lanes 1-7, 10-12, 14, 16-17 and 19-21) had detectable BFDV 
DNA. Twenty days post challenge (Figure 5.9), all non-vaccinated controls were still 
positive, and still no vaccinated birds had PCR detectable BFDV DNA. PCR of samples 
taken on day 53 (26 days post challenge) (Figure 5.10), 4 non-vaccinated controls were still 
positive and 1 vaccinated bird had become weakly positive. The two vaccinated birds tested 
on days 50, 64 and 92 were negative. Forty one days post challenge (Figure 5.11), 3 non-
vaccinated controls tested PCR positive (lanes 8, 16, 18) and 3 vaccinated had weak positive 
results (lanes 1, 17, 20). The 2 birds tested on day 57, were negative. Ninety seven days post 
challenge (Figure 5.12) all birds were found to be PCR negative. Chapter 5. Vaccination  
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Figure  5.5 PCR products of samples collected from the birds on the day of primary vaccination (day 
0, lanes 1-23) and on the day of secondary vaccination (day 11, lanes 24-49). As can be observed in 
the gel, all birds were PCR negative for BFDV. 
Lanes; 
M: Promega 100bp molecular weight ladder.  
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird B009 (non-vaccinated control bird). 
9: Bird EF7E (galah, cancelled from the 
experiment).  
10: Bird C852.  
11: Bird C548.  
12: Bird F357 (non-vaccinated control bird).  
13: Bird D6F7.  
14: Bird C8AE.  
15: Bird 52A5 (non-vaccinated control bird).  
16: Bird F7DD (galah, cancelled from the 
experiment).  
17: Bird 1245.  
18: Bird 07E4.  
19: Bird F0A8.  
20: DNA extraction positive control.  
21: DNA extraction negative control.  
22: PCR positive control reaction.  
23: PCR negative control reaction.  
24: Bird E25E.  
25: Bird DF28.  
26: bird E9FF.  
27: Bird A3F2.  
28: Bird E035.  
29: Bird E76C.  
30: Bird 2196.  
31: Bird FEF8 (non-vaccinated control bird).  
32: Bird B009 (non-vaccinated control bird).  
33: Bird EF7E (galah, cancelled from the 
experiment).  
34: Bird C852.  
35: Bird C548.  
36: Bird F357 (non-vaccinated control bird).  
37: Bird D6F7.  
38: Bird C8AE.  
39: Bird 52A5 (non-vaccinated control bird).  
40: Bird F7DD (galah, cancelled from the 
experiment).  
41: Bird 1245.  
42: Bird 89A0 (non-vaccinated control bird)  
43: Bird 07E4.  
44: Bird F0A8.  
45: Bird BF10.  
46: DNA extraction positive control.  
47: DNA extraction negative control.  
48: PCR positive control reaction.  
49: PCR negative control reaction.Chapter 5. Vaccination  
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Figure  5.6 PCR products of blood samples collected on the day of live virus challenge (day 27). As 
can be observed in the gel, all birds were PCR negative for BFDV DNA. 
 
Lanes;  
M: Promega 100bp molecular weight ladder.  
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird FEF8 (non-vaccinated control bird).  
9: Bird B009 (non-vaccinated control bird).  
10: Bird EF7E (galah, cancelled from the 
experiment).  
11: Bird C852.  
12: Bird C548.  
13: Bird F357 (non-vaccinated control bird).  
14: Bird D6F7.  
15: Bird C8AE.  
16: Bird 52A5 (non-vaccinated control bird).  
17: Bird F7DD (galah, cancelled from the 
experiment).  
18: Bird 1245.  
19: Bird 89A0 (non-vaccinated control bird).  
20: Bird 07E4.  
21: Bird F0A8.  
22: Bird BF10.  
23: DNA extraction positive control.  
24: DNA extraction negative control.  
25: PCR positive control reaction.  
26: PCR negative control reaction. Chapter 5. Vaccination  
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Figure  5.7 PCR products of blood samples taken on the day of challenge for two birds (32 days post 
primary vaccination). As can be observed in the gel, all birds were PCR negative for BFDV DNA. 
 
Lanes;  
M: Promega 100bp molecular weight ladder.  
1: Bird C8AE.  
2: Bird BF10.  
3: DNA extraction positive control.  
4: DNA extraction negative control.  
5: PCR positive control reaction.  
6: PCR negative control reaction. Chapter 5. Vaccination  
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Figure  5.8  PCR products of blood samples collected 13 days post live virus challenge (day 40). As 
can be observed in the gel (lanes 8, 9, 13, 15, 18), all 5 non-vaccinated control birds were PCR 
positive for BFDV DNA and all vaccinated birds were PCR negative. 
 
Lanes;  
MW: Promega 100bp molecular weight ladder.  
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird FEF8 (non-vaccinated control bird).  
9: Bird B009 (non-vaccinated control bird).  
10: Bird EF7E (galah, cancelled from the 
experiment).  
11: Bird C852.  
12: Bird C548.  
13: Bird F357 (non-vaccinated control bird).  
14: Bird D6F7.  
15: Bird 52A5 (non-vaccinated control bird).  
16: Bird F7DD (galah, cancelled from the 
experiment).  
17: Bird 1245.  
18: Bird 89A0 (non-vaccinated control bird).  
19: Bird 07E4.  
20: Bird F0A8.  
21: Bird BF10.  
22: DNA extraction positive control.  
23: PCR positive control reaction.  
24: PCR negative control reaction. Chapter 5. Vaccination  
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Figure  5.9  PCR of blood samples collected on day 47 (20 days post live virus challenge). As can be 
observed in the gel, all 5 non-vaccinated control birds (lanes 8, 9, 13, 15 and 18) and 1 vaccinated 
corella (lane 3) were PCR positive for BFDV DNA. The remaining vaccinated birds were all negative. 
Lanes;  
M: Promega 100bp molecular weight ladder.  
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird FEF8 (non-vaccinated control bird).  
9: Bird B009 (non-vaccinated control bird).  
10: Bird EF7E (galah, cancelled from the 
experiment).  
11: Bird C852.  
 
12: Bird C548.  
13: Bird F357 (non-vaccinated control bird).  
14: Bird D6F7.  
15: Bird 52A5 (non-vaccinated control bird).  
16: Bird F7DD (galah, cancelled from the 
experiment).  
17: Bird 1245.  
18: Bird 89A0 (non-vaccinated control bird).  
19: Bird 07E4.  
20: Bird F0A8.  
21: DNA extraction positive control.  
22: DNA extraction negative control.  
23: PCR positive control reaction.  
24: PCR negative control reaction. Chapter 5. Vaccination  
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Figure  5.10  PCR products of blood samples collected on day 53 (lanes 1-26, 26 days post live virus 
challenge), day 50 (lanes 27-28, 18 days post live virus challenge), day 71 (lane 29, 44 days post live 
virus challenge), day 64 (lane 30-31, 37 days post live virus challenge). As can be observed in the gel, 
4 of 5 non-vaccinated control birds (lanes 9, 13, 16 and 19) and 1 vaccinated corella (lane 18) were 
PCR positive for BFDV DNA. The remaining vaccinated birds were PCR negative. 
Lanes;  
M: Promega 100bp molecular weight ladder.  
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird FEF8 (non-vaccinated control bird).  
9: Bird B009 (non-vaccinated control bird).  
10: Bird EF7E (galah, cancelled from the 
experiment).  
11: Bird C852.  
12: Bird C548.  
13: Bird F357 (non-vaccinated control bird).  
14: Bird D6F7.  
15: Bird C8AE.  
16: Bird 52A5 (non-vaccinated control bird).  
17: Bird F7DD (galah, cancelled from the 
experiment).  
18: Bird 1245.  
19: Bird 89A0 (non-vaccinated control bird).  
20: Bird 07E4.  
21: Bird F0A8.  
22: Bird BF10.  
23: DNA extraction positive control.  
24: DNA extraction negative control.  
25: PCR positive control reaction.  
26: PCR negative control reaction.  
27: Bird C8AE.  
28: Bird BF10. 
29: Bird EF7E (galah, cancelled from the 
experiment).  
30: Bird C8AE.  
31: Bird BF10. 
32: Bird C8AE. 
33: Bird BF10.  
34: DNA extraction positive control.  
35: DNA extraction negative control.  
36: PCR positive control reaction.  
37: PCR negative control reaction. Chapter 5. Vaccination  
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Figure  5.11 PCR products of blood samples collected on day 68 (41 days post live virus challenge, 
lanes 1-14 and 16-20) and day 57 (25 days post challenge, lane 15 and 21). As can be observed in the 
gel, 4 of 5 non-vaccinated control birds (lanes 8, 13, 16 and 18) and 3 vaccinated corellas (lanes 1, 17 
and 20) were PCR positive for BFDV DNA. The remaining vaccinated birds were PCR negative. 
 
Lanes; 
M: Promega 100bp molecular weight ladder.  
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird FEF8 (non-vaccinated control bird).  
9: Bird B009 (non-vaccinated control bird).  
10: Bird EF7E (galah, cancelled from the 
experiment).  
11: Bird C852.  
12: Bird C548.  
13: Bird F357 (non-vaccinated control bird).  
14: Bird D6F7.  
15: Bird C8AE.  
16: Bird 52A5 (non-vaccinated control bird).  
17: Bird 1245.  
18: Bird 89A0 (non-vaccinated control bird).  
19: Bird 07E4.  
20: Bird F0A8.  
21: Bird BF10.  
22: DNA extraction positive control.  
23: DNA extraction negative control.  
24: PCR positive control reaction.  
25: PCR negative control reaction.Chapter 5. Vaccination  
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Figure  5.12 PCR products of blood samples collected on day 124 (97 days post live virus challenge). 
As can be observed in the gel, 1 non-vaccinated control bird (lane 14) was still PCR positive for 
BFDV DNA. The remaining birds were PCR negative. 
 
Lanes;  
M: Promega 100bp molecular weight ladder.  
1: Bird E25E.  
2: Bird DF28.  
3: bird E9FF.  
4: Bird A3F2.  
5: Bird E035.  
6: Bird E76C.  
7: Bird 2196.  
8: Bird FEF8 (non-vaccinated control bird).  
9: Bird B009 (non-vaccinated control bird).  
10: Bird C852.  
11: Bird C548.  
 
 
12: Bird F357 (non-vaccinated control bird).  
13: Bird D6F7.  
14: Bird 52A5 (non-vaccinated control bird).  
15: Bird 1245.  
16: Bird 89A0 (non-vaccinated control bird).  
17: Bird 07E4.  
18: Bird F0A8.  
19: DNA extraction positive control.  
20: DNA extraction negative control.  
21: PCR positive control reaction.  
22: PCR negative control reaction Chapter 5. Vaccination  
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5.4.6 HI  
 
Figure 5.13 illustrates the difference between vaccinated and non-vaccinated control 
bird’s seroconversion and Figures 4.14-4.17 are the HI results of the individual birds. Table 
5.2 summarizes the mean HI results. Prior to starting the vaccination and challenge studies, 
no birds had detectable levels of anti-BFDV-antibody using HI. Eleven days after primary 
vaccination only one vaccinated bird had detectable HI (log2 3 HIU/50 μL) and non-
vaccinated control bird blood samples did not have HI activity. There was an increase in HI 
antibody titre on day 27 (16 days post secondary vaccination) when 9 of 13 vaccinated birds 
had a detectable HI (mean HI titre ± SD = log2 2.67±1.12 HIU/50 μL).On day 40 (13 days 
post challenge) 10 of 13 vaccinated birds had detectable HI (vaccinated birds mean HI titre ± 
SD = log2 2.50±1.43 HIU/50 μL). On this day, 4 of 5 non-vaccinated control birds had a 
detectable HI (mean HI titre ± SD = log2 2.75±1.50 HIU/50 μL). By day 47 (20 days post 
challenge) all vaccinated birds had detectable HI titre (mean HI titre ± SD = log2 3.46 ± 1.51 
HIU/50 μL) and 4 of 5 non-vaccinated control birds had detectable HI (mean ± SD = log2 
5.00 ± 0.82 HIU/50 μL). On day 53 vaccinated birds had mean HI titre ± SD = log2 4.38 ± 
1.26 HIU/50 μL) and non-vaccinated control birds mean HI titre ± SD was log2 5.25 ± 1.26 
HIU/50 μL). On day 68, all non-vaccinated control birds had seroconverted (mean HI titre ± 
SD = log2 4.40 ± 1.95 HIU/50 μL) and vaccinated birds had a mean HI titre ± SD = log2 5.00 
± 1.00 HIU/50 μL). Finally, on day 124 of the experiment, vaccinated birds mean HI titre ± 
SD was log2 5.00 ± 1.15 HIU/50 μL) and the non-vaccinated control birds mean HI titre ± SD 
was log2 6.00 ± 1.22 HIU/50 μL). 
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5.4.7 Statistical analysis 
 
The Tukey’s multiple comparison post test did not find any significant difference 
between group means at each time point. However vaccinated birds had significantly 
different HI antibody titres on day 27 compared with day 68 (P<0.01). Similarly there were 
statistically significant differences between vaccinated birds on day 27 compared with day 
124 (P<0.01); vaccinated birds on day 27 compared with non-vaccinated control birds on day 
124 (P<0.01); vaccinated birds on day 40 compared with day 68 (P<0.01); vaccinated birds 
on day 40 compared with day 124 (P<0.01); vaccinated birds on day 40 compared with non-
vaccinated control birds on day 53 (P<0.05); vaccinated birds on day 40 compared with day 
124 (P<0.001); vaccinated birds on day 47 compared with non-vaccinated control birds on 
day 124 (P<0.05); and non-vaccinated control birds on day 40 compared with non-vaccinated 
control birds on day 124 (P<0.05). 
 
 
Table 5.2  Mean log2 HI titres ± SD vs. days post challenge. n: The number of birds that had 
detectable HI titre in that group. The vaccinated birds received the primary vaccine dose on day 0 and 
secondary dose on day 11. The live BFDV suspension was administered to all vaccinated and non-
vaccinated control birds on day 27. 
   Vaccinated birds Non-vaccinated control birds 
Days post 
challenge 
Mean log2HI 
titre SD  n 
Mean log2HI 
titre SD  n 
0 nil  nil  13  nil  nil  3 
11 3.00  -  1  nil  nil  5 
27 2.67  1.12  9  nil  nil  5 
40 2.50  1.43  10  2.75  1.50  4 
47 3.46  1.51  13  5.00  0.82  4 
53 4.38  1.26  13  5.25  1.26  4 
68 5.00  1.00  13  4.40  1.95  5 
124 5.00  1.15  13  6.00  1.22  5 
  Chapter 5. Vaccination  
  115
 
 
 
 
 
 
Figure  5.13  Comparison of vaccinated (n=13) and non-vaccinated (n=5) corellas showing 
seroconversion after vaccination and post BFDV challenge. Serum HI antibody titres as mean ± SD 
serum log2 HI titres for each group and the number of seropositive birds are shown at each time point. 
The individual feather HA and serum HI antibody results for one non-vaccinated control bird (52A5) 
are shown as bars along with the time points (asterisks) when this bird was PCR positive. 
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Figure 5.14a      Figure 5.14b 
 
 
Figure 5.14c      Figure 5.14d 
 
 
Figure 5.14e 
 
Figure 5.14 a-e Graphs showing log2 HI titres vs. days post start of experiment of individual non-
vaccinated control birds, that were injected with live BFDV on day 27). The birds were challenged on 
day 27 (black arrow). Red arrows indicate PCR positive time points. 
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Figure 5.15a                Figure 5.15b 
 
 
Figure 5.15c 
 
Figure 5.15a-c Graphs showing log2 HI titres vs. days post primary vaccination of 3 individual 
vaccinated birds that were transiently PCR positive during the period post live virus challenge. The 
birds received primary vaccine on day 0 (blue arrow), secondary vaccine on day 11 (green arrow) and 
were challenged on day 27 (black arrow). Red arrows indicate PCR positive time points. 
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Figure 5.16a      Figure 5.16b 
 
 
Figure 5.16c      Figure 5.16d 
 
 
Figure 5.16e      Figure 5.16f 
 
Figure 5.16a-f  Graphs showing log2 HI titres vs. days post primary vaccination of 6 individual 
vaccinated birds. The birds received primary vaccine on day 0 (blue arrow), secondary vaccine on day 
11 or 16 (green arrow) and were challenged on day 27 or 32 (black arrow), secondary vaccine on day 
11 or 16 (green arrow) and were challenged on day 27 or 32 (black arrow). Chapter 5. Vaccination  
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Figure: 5.17a      Figure: 5.17b 
 
 
Figure: 5.17c      Figure: 5.17d 
 
 
Figure: 5.17e      Figure: 5.17f 
 
Figure 5.17a-f  Graphs showing log2 HI titres vs. days post primary vaccination of 6 individual 
vaccinated birds. The birds received primary vaccine on day 0 (blue arrow), secondary vaccine on day 
11 (green arrow) and were challenged on day 27 (black arrow). 
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5.4.8 HA 
 
Excretion of virus from feathers could not be detected in any samples from vaccinated 
birds using HA. Of 5 non-vaccinated control birds, only 1 bird tested positive by HA for 
excretion of virus in feathers. This bird was HA negative on days 0, 11, 27, 40, 47 and 124. 
However, on day 53 (26 days post challenge) and day 68 (41 days post challenge) this bird 
had a HA titre of log2 12 HAU/50 μL and > log2 12 HAU/50 μL, respectively. This birds HA 
and HI developments are illustrated in Figure 5.13.  
 
5.4.9 qRT PCR 
 
These results were obtained and provided by Dr. Patrick Shearer and published in 
Shearer et al. (2009). The assay successfully detected BFDV DNA in the blood of all control 
(non-vaccinated) corellas (Figure 5.18A) In non-vaccinated control birds the viral load±SE 
was estimated at 1 358 473±1 113 226 copies/µL (range 14 478 to 5 768 973 copies/µL) at 2 
weeks post challenge and rose to a peak of 4 850 482±4 775 008 copies/µL (range 1 709 and 
23 949 983 copies/µL) by 4 weeks post challenge before dropping to 575 486±551 069 
copies/µL (range 823 and 2 779 419 copies/µL) at 6 weeks post challenge. Transient low-
level viraemia of between 58 and 4 057 copies/µL was detected in 6 vaccinated birds at 
various time points, but all birds were seropositive at the times when viral DNA was present 
in blood samples. The viral load in blood samples of vaccinated birds followed a similar 
pattern to that of the non-vaccinated control birds, with mean viral loads increasing in a 
curvilinear fashion from 58 copies/µL at 2 weeks post challenge to a peak of 1177±723 
copies/µL (range 209 to 4 057 copies/µL) by 6 weeks post challenge (Figure 5.18A). Specific 
peaks were present in the melt curves of BFDV-positive samples between 82 – 84.5ºC. 
The assay also detected BFDV DNA in the DNA extracts of HA feather preparations 
(Figure 5.18B). The mean viral load±SE in feather extracts of control birds was estimated at Chapter 5. Vaccination  
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8 831±4 662 (range 262 to 20 639 copies/µL) at 2 weeks post challenge, rose to a peak of 852 
500 308±681 941 583 copies/µL (range 2 591 to 3 409 766 576 copies/µL) at 4 weeks post-
challenge, then decreased to 380 734 071±380 729 701 copies/µL (range 430 to 1 903 652 
876 copies/µL) by 6 weeks post challenge. Virus was detectable by HA in the feather 
samples of only one control bird at 4 and 6 weeks post challenge, which were also the 
samples that had the greatest amount of viral DNA present. Viral DNA was present in the 
feather extracts of 3 vaccinated birds 2 weeks post-challenge, 6 vaccinated birds at 4 weeks 
post-challenge and 10 vaccinated birds 6 weeks post-challenge. However, none of these 3 
birds had detectable viral DNA in the equivalent blood sample at 2 weeks post-challenge. At 
4 and 6 weeks post challenge, only 1 of 6 and 4 of 10 birds respectively had detectable 
amounts of viral DNA in the equivalent blood sample (between 193 and 420 451 copies/µL). 
The samples which were positive on qRT PCR of feather extracts but negative on blood 
samples were considered to be false positives. 
 
 
 
 
Figure 5.18 Mean viral load in A: blood and B: feather preparations of control and vaccinated birds 
after challenge with beak and feather disease virus (BFDV). Peak viral load was greater in feather 
preparations than in blood samples for both groups of birds. Bars indicate standard error. Chapter 5. Vaccination  
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5.4.10 Clinical and post mortem observations 
 
Non-vaccinated control birds developed feather sheath thickening and dysplasia of 
varying severity in individual developing powder-down and crest feathers 2-4 weeks post 
challenge. This included pinching-off of the developing calamus which is a pathognomonic 
sign for PBFD. No other clinical signs were observed in non-vaccinated control birds or 
vaccinated birds. 
 
Compared with a geometric mean HI antibody titre of log2 4.48 (combined results) at 
97 days post-BFDV challenge at 270 days post-challenge the geometric mean HI antibody 
titre was log2 4.47 and all birds were blood, feather and liver PCR negative. All birds 
appeared clinically normal with no evidence of gross or histological lesions detected in skin 
or visceral organs. There was a range in size of the bursa of Fabricius but in the majority the 
bursa was approximately of equal size to the spleen and both of these organs contained 
evidence of normal lymphoid follicles at different stages of development or involution and 
there was no evidence of intracytoplasmic BFDV inclusions. Also, there was no evidence of 
intracytoplasmic BFDV antigen in any tissues by IHC (Figure 5.19).  
 
The 2 galahs included in this experiment became ill within 4 weeks after virus 
challenge and were euthanized. These 2 birds were weakened and had lost body weight due 
to inability to eat caused by loss of body tone. They were still trying to ingest food however; 
they were incapable of maintaining natural posture and incapable of lifting their necks. No 
clear clinical signs of PBFD were observed and they had tested consistently negative in PCR 
and HA for BFDV up to the day of euthanasia. However, these 2 birds did seroconvert with Chapter 5. Vaccination  
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maximum HI titres of log2 5. The cause of their illness was not confirmed and histological 
examination of their organs, also did not demonstrate any significant lesions (Dr G Knowles, 
personal communication). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.19  IHC results. A) Positive control; a section of feather from an unrelated PBFD- affected 
galah and B) example IHC of a section of feather from a non-vaccinated control corella (F357) in this 
experiment. As can be seen in these sections, the positive control feather (A) had many positively 
(brown) intracytoplasmic BFDV inclusions, whereas the feather section from the non-vaccinated 
corella (B) did not. 
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5.5 Discussion 
 
The results obtained in this experiment indicate that the use of recombinant BFDV 
capsid protein is a viable option for vaccination to stimulate an adaptive immune response to 
BFDV. Vaccinated birds were found to develop low HI antibody titres after vaccination and 
did not develop clinical signs consistent with acute infection after BFDV challenge. The 
frequency of PCR and HA positive time points was lower in vaccinated birds compared to 
non-vaccinated control birds. Vaccinated birds were never PCR positive in blood at more 
than one time point and did not have HA detectable feather excretion, whereas non-
vaccinated control birds remained PCR positive for more than 3 weeks and HA feather 
excretion was detected twice. 
 
The objective of vaccination is to stimulate the adaptive immune system and thereby 
limit the potential for development of clinical disease following exposure to pathogens. 
Vaccination as a means of control of BFDV has been proven effective (Raidal et al. 1993a; 
Raidal and Cross 1994a). However, these early investigations into vaccination against BFDV 
relied on the production of vaccine from feathers of chronically infected sulphur crested 
cockatoo. As BFDV has not been successfully propagated in vitro, the development of a 
useful vaccine against BFDV has been hindered by the lack of suitable method of vaccine 
production and the problems with acquiring suitable BFDV-free flocks of psittacine birds. 
Stewart et al. (2007) therefore used recombinant protein technology for production of BFDV 
antigens that, amongst other things, could potentially be used for successful immunization of 
psittacine birds against BFDV. 
This baculovirus expressed recombinant BFDV capsid protein was predicted to be a 
good candidate for vaccination against BFDV, as it was found capable of self assembly into 
virus like particles and that it haemagglutinated, indicating that epitopes involved in virus Chapter 5. Vaccination  
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attachment had been reproduced in the recombinant capsid protein. Therefore, this method of 
recombinant vaccine production was chosen for assessment of the possibility of control of 
BFDV via vaccination.  
 
In this presented experiment, 15 corellas and 2 galahs were given a primary 
vaccination with baculovirus expressed recombinant BFDV capsid protein and then received 
secondary vaccination 11 or 16 days later with the same vaccine. Five corellas were 
maintained as non-vaccinated control birds that did not receive any vaccine and were housed 
together with the vaccinated birds throughout the experiment. All birds used in this 
experiment were proven free of BFDV and free of BFDV antibody prior to the start of the 
experiment. On day 27 post primary vaccination, all vaccinated and non-vaccinated control 
birds were challenged with live BFDV that had been isolated from the feathers of a BFDV 
affected sulphur-crested cockatoo. All birds were sampled for blood and feathers before each 
vaccination and the challenge and then at several time points up to 124 days post primary 
vaccination. The blood samples were tested for BFDV DNA by PCR and for anti-BFDV 
antibody by HI. Feathers were tested for excreted BFDV by HA. 
 
As early as 11 days post vaccination, HI detectable antibody was present in some 
vaccinated birds (Figure 5.15b). As expected, non-vaccinated control birds (having not 
received any vaccine) did not seroconvert until after being challenged with live BFDV 
(Figures 4.14a-e). Thirteen days post challenge, all non-vaccinated control birds were PCR 
positive in blood (Figures 4.14a-e), whereas vaccinated birds remained PCR negative. At the 
same time point, non-vaccinated control birds had a mean HI rise from log2 0 HIU/50 μL on 
the day of challenge to log2 2.2 HIU/50 μL (13 days post challenge). Vaccinated birds had a 
mean HI rise from log2 1.85 HIU/50 μL to log2 1.92 HIU/50 μL (Figure 5.13). 
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Some vaccinated birds became PCR positive on separate occasions later than 13 days 
post challenge (Figures 5.15a-c). However, these vaccinated birds did not remain PCR 
positive at subsequent time points. Non-vaccinated control birds on the other hand were all 
PCR positive in blood 13 and 20 days post challenge and remained PCR positive in blood up 
to 97 days post challenge.  
 
The qPCR results provided by Dr Patrick Shearer and published in Shearer et al. 
(2009) indicated that there was reduced virus replication in vaccinated corellas compared 
with non-vaccinated control corellas. The qPCR assay detected viral DNA in birds that tested 
negative by the standard PCR and demonstrated that the viral load in both vaccinated and 
control birds increased for the first 4 weeks after challenge. That this occurred despite 
vaccinated birds having detectable anti-BFDV antibodies before being challenged indicates 
that vaccination does not prevent viral replication. This is a common scenario with other 
vaccines (Opriessnig et al. 2006) and is not surprising in this case. This is evidence that viral 
replication may not have been detected if a standard PCR assay alone had been used. Given 
that vaccination does not prevent viral replication, it is likely that the chicks of vaccinated 
birds will still be susceptible to transient infection and virus replication in the presence of 
maternal antibodies, as occurs with porcine circovirus type 2 (Larochelle et al. 2000) and 
chicken anemia virus (Brentano et al. 2005). This has implications for the management of the 
disease in infected flocks. 
 
Thus, as was found by Raidal (1994), vaccination did not prevent virus replication 
and if latent infections do occur with BFDV, this might not be prevented. However, more 
than 1 year post challenge these vaccinated birds have remained clinically normal. 
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One non-vaccinated control bird (bird ID 52A2) had test results typical of acute 
PBFD; PCR positive for BFDV DNA in blood before it was HI positive and had virus 
excretion in the feathers (Figure 5.13). This bird was PCR positive throughout the challenge 
period and was the latest to develop detectable HI (day 68, log2 1 HIU/50 μL). The inability 
to produce early HI detectable antibody was probably the reason for this bird being the only 
individual with feather HA excretion. The difference between this bird and other non-
vaccinated control birds could be attributed to biological differences. For example, this bird 
may have had a higher affinity of virus to cell surface receptor, which would increase the 
relative infectivity of the virus. Also, this bird may have been immunologically weaker than 
the others either through genetics or through harbouring immunosuppressive pathogens. 
Environmental factors such as presence of toxic materials, of which it may have consumed, 
could have caused immune suppression, however this is unlikely as other birds would have 
been influenced as well and the bird maintenance rooms were set up with these factors in 
mind. 
The two galahs included in this study, both became severely ill after challenge with 
BFDV. The reasons for this are not clear. Post mortem examination did not reveal any lesions 
consistent with PBFD, neither did PCR, HI and HA testing show evidence consistent with 
PBFD. Therefore, it seems unlikely that the disease seen in these birds was related to BFDV 
infection. These findings could however be related to the vaccine, perhaps this is an 
indication of the recombinant protein being toxic to galahs or properties of the adjuvant. 
Freuds incomplete adjuvant is used in experimental vaccinations, due to its efficient immune 
stimulatory effects, but is not incorporated into commercial vaccination protocols, due to its 
potential adverse effects. 
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Previous vaccination and challenge experiments by Raidal (1994) utilized 9 nestling 
sulphur-crested cockatoo and 4 nestling galahs that were vaccinated and then challenged and 
3 galah and 6 sulphur-crested cockatoo nestlings that only received the challenge dose. All 
these birds were challenged with the exact same inoculum as was used in the current 
experiment and the inoculum was produced from a chronically infected sulphur-crested 
cockatoo. Birds used by Raidal (1994) received 0.5 mL of inoculum orally and 0.5 mL IM. 
The current experiment used 0.4 mL inoculum IM and 0.1 mL orally. Vaccinated sulphur-
crested cockatoos remained clinically normal after challenge and developed high HI titres 
(log2  6-12 HIU/50μL). In the vaccinated galahs, HA titres (log2 3-5 HAU/50μL) were 
detected in grossly normal contour feathers and their HI titres went from log2 3 HIU/50μL on 
the day of challenge to 0 HIU/50μL in concurrent samples. The non-vaccinated control birds 
developed acute PBFD. Raidal (1994) also found that this inoculum caused fatal PBFD in 
sulphur-crested cockatoo chicks. 
 
In this presented experiment, none of the vaccinated corellas developed clinical signs 
of PBFD and viral excretion in their feathers could not be detected by HA. Their HI titres 
after challenge were high (maximum: log2 7 HIU/50 µL) but were of lower magnitude than 
that observed previously (Raidal 1994). Non-vaccinated corellas showed only mild clinical 
signs, but one bird was found to have BFDV excretion in the feathers. This bird had test 
results typical of acute PBFD. Thus the results obtained here and those by Raidal (1994) are 
similar, but Raidal (1994) observed a higher frequency of clinical disease in non-vaccinated 
birds. Non-detectable feather excretion of virus by HA does not necessarily mean lack of 
virus excretion. Failure to detect virus excretion is likely to be due to the sensitivity of the 
HA assay. An ELISA assay would be more useful for detecting and quantifying virus Chapter 5. Vaccination  
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excretion in feathers, however a BFDV ELISA assay was not available at the time of this 
experiment.  
 
The differences between the two experiments could be accountable to several factors: 
The inoculum had been stored for a long time and HA titration showed a 2 log2 decrease in 
viral titre. However this is not a large difference and if intra-test variation is kept in mind, the 
actual difference may be even smaller. The amount of inoculum delivered to each bird in the 
experiment by Raidal (1994) was twice that used in the current experiment. This is 
significantly different and may amount to some of the differences in observations. However, 
the challenge doses used in these two experiments are probably much higher than a “natural” 
challenge dose, and should therefore be ample to produce clinical disease if such is dose 
dependant. Additionally, IM injection is a highly effective way of transmitting disease. 
Additionally, BFDV is thought to transmit through ingestion of virus through for example 
preening, a process that was simulated in this experiment by oral administration of virus. The 
orally administered dose alone could be considered a much higher dose than a “natural” 
challenge dose. 
 
In the current literature, there is debate about the existence of species specific or 
species adapted genotypes of BFDV (Bassami et al. 2001; Phenix et al. 2001; Ritchie et al. 
2003; Raue et al. 2004; Khalesi et al. 2005). If such species adaptation is a reality, then it 
would be fair to propose this as a factor influencing the difference in infectivity observed in 
these two experiments, as different genotypes may have differing epitopes and thus differing 
antigen – receptor affinity between bird species. However, in pathogenesis studies by Raidal 
(1994), 18 adult galahs, 3 nestling galahs and 6 nestling sulphur-crested cockatoos (6-7 
weeks of age) were challenged with the previously mentioned inoculum. Only 1 adult galah Chapter 5. Vaccination  
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had signs indicative of PBFD (diarrhoea and high faecal excretion of virus followed by 
death). Nestling galahs had a gradual onset of PBFD clinical signs (dystrophic plumage) and 
developed high titres of excreted virus in the feathers. Nestling sulphur-crested cockatoos 
developed acute PBFD within 4 weeks and died. Common clinical signs observed in these 
birds were: lethargy, inappetence, crop stasis, green faeces containing urates and green 
discoloration of the periophthalmic skin. Wing tips were swollen and painful associated with 
necrosis and fracturing of developing remiges. Thus adult galahs appear more resistant to 
developing clinical PBFD than nestling galahs and nestling sulphur-crested cockatoos also 
develop serious clinical disease but it is not known whether adult sulphur-crested cockatoos 
are equally susceptible.  
 
The age of the birds in the current experiment ranged from 13 weeks to 16 weeks of 
age. It is therefore also possible that the age difference between birds in the two experiments 
was an influencing factor on the development of clinical signs. This is supported by nestling 
birds having an immature immune system due to their age. A vital part of a bird’s immune 
system development is the bursa of Fabricius (BF), which only exists in immature birds. The 
BF is required for the development of a B-cell repertoire. Immature B-cells migrate from the 
bone marrow to the BF where there is negative selection, generation of diversity by gene 
conversion and positive selection. After these selection processes, mature B-cells migrate to 
secondary lymphoid organs and other tissues where they can encounter antigens and be 
stimulated to secrete antibodies. In these peripheral tissues, further diversity is accomplished 
by somatic mutation (Tizard 2002).  
 
In Galliforme birds, the BF reaches its largest size 4 to 6 months post hatching. After 
this, involution starts and the BF is completely gone by 1 year post hatch (Glick 1983; Chapter 5. Vaccination  
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Naukkarinen and Sorvari 1984). However, nothing is known about the development and 
subsequent involution of the BF in cockatoos. Nonetheless, nestling birds are less 
immunologically competent than older birds and this is a likely reason for why the non-
vaccinated chicks in the experiment by Raidal (1994) developed more serious clinical disease 
than the non-vaccinated birds in this experiment. The BF has been suggested as a primary site 
of virus replication along with intestinal epithelium and the duodenum (Pass and Perry 1984). 
Thus, mature birds may have an advantage over young birds in overcoming infection, in that 
they are lacking one of the sites of virus replication, namely the BF, which could contribute 
to the difference in clinical observations between the two experiments. This is supported by 
observations made in pathogenesis studies, where galah and sulphur-crested cockatoo chicks 
developed acute PBFD, whereas adult birds of these species remained clinically normal 
(Raidal et al. 1993a). 
 
The species of bird may also affect the ability for virus to cause disease in other ways. 
Entry of virus into tissues and thus its ability to cause clinical disease is dependant on viral 
attachment to cellular receptors to gain entry into cells (Flint et al. 2000). The virus to 
cellular receptors affinity may vary between species and also between individuals within 
species thereby influencing susceptibility to infection. Although experiments to determine 
this have not been conducted, this theory is supported by findings in our laboratory and in the 
literature (Raidal et al. 1993c); not all birds, even within one species, have erythrocytes that 
can be sensitized with BFDV for use in haemagglutination assays, thus bird genetics is likely 
to be influential. 
 
The small decline in HI antibody data between days 97 and 270 days post BFDV-
challenge indicates that anti-BFDV HI antibody persists in immune birds and may well do so Chapter 5. Vaccination  
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for many years. Epidemiological data supports this observation (Raidal et al., 1993b). An 
annual rate of decline of log2 0.22 can be calculated from the data because during these 2 
time points it is likely that that antibody titres were not being maintained by on-going 
immune stimulation. The birds were held as a closed flock and no evidence of persistent 
BFDV infection or excretion was detected in blood samples collected on day 97 and blood, 
feathers and liver collected at post mortem on day 270 post-challenge. At this time point they 
were all at least 1 year old and all, including the control birds had normal lymphoid tissue in 
the bursa of Fabricius and spleen.   
 
These results are significant for understanding the pathogenesis of PBFD since it has 
been previously hypothesised that infected birds might have a long latency period of up to 2 
years, whereby they remain clinically normal until the progression of the disease is 
accelerated following stress or moulting is commenced. It is also well accepted that birds 
with acute or chronic PBFD lesions suffer from a compromised immune system with the 
presence of characteristic intracytoplasmic viral inclusions readily identifiable in the bursa 
and the presence of chronically persistent viral excretion. As far as this author is aware, this is 
the first report that demonstrates the relatively long retention (greater than 1 year) of bursal 
activity in any Cacatua species. The involution of the bursa of Fabricius in chickens occurs 
much earlier than this and is completely atrophied by 24 weeks of age (Naukkarinen and 
Sorvari 1984). Given the data presented in this Chapter it seems likely that the bursa of 
Fabricius of C. tenuirostris retains significant function as a peripheral lymphoid organ until at 
least 1 year of age. It may be that primary immune-suppression is first required to permit 
establishment of chronic BFDV infection, excretion and the pathogenesis of chronic feather 
and lymphoid lesions at least in fledgling corellas up to the age of 2 years.  
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In this experiment, vaccination with recombinant BFDV capsid protein was found to 
elicit immune response detectable by HI assay. The observation of mild clinical signs and 
detection of consistent viraemia by PCR in non-vaccinated control birds shows that the 
challenge inoculum was infective and disease causing, even after approximately 15 years of 
storage. The lack of clinical signs and detection of only occasional transient viraemia in 
vaccinated birds provides evidence for the protective properties of this vaccine, but also 
supports the notion that vaccination does not stop virus replication. Excretion of virus in 
feathers is an indication of disease development, as replication of virus in feather follicles and 
other organs is associated with PBFD.  
 
Although only 1 bird (non-vaccinated control, 52A5) had feather excretion of virus, 
this does not necessarily mean that the inoculum is not highly infective, as there were only 5 
controls and this is a statistically low number. In contrast, none of the 17 vaccinated birds had 
virus excretion in feather that could be detected by HA, thus there is seems to be significant 
difference in the progression of infection between vaccinated and non-vaccinated birds that 
were challenged with BFDV. 
 
This vaccine was found to decrease infectivity of BFDV, thereby inhibiting 
development of clinical disease and can be considered useful for control of BFDV in 
cockatoos. However the data presented here does not give evidence for the usefulness of 
vaccination to eradicate BFDV in infected flocks. Additionally, the long term protection of 
this vaccine has not been determined as it was outside the scope of this project. It would be 
useful to challenge these birds again years later to determine whether this vaccine also 
elicited a memory immune response. Further work is needed to determine an optimal 
vaccination regime. This would include determining optimum antigen dosage per vaccination Chapter 5. Vaccination  
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dose, the amount of time between primary and secondary vaccination; the appropriate ages of 
bird that could be vaccinated; the positive and negative effects of passive transfer of maternal 
antibody; the choice and effect of suitable adjuvant and the safety of various routes of 
administration. 
 
This baculovirus expressed recombinant BFDV capsid protein was immunogenic as 
vaccinated birds developed HI detectable anti-BFDV antibody and non-vaccinated controls 
did not. This vaccine also elicited protection against challenge with live BFDV, the evidence 
for this given by vaccinated birds not developing consistent PCR detectable viremia after 
challenge and did not develop clinical signs. Non-vaccinated control birds however, were all 
PCR positive within 13 days of challenge and remained PCR positive up to 97 days post 
challenge and had mild clinical disease. This indicates that the administration of recombinant 
BFDV protein decreases infectivity of BFDV in Cacatua tenurostris. This is a good indicator 
for the usefulness of recombinant BFDV capsid protein in controlling PBFD. Chapter 6. Haematological response 
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Chapter 6 : Haematology of Corellas during a 
BFDV Vaccination and Challenge Study 
 
6.1 Summary 
 
The haematological characteristics of juvenile long-billed corellas, with or without 
prior administration of a BFDV vaccine were studied for 97 days after experimental infection 
with BFDV. It was found that the pre-challenge haematological values were similar between 
vaccinated and non-vaccinated corellas. Most pre-challenge parameters were comparable to 
previously reported values of other cockatoos and psittacine birds. Significant differences 
were seen in both groups when comparing pre-challenge values with post challenge values 
for total and differential leukocyte concentrations, but PCV and TSP were not significantly 
affected by BFDV challenge. 
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6.2 Introduction 
 
Haematology is a valuable tool for the diagnosis and monitoring of disease in animals, 
including birds. In order to use haematology for diagnostics and prognostics, established 
haematological reference values for the species is a minimum requirement. Observed changes 
in haematology can indicate the presence of disease, increased or decreased immune system 
activity and aid in diagnostics and prognostics. However, avian haematology is a field in its 
infancy. The number of species, both within the Class Aves and within the Order 
Psittaciformes, makes the task of collecting information on haematological aspects a 
significant challenge. Normal haematological values for birds typically have a wide range 
compared to those of domestic mammals. This is due to several factors, both intrinsic and 
extrinsic. The variability results from different environment and management factors that 
may influence physiological responses. Some examples are factors such as stress related to 
age, capture or captivity, caging, social interactions, environmental conditions, moult, 
disease, temperature, seasons, growth rate, diurnal rhythm, gender, age and diet which may 
affect leukocyte numbers. In example, birds often become stressed during blood collection 
and physiological leukocytosis may result. Because of this, published reference values should 
only be used as guidelines (Campbell and Ellis 2007).  
 
Avian medicine is a niche field, with comparatively few veterinarians choosing to 
specialize in this field despite the increasing popularity of birds as pet and the increasing need 
for conservation of these species. As a result, there is comparatively little knowledge of 
aspects such as haematology in birds and information is mainly available for birds relevant to 
industry, such as poultry. Characterised psittacine species include; white cockatoo (Cacatua 
alba), Goffin’s cockatoo (Cacatua goffini), black cockatoo (Calyptorhynchus funereus), 
yellow Amazon (Ara ararauna), blue-fronted Amazon (Amazona aestiva), orange-winged Chapter 6. Haematological response 
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Amazon (Amazona amazonica), festive Amazon (Amazona festiva), vinaceous Amazon 
(Amazona vinacea), Cuban Amazon (Amazona leukocephala), scarlet macaw (Ara macao), 
green-winged macaw (Ara chloroptera), military macaw (Ara militaris), golden conure 
(Aratinga guarouba), Patagonian conure (Cyanoliseus patagonus), palm cockatoo 
(Probosciger aterrimus), African grey parrot (Psittacus erithacus), hyacinth macaw 
(Anodorhynchus hyacinthinus), red lory (Eos bornea), African grey timneh (Psittacus 
erithacus timneh), yellow-fronted Amazon (Amazona ochrocephala ochrocephala), double 
yellow-headed Amazon (Amazona oratrix), yellow-naped Amazon (Amazona auropalliata), 
mealy Amazon (Amazona farinosa farinosa),  sulfur-crested cockatoos (Cacatua sulfurea 
sulfurea, C. s. abbotti , C. s. citrinocristata),  greater sulfur-crested cockatoo (Cacatua 
galerita triton), Moluccan cockatoo (Cacatua moluccensis), red-and-blue lory (Eos histrio), 
violet-necked lory (E. squamata), blue-streaked lory (E. reticulate) and black-winged lory (E. 
cyanogenia) (Lumeij and Overduin 1990; Polo et al. 1998; Scope et al. 2000).  
 
The haematology of birds during anti-BFDV vaccination and BFDV infection is also 
lacking heavily in depth. Birds affected by BFDV commonly die due to secondary infections 
and is therefore believed to be immune-suppressive (Latimer et al. 1990; Latimer et al. 1992; 
Schoemaker et al. 2000). Bursal and thymic lesions are commonly observed in BFDV 
infected birds and this supports this notion (Latimer et al. 1990). Cytoplasmic inclusions are 
also frequently found in macrophages present in affected epidermis, in the feather pulp cavity 
and in lymphoid tissue which also strengthens the hypothesis of immune-suppression caused 
by BFDV (Latimer et al. 1991).  
 
The abnormal feathering seen in BFDV infection is caused by a dystrophic process 
within the epidermis of the feather (Pass and Perry, 1984). The virus appears to target Chapter 6. Haematological response 
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actively dividing cells of the basal layers of the epithelium (Latimer et al. 1991). As the virus 
has an affinity for dividing epithelial cells [feather pathology is evident during the moulting 
season, outside this season there is little feather pathology (Pass and Perry 1984)], it is 
possible that this affinity is due to the dividing nature of the cell, rather than the epithelial 
nature of the cell (or both). This would make sense, as the dividing cell is already actively 
replicating DNA and transcribing proteins, two processes that are also necessary for the 
replication of virus. Thus an infected bird will be stimulated to replicate cells of the immune 
system, which would further cause the virus to seek out these cells for its own replication. 
Viral replication within these cells would then be responsible for the depletion of immune-
cells and associated immune-suppression. 
 
In young birds, the bursa of Fabricius is an important organ for development of B-cell 
repertoire (Tizard 2002). Since BFDV commonly causes atrophy of lymphoid tissue and 
focal necrosis of the bursa and thymus (Latimer et al. 1991), it is likely that such destruction 
could contribute to leukocyte depletion and associated immune-suppression. 
 
There have been reports of BFDV aggregates in macrophages (Pass and Perry 1984; 
Latimer et al. 1991; Kiatipattanasakul-Banlunara et al. 2002) and in basophils (Schoemaker 
et al. 2000). However, it is not clear whether these intra-macrophage aggregates were due to 
the normal function of macrophages or because of the virus entering the cell for its own 
purposes. 
 
A case study of 2 juvenile BFDV affected African grey parrots by Doneley (2003) 
found splenic and hepatic erythrophagocytosis, multi-focal necrosis in the spleen associated 
with eosinophilic intranuclear inclusion bodies and numerous large, basophilic, amorphous Chapter 6. Haematological response 
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intracytoplasmic inclusion bodies in the bursa of Fabricius. These birds were diagnosed as 
immune-suppressed (due to BFDV) with secondary viral and fungal infections. In these birds, 
there was severe depletion of lymphoid tissue and multifocal necrosis with leukocytic 
infiltration and stromal oedema, accompanied by moderate infiltrates of lymphocytes and 
plasma cells. Necrosis and dysplastic regeneration were observed in medullary macrophages 
and reticular epithelial cells. Large intracytoplasmic and intranuclear basophilic inclusion 
bodies were also seen. 
 
Only a few reports on the haematological aspects involved in the progression of 
PBFD have been made. In a case report of 14 BFDV infected African grey parrots 
(Schoemaker et al. 2000) there was severe leukopaenia and anaemia or pancytopaenia, 
despite lacking feather and beak abnormalities. A study by Jacobson et al. (1986) found that 
BFDV infected south-east Asian Cacatua spp. had very low serum protein concentrations. 
Other than this, there have been no reports on haematology associated with BFDV infection 
and current assessment of birds undergoing BFDV infection only consider antibody levels, 
presence of BFDV particles and BFDV DNA in blood and feathers and observation of 
clinical signs. Information on haematological changes in BFDV infection would be useful for 
assessing development of disease and for prognostics.  
 
To date, there have been no reports on the haematological aspects of healthy as well 
as diseased corella (Cacatua tenuirostris). However, there is a belief that there is little 
variation in these parameters across species (Polo et al. 1998). This in addition to the wide 
range in reference values makes it possible to use related species’ reference values as a guide 
for studying previously unstudied species. However, as these aspects have not been 
previously described, care must be taken when using cross species references. This Chapter 6. Haematological response 
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experiment investigated the normal haematology of anti-BFDV vaccinated and non-
vaccinated corella and compared these values to normal values available for other Cacatua 
and psittacine species. Specifically TSP, PCV, total leukocyte counts and differential 
leukocyte counts were performed. Further, to assess whether BFDV infection causes 
depletion of circulating leukocytes and other haematological changes; the mentioned 
parameters were measured before challenge and at several time points after challenge with 
BFDV and compared to each other. 
 
Although leukocytes have been described in a number of psittacine birds, an exact 
morphological description of corella and galah leukocytes is not currently available in the 
literature. Therefore, the morphology of corella leukocytes including monocytes, 
lymphocytes, heterophils, eosinophils and basophils was studied to establish accurate 
descriptions of these cells in order to facilitate the haematological measurements that require 
identification of specific white blood cells. Studying haematological aspects of psittacine 
birds undergoing BFDV infection may provide information on the proposed 
immunosuppresion caused by BFDV. 
 
The aim of this study was to determine normal haematological values for corellas 
(both anti-BFDV vaccinated and non-vaccinated) and then to determine whether vaccinated 
and non-vaccinated corellas show evidence of altered haematology after challenge with 
BFDV and finally whether there was a significant difference between these two groups in 
their haematological response to BFDV. 
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6.3 Materials and Methods 
6.3.1 Blood samples 
 
The corellas and galahs described in Chapter 5 were used to obtain blood samples for 
this experiment. Blood was collected by jugular venepuncture before BFDV challenge; then 
at 13, 20, 26, 41 and 97 days post challenge; and preserved in 0.2 mL EDTA tubes (Becton-
Dickenson). Tubes were carefully inverted to mix the blood with the EDTA. Tubes with 
blood were left on an automatic mixer until used. 
 
6.3.2 PCV 
 
The packed cell volume of each sample was determined by haematocrit capillary tube 
centrifugation (Clements Micro Haematocrit centrifuge, 5 min) using 75 μL haematocrit 
capillary tubes (Hirschmann Laborgeräte) and the PCV determined using the supplied micro 
haematocrit reader. 
 
6.3.3 TSP 
 
Serum was isolated by haematocrit centrifugation as described above and then loaded 
into a refractometer (Reichert TS reader) and the total serum protein concentration read. 
 
6.3.4 Acidophil concentration 
 
Total acidophils (heterophils and eosinophils) counts were performed using Kova 
chambers (Hycor Biomedical, Blackwell Scientific, Australia) and eosin stain (0.1 g eosin, 10 
mL acetone, 100 mL distilled water). Fifty μL of whole blood was added to a 3DT tube 
containing 1.95 mL of eosin stain, mixed by gentle inversion. Using a haematocrit capillary 
tube, stained blood was transferred to a Kova chamber. The chamber was then left in a Chapter 6. Haematological response 
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humidified box for at least 5 min, to allow cells to settle and then the total acidophil count 
determined by counting all squares in the chamber. The acidophil concentration was then 
determined with Equation 6.0. 
 
Equation 6.0  acidophils ×10
9/L = (acidophil count × 1.1 × 40 /1000) (×10
9/L) 
 
Definition of acidophil: ‘Acidophil’ refers to heterophils and eosinophils. The morphology 
of these two cell types is further described below. 
 
6.3.5 Leukocyte ratios 
 
Blood smears were made by spreading EDTA preserved blood on glass microscope 
slides with a glass spreader and allowed to air-dry. Smeared blood was then stained with 
modified Wright’s stain (Bayer Healthcare, Siemens, Australia) and a microscope slide cover 
slip added. One hundred leukocytes were then counted on each slide giving the observed 
percentage proportions of each leukocyte type (lymphocytes, macrophages, heterophils, 
eosinophils and basophils). 
 
6.3.6 Total leukocytes concentration 
 
The concentration of leukocytes (total leukocytes ×10
9/L) in each blood sample was 
determined with Equation 6.1. 
 
Equation 6.1:  
Total leukocytes ×10
9/L = [total acidophil count / (%heterophils + %eosinophils)] × 100 
(×10
9/L) 
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6.3.7 Leukocyte differentials 
 
The cells per volume concentration (Leukocyte ×10
9/L) of each type of leukocyte, 
was determined with Equation 6.2. 
 
Equation  6.2:  
Leukocyte ×10
9/L = [(total leukocytes × %leukocyte) / 100] (×10
9/L) 
 
6.3.8 Determining the coefficient of variation 
 
The coefficient of variation (CV) was determined by performing 10 Kova chamber 
counts on a single blood sample from a single bird. The Kova chamber count was then 
converted to acidophil concentration (cells ×10
9/L) with Equation 6.3. 
 
Equation 6.3: 
Acidophil concentration (cells ×10
9/L) = N×1.1×40/1000 
 
Further, the standard deviation of the calculated acidophil concentrations and mean acidophil 
concentration were calculated. Finally, the %CV was calculated using Equation 6.4. 
 
Equation 6.4:  
%CV= (standard deviation/mean) × 100 
6.3.9 Statistical Analysis 
 
One-way ANOVA with Tukey’s multiple comparison post test was performed using 
GraphPad Prism version 4.02 for Windows (GraphPad Software, San Diego California USA, 
www.graphpad.com). 
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6.4 Results 
 
Graphs of individual bird’s TSP, PCV, total leukocytes, acidophil counts and specific 
leukocyte counts (heterophils, lymphocytes, monocytes, basophils, eosinophils) can be 
viewed in the Appendix (page 187). The following results are mean results for the flock.  
 
6.4.1 Mean TSP 
 
The mean TSP results (g/L ± SD) are presented in Tables 6.1 and 6.2 and illustrated in 
Figure 6.1. Before administration of challenge dose, vaccinated corellas and non-vaccinated 
corellas had a mean TSP of 36.64 ± 2.803 g/L and 38.40 ± 3.44 g/L, respectively. Thirteen 
days post challenge vaccinated corellas mean TSP was 38.60 ± 5.38 g/L and non-vaccinated 
corellas; 41.60 ± 6.84 g/L. The Tukey’s post test found that these were not significantly 
different and neither were there any significant differences between any of the subsequent 
time points.  
 
6.4.2 Mean PCV 
 
The mean PCV vs. days post challenge is illustrated in Figure 6.2 and specific value 
can be found in Tables 6.1 and 6.2. Prior to challenge with the BFDV inoculum, vaccinated 
and non-vaccinated corellas had a mean PCV of 0.49 ± 0.03 L/L and 0.50 ± 0.02 L/L, 
respectively. The subsequent means were not found significantly different (P>0.05) with the 
one-way ANOVA and the Tukey’s post test. 
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Figure  6.1 Mean total serum protein (g/L) ± SD vs. days post challenge for vaccinated and non-
vaccinated control corellas. The number of birds measured at each time point is supplied in Tables 6.1 
and 6.2. 
 
 
 
 
Figure  6.2  Mean PCV (L/L)±SD vs. days post challenge for vaccinated and non-vaccinated control 
corellas. The number of birds measured at each time point is listed in Tables 6.1 and 6.2. 
 
6.4.3 Mean acidophil concentration 
 
The changes in mean acidophil concentration over time for vaccinated corellas vs. 
non-vaccinated control corellas can be viewed in Figure 6.3. Prior to challenge with the 
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BFDV inoculum, vaccinated and non-vaccinated corellas had mean acidophil concentrations 
of 4.18 ± 2.20 ×10
9/L and 4.15 ± 2.08 ×10
9/L, respectively (P>0.05). Thirteen days post 
challenge vaccinated corellas mean acidophil concentration was 0.26 ± 0.18 ×10
9/L and non-
vaccinated corellas was 0.43 ± 0.34 ×10
9/L. This was found to be significantly less than 
before BFDV challenge (P<0.001) using the Turkey’s post test. Twenty days post challenge 
vaccinated and non-vaccinated corellas mean acidophil concentration had not changed 
significantly (0.84 ± 1.12 ×10
9/L and 0.76 ± 0.33 ×10
9/L, respectively, P>0.05). Subsequent 
time points did not show any significant change to the succeeding time point.  
 
6.4.4 Mean total leukocyte concentration 
 
The mean total leukocyte concentrations measured in this experiment are listed in 
Tables 6.1 and 6.2 and illustrated in Figure 6.4. Before challenge with the BFDV inoculum, 
vaccinated and non-vaccinated control corellas had mean total leukocyte concentrations of 
15.54 ± 5.35×10
9/L and 16.60 ± 10.20×10
9/L, respectively (P>0.05). The least mean total 
leukocyte concentration for vaccinated corellas was 0.70 ± 0.41×10
9/L on day 13 and for 
non-vaccinated control birds 1.38 ± 0.76×10
9/L on day 26. In the vaccinated group, the mean 
total leukocyte concentration was found to be significantly different at each subsequent time 
point when compared to day 0 (P<0.001). Similarly, in the non-vaccinated control group, the 
mean total leukocyte concentration was found to differ significantly between day 0 and days 
13, 20, 26 and 41 (P<0.001) and day 97 (P<0.01). 
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Figure  6.3 Mean acidophil concentration (cells ×10
9/L) ± SD vs. days post challenge for vaccinated 
and non-vaccinated control birds. The number of birds measured at each time point is given supplied 
in Tables 6.1 and 6.2. 
 
 
 
 
Figure  6.4 Mean total leukocyte concentration (cells ×10
9/L) ± SD vs. days post challenge for 
vaccinated and non-vaccinated control corellas. The number of corellas measured at each time point is 
given in Tables 6.1 and 6.2. 
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6.4.5 Morphology of leukocytes observed in this experiment 
 
6.4.5.1 Morphology of corella lymphocyte:  
 
The lymphocytes observed in this experiment were round to irregular shaped. 
Cytoplasmic irregularity was commonly found, generally due to moulding around adjacent 
cells. The nuclei of these cells were usually eccentrically positioned with an approximately 
round shape. In the corella lymphocyte, the nuclear chromatin had a clumped appearance. 
The lymphocytes had a high nucleus to cytoplasm ratio. The cytoplasm was a homogeneous 
pale blue without granules or vacuoles. Pleomorphism was commonly encountered in corella 
lymphocytes (Plate 6.1). 
 
 
Plate 6-1 Three small corella lymphocytes amongst erythrocytes in a blood film from stained with 
Wright’s stain. The short arrow points to the nucleus and the long arrow points to the cytoplasm. 
1000× magnification. Chapter 6. Haematological response 
  149
 
6.4.5.2 Morphology of corella thrombocyte:  
 
Thrombocytes can be mistaken for small lymphocytes and the cytoplasmic features are 
important when differentiating these cells from each other. The cytoplasm of the corella 
thrombocyte is clear, virtually colourless and occasionally appears vacuolated and may 
contain a few granules. The thrombocyte cytoplasm commonly had irregular shape with 
pseudopodia (Plate 6.2). The thrombocyte nucleus is generally rounder than the lymphocyte 
nucleus, similar coloured with Wright’s stain, but appears less clumped and more solid than 
the lymphocyte counterpart. 
 
 
 
Plate 6-2 Six thrombocytes amongst erythrocytes in a blood film from a corella stained with Wright’s 
stain. The short arrow points to the nucleus and the long arrow points to the scant cytoplasm. 1000× 
magnification. Chapter 6. Haematological response 
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6.4.5.3 Morphology of corella monocyte 
 
The monocytes found in blood films from corellas in this experiment were similar to 
lymphocytes. However, the monocyte nucleus was more irregular shaped and the cytoplasms 
were vacuolated. The colour of the monocyte nucleus and cytoplasm was similar to that of 
lymphocytes from the same bird, but the cytoplasm was a paler blue. The nuclei of 
monocytes were more irregular than those of the lymphocytes (Plate 6.3). Observed 
monocytes were larger than the lymphocytes. 
 
 
 
Plate 6-3 A monocyte surrounded by erythrocytes in a blood film from a corella. The blood smear 
was stained with Wright’s stain. The short arrow points to the nucleus, the long arrow to a vacuole in 
the cytoplasm and the red arrow to a nuclear lobe. 1000× magnification. 
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6.4.5.4 Morphology of corella heterophil 
 
The heterophils observed in corellas used in this experiment had an irregular shape, 
with an intensely blue staining, lobed (usually 2, sometimes 3) nucleus with some clumping. 
Cytoplasm was seldom seen as it was colourless and filled with granules that stained a dark 
orange or pink with Wright’s stain. The granules were elongate, with a prominent central 
core, which commonly appeared refractile. Such refractile appearance is a commonly 
encountered staining artefact (Plate 6.4). There was little variation in the sizes of heterophils 
seen in this experiment. 
 
 
 
Plate 6-4 Two corella heterophils amongst erythrocytes in a blood film stained with Wright’s stain. 
The long arrow on the left points to the granule filled cytoplasm. The long arrow on the right points to 
the refractile central core of a cytoplasmic granule. The short arrow points to the lobed nucleus.  
1000× magnification. Chapter 6. Haematological response 
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6.4.5.5 Morphology of corella eosinophil 
 
The corella eosinophils seen in this experiment were of similar size to the heterophils. 
The high density of deeply eosinophilic granules in the clear blue cytoplasm often obscured 
the dark blue staining nucleus. Compared to the heterophil nucleus, the eosinophil nucleus 
was much darker. The cytoplasmic granules were always circular (Plate 6.5). 
 
 
 
 
Plate 6-5 A corella eosinophil and erythrocytes in a blood film stained with Wright’s stain. The long 
arrow points to the nucleus and the short arrow to the high density granule containing cytoplasm. 
1000× magnification. 
 
 Chapter 6. Haematological response 
  153
6.4.5.6 Morphology of corella basophil 
 
The corella basophils were found to be round with dark purple staining non-lobed 
nucleus which was often obscured by deeply metachromic cytoplasmic granules.  The 
cytoplasm also stained a purple colour, although it was a lighter shade to that of the nucleus 
and granules. Basophil size was comparable to the size of eosinophils from the same bird 
(Plate 6.6). 
 
 
 
 
Plate 6-6  A corella basophil amongst erythrocytes in a blood film stained with Wright’s stain. The 
long arrow points to the nucleus and the short arrow points to a metachromic granule in the 
cytoplasm. 1000× magnification. 
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6.4.6  Mean heterophil concentration 
 
The results for mean heterophil concentrations in vaccinated and non-vaccinated 
control corellas are displayed in Table 6.1 and 6.2 and Figure 6.5. Vaccinated and non-
vaccinated control corellas had mean heterophil concentrations of 3.96 ± 2.14 ×10
9/L and 
3.57 ± 1.91 ×10
9/L, respectively before BFDV challenge. There was no significant difference 
in the mean heterophil concentration between vaccinated and non-vaccinated control corellas 
on day 0 (P>0.05). The least mean heterophil concentration for vaccinated corellas was on 
day 13 and for non-vaccinated control corellas on day 26. At the time points subsequent to 
day 0, there was no significant difference between each group (P>0.05). However, the mean 
heterophil concentration for vaccinated corellas was significantly less at subsequent time 
points compared to the pre-BFDV challenge heterophil concentration (P<0.001). Similarly, 
non-vaccinated control corellas had a significant decrease in heterophil concentration at the 
time points subsequent to day 0 (days 13 and 26; P< 0.001, days 20, 41, and 97; P<0.01). 
 
 
 
Figure  6.5  Mean heterophil concentration (cells × 10
9/L) ± SD vs. days post challenge for 
vaccinated and non-vaccinated control corellas. The number of corellas measured at each time point is 
given in Tables 6.1 and 6.2. 
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Table 6.1  Haematological (mean ± SD) values obtained for vaccinated corellas before BFDV challenge and up to 97 days after challenge. 
Days post 
challenge 0  13 20 26 41 97 
 
TSP   36.64±0.85(11)a 38.60±1.70(10)a 38.38±1.04(13)a 39.00±0.93(13)a 40.38±1.04(13)a 41.82±1.37(11)a g/L 
PCV   0.49±0.03(11)a 0.47±0.04(8)a 0.47±0.03(13)a  0.47±0.06(13)a 0.48±0.03(13)a 0.49±0.03(12)a  L/L 
Leu  15.54±5.35(11)a 0.70±0.41(9)b  2.41±2.17(12)b 4.00±6.14(12)b 5.74±5.22(13)b 2.83±2.70(13)b  10
9/L 
Het  3.96±2.14(11)a  0.25±016(9)b  0.81±1.13(12)b 0.89±1.22(12)b 1.21±0.79(13)b 0.47±0.37(13)b  10
9/L 
Lym  10.43±3.65(11)a 0.37±0.25(9)b  1.49±1.16(12)b 3.03±4.90(12)b 4.36±4.56(13)b 2.18±2.24(13)b  10
9/L 
Mon  1.24±0.91(11)a 0.05±0.03(9)b 0.08±0.07(11)b  0.04±0.04(11)b 0.11±0.05(10)b 0.11±0.15(13)b  10
9/L 
Eos  0.33±0.25(9)a 0.03±0.02(8)b 0.04±0.02(7)b  0.09±0.09(5)a,b 0.12±0.06(5)a,b 0.07±0.08(9)a,b  10
9/L 
Bas  0.20±0.06(7)a 0.01±0.01(5)a 0.03±0.02(7)a 0.02±0.01(3)a 0.06±0.04(7)a 0.03±0.04(5)a 10
9/L 
 
Mean ± SD of haematological values obtained for vaccinated corellas before BFDV challenge and up to 97 days after challenge. SD; 
standard deviation, TSP; total serum protein, PCV; packed cell volume, Leu; total leukocyte concentration, Het; heterophils, Lym; 
lymphocytes, Mon; monocytes, Eos; eosinophils, Bas; basophils. n is given in brackets. a, b, c: the values for the parameters are 
significantly different (P<0.05) when the letters are different. 
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Table 6.2  Haematological values (mean ± SD) obtained for non-vaccinated control corellas before BFDV challenge and up to 97 days after 
challenge. 
Days post 
challenge  0  13 20 26 41 97   
TSP   38.40±1.54(5)a 41.6±3.06(5)a 39.50±3.07(4)a  38.40±1.29(5)a 42.00±1.92(5)a 41.80±0.80(5)a  g 
PCV   0.50±0.02(5)a 0.48±0.06(5)a 0.46±0.03(5)a 0.47±0.04(5)a 0.48±0.05(5)a 0.46±0.05(5)a L/L 
Leu  16.60±10.2(5)a 1.52±2.20(5)b  2.33±1.37(4)b  1.38±0.76(5)b 2.71±2.84(5)b 3.94±2.97(5)b  10
9/L 
Het  3.57±1.91(5)a 0.37±0.38(5)b 0.51±0.34(4)b 0.31±0.31(5)b 0.49±0.37(5)b 0.73±0.53(5)b  10
9/L 
Lym  10.06±6.96(5)a 1.01±1.62(5)b  1.44±1.11(4)b  0.97±0.58(5)b 1.33±1.09(5)b 2.84±2.28(5)b  10
9/L 
Mon  0.81±1.11(5)a 0.10±0.16(5)a 0.14±0.05(3)a 0.04±0.03(5)a 0.01±0.01(3)a 0.12±0.17(5)a  10
9/L 
Eos  0.26(1) 0.01±0.004(3)a  0.09±0.04(2)a  0.02±0.01(3)a 0.10±0.16(4)a 0.17±0.27(5)a  10
9/L 
Bas  0.32±0.29(5)a 0.05±0.08(4)b  0.03±0.02(2)a,b  0.01±0.001(2)b,c 0.08±0.08(3)a,b,c 0.15(1) 10
9/L 
 
Mean ± SD of haematological values obtained for non-vaccinated control corellas before BFDV challenge and up to 97 days after 
challenge. SD; standard deviation, TSP; total serum protein, PCV; packed cell volume, Leu; total leukocyte concentration, Het; 
heterophils, Lym; lymphocytes, Mon; monocytes, Eos; eosinophils, Bas; basophils. n is given in brackets. a, b, c: the values for the 
parameters are significantly different (P<0.05) when the letters are different. 
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6.4.7  Mean lymphocyte concentration  
Figure 6.6 illustrates the changes in lymphocyte concentration over time and Table 
6.1 and 6.2 list the specific mean values that were obtained. Vaccinated and non-vaccinated 
control corellas had mean lymphocyte concentrations (10.43 ± 3.65 ×10
9/L and 10.06 ± 6.96 
×10
9/L, respectively) that were not significantly different to each other before BFDV 
challenge (P>0.05). The least mean lymphocyte concentration for vaccinated corellas was on 
day 13 (0.37 ± 0.25 ×10
9/L) and for non-vaccinated control corellas on day 26 (0.97 ± 0.58 
×10
9/L). At subsequent time points, vaccinated corella mean lymphocyte concentration was 
significantly less than day 0 (days 13, 20, 26 and 97; P<0.001, day 41; P<0.01). Similarly, the 
mean lymphocyte concentration for non-vaccinated control corellas was decreased (days 13, 
26 and 41; P<0.01, days 20 and 97; P<0.05). 
 
6.4.8  Mean monocyte concentration 
Mean monocyte concentrations for vaccinated and non-vaccinated control corellas 
observed in this study are listed in Tables 6.1 and 6.2, respectively. Figure 6.7 illustrates the 
changes in mean monocyte concentrations over time. Prior to BFDV challenge the mean 
monocyte concentration of vaccinated and non-vaccinated control corellas was 1.24 ± 0.91 
×10
9/L and 0.81 ± 1.11 ×10
9/L, respectively. There was no significant difference (P>0.05) in 
the mean monocyte concentration between the two groups on this day. The least mean 
monocyte concentration was 0.04 ± 0.04 ×10
9/L, 26 days after BFDV challenge for 
vaccinated corellas and 0.01 ± 0.01 ×10
9/L on day 41 after challenge for non-vaccinated 
control birds. The Turkey’s multiple comparison test showed that the mean monocyte 
concentration of vaccinated corellas was significantly less (P<0.001) at all time points after Chapter 6. Haematological response 
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challenge compared with the pre-challenge mean concentration. Similarly, non-vaccinated 
control corella means were significantly less after challenge (days 13, 26 and 97; P<0.001 
and days 20 and 41; P<0.01). 
 
Figure  6.6  Mean lymphocyte concentration (cells ×109/L) ± SD vs. days post challenge for 
vaccinated and non-vaccinated control corellas. The number of birds measured at each time point is 
given in Tables 6.1 and 6.2. 
 
 
 
 
Figure  6.7  Mean monocyte concentration (cells ×10
9/L) ± SD vs. days post challenge for vaccinated 
and non-vaccinated control corellas. The number of birds measured at each time point is given in 
Tables 6.1 and 6.2. 
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6.4.9  Mean eosinophil concentration 
 
The observed mean eosinophil concentrations can be found in Tables 6.1 and 6.2 and 
Figure 6.8 illustrates the observations. Prior to BFDV challenge, the mean eosinophil 
concentration in vaccinated corellas was 0.33 ± 0.25 ×10
9/L and 0.26 ×10
9/L (n=1) in non-
vaccinated control corellas and was not found to be significantly different (P>0.05) between 
the two groups. In both vaccinated and non-vaccinated control corellas, the least mean 
eosinophil concentration (0.03 ± 0.02 and 0.01 ± 0.004 ×10
9/L, respectively) was on day 13 
after BFDV challenge. The mean eosinophil concentration was significantly less in 
vaccinated corellas on days 13 (P<0.01), 20 and 97 (P<0.05) but not on days 26 and 41 
(P>0.05). In non-vaccinated control corellas there was no significant differences in mean 
eosinophil concentration before and after challenge (P>0.05). 
 
 
6.4.10  Mean basophil concentration 
 
The mean basophil values observed in this study are found in Tables 6.1 and 6.2and in 
illustrated in Figure 6.9. Pre-challenge mean basophil concentration was not significantly 
different between vaccinated (0.20 ± 0.06×10
9/L) and non-vaccinated control corellas (0.32 ± 
0.29 ×10
9/L) (P>0.05). Thirteen days after BFDV challenge, non-vaccinated control corellas 
mean basophil concentration (0.05 ± 0.08 ×10
9/L) had become significantly less (P<0.05). In 
non-vaccinated control corellas the least mean basophil concentration was on day 26 (0.01 ± 
0.00×10
9/L) which was found to be significantly less (P<0.05) than day 0, but not 
significantly different to day 13. 
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Figure  6.8 Mean eosinophil concentration (cells × 109/L)±SD vs. days post challenge for vaccinated 
and non-vaccinated control birds. The number of birds measured at each time point is provided in 
Tables 6.1 and 6.2. 
 
 
 
 
Figure  6.9 Mean basophil concentration (cells ×109/L)±SD vs. days post challenge for vaccinated 
(blue curve) and non-vaccinated control birds (red curve). The number of birds measured at each time 
point is supplied in Tables 6.1 and 6.2. 
 
6.4.11  Determining the % coefficient of variation (CV) 
 
The CV was calculated to be 36.84% for acidophil counts. 
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6.5  Discussion 
 
Haematological methods are commonly used in veterinary practice to asses the health 
status of animals. However, the normal haematology of many avian species, including the 
majority of psittacine species, has not been determined. Further, haemopathology associated 
with BFDV infection has been poorly documented and there has only been one report 
addressing haematological changes in psittacine birds undergoing BFDV infection 
(Schoemaker et al. 2000). Therefore, this experiment investigated the normal haematology of 
vaccinated and non-vaccinated corellas and the haematological changes that occurred when 
these birds had been challenged with BFDV. The haematological parameters that were 
assessed were; PCV, TSP, total leukocyte concentrations, total acidophil concentrations and 
concentrations of each leukocyte type. 
 
PCV is the easiest and most rapid method available for assessing the erythrocyte mass 
to plasma ratio. A low PCV can be an indication of anaemia. Anaemia can result from several 
conditions, including haemorrhagic anaemia, haemolytic anaemia and hypoplastic anaemia. 
However, other factors can also influence the PCV. These include; size of the erythrocytes 
and changes in the plasma volume. The latter can be caused by increased plasma volume 
(haemodilution), decreased plasma volume (haemoconcentration), improper blood sampling 
(haemodilution), and epinephrine administration and hypothermia, causing 
haemoconcentration (Campbell and Ellis 2007). In many species of birds, the normal PCV 
ranges from 35% to 55%. Thus, a PCV of higher than 55% suggests dehydration or 
erythrocytosis (polycythaemia). Dehydration and erythrocytosis can be differentiated using 
TSP, which is a measure of free protein in circulation. An elevated TSP is indicative of 
dehydration. Normal to low TSP is indicative of erythrocytosis (Campbell and Ellis 2007). 
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Differential leukocyte counts can measure the concentration of each type of 
circulating cell and indicates alteration in specific leukocyte levels (when values are available 
for before and after onset of disease) or whether levels are different to expected values 
(‘reference values’). Such alterations are indicative of decreased/increased production of 
leukocytes or increased/decreased destruction of leukocytes.  
 
Normal haematological values have been reported for a number of psittacine birds 
(Lumeij and Overduin 1990; Polo et al. 1998; Scope et al. 2000). However, there are no 
values available for healthy or diseased birds of the species that were used in this experiment 
(C. tenuirostris). On the other hand, there appears to be little variation in haematological 
values between psittacine species and especially between cockatoo species (Polo et al. 1998). 
Reference values for other cockatoos can be used as a guide for assessing the haematology of 
corellas; however here may be unknown differences between corellas and other species, so 
care must be taken. 
 
Therefore, this experiment set out to obtain reference values for non-diseased, anti-
BFDV vaccinated and non-vaccinated corella. Further, the haematological changes that occur 
in vaccinated and non-vaccinated corella after challenge with BFDV was studied. As corella 
leukocytes have not been previously described in the literature, this study compared the 
morphology of corella leukocytes to general morphological descriptions of avian leukocytes 
found in the literature. Further, there have been few reports considering haematological 
aspects of BFDV infection. Therefore this experiment set out to investigate changes that 
might occur in the haematological parameters during BFDV infection. 
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In this experiment, corella leukocytes were identified with the use of general 
morphological descriptions of avian leukocytes found in the literature. The observed 
morphologies seen in this experiment correlated well with descriptions published for avian 
leukocytes.  
 
At the start of this experiment, the mean TSPs of vaccinated and non-vaccinated 
corellas were 36.63 ± 0.85 and 38.40 ± 1.54 g/L. These values are comparable to TSP values 
reported by others for cockatoos (Lumeij and Overduin 1990; Polo et al. 1998; Campbell 
2000). Only small fluctuations in the mean TSP between time points were seen in each group. 
These fluctuations were insignificant. The differences in TSP between groups, was also 
insignificant.  
 
The small fluctuations in TSP between time points, that were observed, could be 
caused by increases and decreases in protein production (both host and pathogen associated), 
hydration and dehydration, proteolytic mechanisms and pathology. Significantly fluctuating 
TSP between groups would probably be due to infection and immunity related issues. 
However, the fluctuations found in this experiment were minor both in vaccinated and non-
vaccinated corellas before and after challenge. Fluctuations in TSP were probably related to 
hydration issues associated with the high summer temperatures in Perth and the associated 
water consumption behaviour. Thus, the difference in TSP found between time points was 
probably due to varying amount of water in circulation rather than varying number of protein 
molecules. Regardless of the reason for the small changes, the variation in TSP both between 
time points and between the 2 groups was found to be insignificant. Thus there was no 
evidence that acute BFDV infection in corella causes alteration in TSP. 
 Chapter 6. Haematological response 
164 
A study by Jacobson et al. (1986) found that BFDV infected south-east Asian 
Cacatua spp. had very low serum protein concentrations. However, in this experiment there 
was no evidence to suggest that corellas also suffer low serum protein levels during BFDV 
infection. This was probably due to the low severity of infection seen in the corellas or due to 
species differences. 
 
PCV values obtained in this experiment were similar to those reported for white 
cockatoo and black cockatoo (Polo et al. 1998). Although there was some variation over the 
course of this experiment, there was no significant change in the mean PCV during this 
experiment within each group. Additionally, there was no significant difference between 
vaccinated and non-vaccinated corellas.  
 
 Schoemaker et al. (2000) reported anaemia in African grey parrots with peracute 
PBFD. In this experiment there was no evidence to support this notion. However, the 
viraemia observed in this experiment (Chapter 5) was short lived and all the corellas 
overcame the infection. Thus, little change in PCV could be due to low severity of infection 
(for reasons discussed in Chapter 5) and the difference between very acute infection seen in 
this experiment and the peracute condition observed by Schoemaker et al. (2000). 
Additionally, biological differences between these species may have been significant. African 
grey parrots are known to be severely affected by BFDV (McOrist et al. 1984; Schoemaker et 
al. 2000; Doneley 2003) whereas there are no reports of the severity of disease in long-billed 
corellas although other cockatoos are known to be highly susceptible to BFDV with severe 
consequences (McOrist et al. 1984; Latimer et al. 1992; Raidal et al. 1993b; Raidal and Cross 
1995; Trinkaus et al. 1998). 
 Chapter 6. Haematological response 
165 
Mean total leukocytes measured for the vaccinated and non-vaccinated corellas in this 
experiment (15.54 ± 5.35 and 16.60 ± 10.2×10
9/L, respectively) was within the ranges 
published by others for various psittacine birds (Lumeij and Overduin 1990; Polo et al. 1998; 
Campbell 2000). In both groups the leukocyte concentration was significantly less 13 days 
after challenge (0.70 ± 0.41 ×10
9/L, P<0.001 and 1.52 ± 2.20 ×10
9/L, P<0.001, respectively). 
At the remaining time points however, there was little change in total leukocyte 
concentration. Thus it was found that the total levels of circulating leukocytes significantly 
decreased within 2 weeks of challenge and that total leukocyte concentration did not revert to 
normal levels within 97 days post challenge.  
 
This is evidence that BFDV infection might cause leukopaenia in corella as was found 
in African grey parrots by Schoemaker et al. (2000) and can further be considered evidence 
for immune-suppression caused by BFDV infection. Further to this, there was no evidence 
for vaccination providing an advantage against leukopaenia in BFDV infection. However, the 
mechanism causing leukopenia in this experiment remains unclear. Histological examination 
did not revile any pathology in haematopoetic tissue. Virus induced intranuclear and 
intracytoplasmic inclusion bodies in macrophages have been reported previously (Latimer et 
al. 1991; Trinkaus et al. 1998). The post mortem examination of the birds in this experiment 
was conducted more than one year after the challenge study (to allow for observation of the 
animals over a significant time period). This in combinantion with the birds having overcome 
the experimental infection is probably the reason why lesions were not detected. 
 
Before BFDV challenge, vaccinated and non-vaccinated corellas had a mean 
heterophil concentration of 3.96±2.14 ×10
9/L and 3.57±1.91 ×10
9/L, respectively (Figure 
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cockatoos (Lumeij and Overduin 1990; Polo et al. 1998; Campbell 2000). After challenge, 
heterophil concentrations were as low as 0.25±0.02 ×10
9/L and never higher than 1.21±0.79 
×10
9/L, the former at 13 days post challenge and the latter at 41 days post challenge for 
vaccinated corellas. Non-vaccinated corellas had a similar change and there seemed to be 
little difference between vaccinated and non-vaccinated corellas. This is lower than the 
available values for normal cockatoos (cockatoo species not listed) (Lumeij and Overduin 
1990; Polo et al. 1998; Campbell 2000). The results at 13 days post challenge for both 
vaccinated and non-vaccinated corellas was significantly different compared to the pre-
infection values for these two groups (P<0.001, respectively). This indicates that there was a 
significant change in heterophil concentration caused by acute BFDV infection. The 
heterophil concentration was not restored to normal levels by the end of the experiment, even 
though PCR (Chapter 5) could not detect viraemia at this stage. Being vaccinated or not 
vaccinated did not significantly influence the changes in heterophil concentration neither 
before nor after challenge. 
 
Before BFDV challenge, vaccinated and non-vaccinated corellas had a mean 
lymphocyte concentration of 10.43 ± 3.65×10
9/L and 10.06 ± 6.96×10
9/L respectively 
(Figure 6.6). These values are considerably larger than reference values for normal cockatoo 
(cockatoo species not listed) and other psittacines (Lumeij and Overduin 1990; Polo et al. 
1998; Campbell 2000). Thirteen days after challenge, the mean lymphocyte concentration 
was 0.37 ± 0.25×10
9/L for vaccinated corellas and 1.01 ± 1.62×10
9/L for non-vaccinated 
corellas. The lymphocyte concentrations before and after challenge were significantly 
different to each other (vaccinated; P <0.001 and non-vaccinated P<0.01). The 2 subsequent 
time points showed an increase in lymphocyte concentration in vaccinated birds before 
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subsequent time points. Non-vaccinated birds also had some fluctuation between subsequent 
time points after 13 days post challenge. Again, these differences were insignificant. At 26 
and 41 days post challenge, vaccinated birds mean lymphocyte values were comparable to 
that reported for healthy psittacine birds (Lumeij and Overduin 1990; Polo et al. 1998; 
Campbell 2000), but non-vaccinated birds were lower and did not reach comparable levels 
until 97 days post challenge. By the end of the experiment, both vaccinated and non-
vaccinated corella lymphocyte mean concentrations were below the pre-infection values. 
Thus this experiment found that the lymphocyte concentration decreased during acute BFDV 
infection.  
 
Vaccinated and non-vaccinated control corellas had mean monocyte concentrations of 
1.24 ± 0.91×10
9/L and 0.81 ± 1.11×10
9/L (Figure 6.7 and Table 6.1 and 6.2) at the start of the 
experiment, respectively. This is comparable to other cockatoos and psittacine birds (Lumeij 
and Overduin 1990; Polo et al. 1998; Campbell 2000). Thirteen days after challenge, there 
was a significant drop in monocyte concentration in vaccinated birds (0.05 ± 0.03×10
9/L, 
P<0.001). Although there was also a drop in monocyte concentration for non-vaccinated 
corellas, the difference before and after challenge was not found to be significant.  
 
This was probably due to the large span of values obtained in these measurements 
caused by inaccuracy of the technique. Even so, the mean monocyte levels in both vaccinated 
and non-vaccinated corellas after challenge was below that of before challenge, and did not 
revert to normal values within the time-span of this experiment. The post challenge mean 
values were also lower than the reference values listed in Lumeij and Overduin (1990), Polo 
et al. (1998) and Campbell (2000). As with the lymphocytes and heterophils, there did not 
seem to be any particular difference between vaccinated and non-vaccinated birds and at all Chapter 6. Haematological response 
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time points post infection, monocyte concentration was lower than before challenge, although 
still within the reference values.  
 
Monocytes are phagocytic cells that migrate into tissues where they become 
macrophages. Biologically active chemicals produced by monocytes and macrophages are 
involved in mediation of inflammation and in destruction of invading organisms (Campbell 
and Ellis 2007). Therefore, if BFDV was not immunosuppressive, it would be expected that 
monocyte levels would increase after challenge, rather than decrease. Thus, the data 
presented here indicates monocytopaenia caused by challenge with BFDV, although 
measured values were within available reference values. 
 
Before injection with the BFDV inoculum, vaccinated corellas had a mean eosinophil 
concentration of 0.33 ± 0.25 ×10
9/L. Eosinophils were only found in 1 non-vaccinated corella 
(0.26 ×10
9/L) (Figure 6.8). These values are higher than those reported for other psittacine 
birds (Lumeij and Overduin 1990; Polo et al. 1998; Campbell 2000). Thirteen days post 
challenge the mean eosinophil concentration of vaccinated corellas had significantly dropped 
(0.03 ± 0.02×10
9/L, P<0.01). At this time point, 3 non-vaccinated corellas had a mean 
eosinophil concentration of 0.01± 0.004 ×10
9/L, however statistical analysis could not be 
performed as n=1 before challenge for this group. Further on, the eosinophil concentrations in 
both groups had small fluctuations during the experiment. On the final day, the vaccinated 
corella mean eosinophil concentration was 0.07 ± 0.08 ×10
9/L, significantly lower than 
before challenge (P<0.05). In non-vaccinated corellas, the final mean eosinophil 
concentration was 0.17 ± 0.27 ×10
9/L, thus could not be claimed to be significantly different 
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The function of eosinophils in inflammation is to phagocytize antibody-antigen 
complexes, thereby maintaining homeostasis during infection (Campbell and Ellis 2007). 
Thus as with monocytes; eosinophil concentrations would be expected to increase during 
infection if the pathogen was not immunosuppressive. However, this experiment found that 
eosinophil concentration decreased and this indicates the immunosuppressive nature of 
BFDV infection in corella. 
 
Prior to challenge BFDV challenge, vaccinated and non-vaccinated corellas had a 
mean basophil concentration of 0.20 ± 0.06 ×10
9/L and 0.32 ± 0.29 ×10
9/L respectively 
(Figure 6.9). Thus there was no significant difference between the two groups before 
challenge and the basophil concentrations were similar to those reported for other psittacine 
birds (Lumeij and Overduin 1990; Polo et al. 1998; Campbell 2000). An insignificant drop in 
mean basophil concentration was seen in vaccinated corellas 13 days post challenge (0.01 ± 
0.01 ×10
9/L, P>0.05). The mean basophil concentration in non-vaccinated corellas had 
dropped significantly at this time point (0.05 ± 0.08 ×10
9/L, P<0.05). No significant change 
was found in either group after this.  
 
These data provide evidence that vaccinated birds suffer less basophilaemia than non-
vaccinated birds in acute BFDV infection. This indicates that basophil concentrations in anti-
BFDV vaccinated corellas are less influenced by BFDV infection than in non-vaccinated 
corellas. 
 
 Schoemaker et al. (2000) reported leukopaenia, anaemia and pancytopenia in African 
grey parrots with peracute PBFD. In the current experiment, there was no evidence for Chapter 6. Haematological response 
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anaemia. This could be due to several factors: the severity of infection, species of bird or 
virus genotype.  
 
There was little difference in leukocyte levels between vaccinated and non-vaccinated 
birds, both before and after challenge. This is supported by the 2 groups having similar 
leukocyte levels before challenge and after challenge and both groups having leukocyte levels 
within the reference values available for other cockatoos before challenge.  
 
A marked reduction in specific leukocyte concentrations was observed in both groups 
after challenge, except basophils in vaccinated birds. This corresponds well with previously 
reported leukopaenia in African grey parrots (Schoemaker et al. 2000). Packed cell volume 
and serum protein concentration did not change significantly between measured time points 
in either group, although both have been reported previously to change significantly in 
African grey parrots (Schoemaker et al. 2000) and south-east Asian Cacatua spp. (Jacobson 
et al. 1986), respectively. 
 
In conclusion; BFDV infected corellas (both vaccinated and non-vaccinated) may 
suffer leukopaenia; involving all leukocyte types, vaccinated corellas have a slight advantage 
(less basophilaemia) and PCV and TSP did not change significantly in either group during 
BFDV infection. Chapter 7.General Discussion 
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Chapter 7 : General Discussion & Conclusions 
 
BFDV is a threat to endangered psittacine bird species such as the orange bellied 
parrot (Neophema chrysogaster) and it is a problem for the pet bird trade. Diagnostic testing 
using PCR and haemagglutination assays have helped with the management and with the 
control of PBFD but a vaccine is needed to assist with this to limiting the spread of BFDV in 
susceptible birds. A number of researchers have investigated the possibility of vaccination 
and found that it is a viable means of reducing the effects of BFDV infection. However, 
methods of inactivated-BFDV vaccine production are not suitable for other than proof of 
concept. This is why a baculovirus system that expresses full-length BFDV capsid protein 
was assessed for PBFD vaccination in this PhD project.  
 
To assess the usefulness of recombinant BFDV capsid protein as a vaccine, a suitable 
flock of susceptible birds was required but attempts to use lovebirds as an experimental 
model in Chapter 2 were unsuccessful.  The results presented in Chapter 2 support the 
widespread anecdotal evidence that lovebirds have a high prevalence of BFDV infection. 
BFDV has been found to be prevalent in captive collections in Europe (Rahaus and Wolff 
2003; Bert et al. 2005) and NSW (Raidal 1994). These results also indicate that commercially 
available lovebirds and possibly other psittacine species may frequently harbour BFDV 
without showing clear signs of infection. Therefore, customers seeking commercial outlets 
may be at risk of purchasing BFDV infected birds. The implications of this are that 
previously acquired, BFDV-free birds may become infected or the customer obtains a 
seemingly healthy bird that may become seriously ill after acquisition. Further to this, the 
results indicate that multiple testing is essential in the pursuit of SPF-animals. Also, as many Chapter 7.General Discussion 
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lovebirds tested in Chapter 2 where initially negative for BFDV DNA, antigen and antibody, 
then subsequently testing positive; it is possible that BFDV exhibits latency with viraemia 
induced by stress. 
 
Wild cockatoos in New South Wales have previously been reported to have a high 
seroprevalence (41 to 94%) of BFDV (Raidal et al. 1993b). The prevalence of BFDV in WA 
cockatoo populations has not, to this author’s knowledge, been investigated previously. In 
Chapter 3, 18 nestling corellas and 2 nestling galahs were taken from a nesting area and 
tested for BFDV. None of these birds were found to have had exposure to BFDV. Thus, 
taking nestlings from the wild for the purpose of obtaining SPF-birds was far more successful 
than using commercially available birds. The difference may be either geographical, in that 
commercial birds live in confined spaces with close proximity to other birds or species 
related susceptibility. Lovebirds (as well as other psittacine species) may act as reservoir 
hosts in commercial aviaries, continually transmitting BFDV to other birds in the aviary. As 
discussed below, none of the lovebirds used in this project showed any clinical signs of 
BFDV infection although they were frequently found to have circulating BFDV DNA. 
Infected birds that do not show clinical signs are unlikely to be removed from the aviary and 
can continue to excrete virus, continually exposing other birds to BFDV. Chapter 3 also 
shows that the use of wild caught nestlings is far more likely to succeed in obtaining larger 
quantities of SPF birds than collecting eggs. 
 
Zimbabwean lovebirds have been reported to have variation in clinical disease and 
species susceptibility (Kock et al. 1993). The lovebirds tested in the current study had a high 
incidence of BFDV infection in the absence of clinical signs. Even lovebirds that had long 
lasting viraemia, thrived, did not develop clinical signs and some developed high antibody Chapter 7.General Discussion 
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titres. The differences may be due to innate host species factors. For example, it is known that 
specific erythrocytes receptors are responsible for the BFDV-induced haemagglutination used 
in HA/HI assays. Erythrocytes from some birds are more sensitive than others. Virus 
attachment to erythrocytes in vivo may be involved in the dispersal of BFDV in the body, as 
has been found with bluetongue virus interaction with erythrocytes in vitro (Brewer and 
MacLachlan 1992), further discussed below. In this way, some individuals may be more 
susceptible or more resistant to BFDV infection than others. 
 
In the pursuit of BFDV-free birds, it was found that the common technique for 
extracting DNA from blood dried on filter paper was at high risk of causing carry-over 
contamination between samples. This is why the investigation in Chapter 4 was conducted. It 
was found that a hole puncher can transfer significant amounts of DNA between samples and 
that this easily can cause false positive PCR results. The method developed for avoiding 
carry-over contamination was efficient and rapid and can be easily incorporated into any 
laboratory’s protocols for DNA extraction, where a common piece of equipment is used for 
more than one sample. The data obtained in Chapter 4 also showed that PCR is a highly 
sensitive diagnostic method and if suitable steps are not taken in the preceding DNA 
extraction, false positive results are likely to occur. Raidal (1994) reviewed work by 
Dahlhausen and Radabaugh (1993) and mentioned that the BFDV diagnostic PCR protocol 
had been claimed to have 100% specificity and sensitivity. Although it is possible that the 
PCR reaction itself would amplify DNA that is added to the reaction with 100% specificity 
and sensitivity, PCR as a diagnostic tool is not necessarily 100% specific as it cannot 
differentiate between DNA stemming from the sample and DNA stemming from carry-over 
contamination. Further to this, the data obtained in Chapter 5 show the value of PCR for 
detecting active viraemia, but also the necessity of using a combination of HI and PCR to Chapter 7.General Discussion 
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monitor viraemia and the physiological response to infection. HA on the other hand, used for 
detecting virus excreted in feathers, only detected excretion of virus in one bird (HA titre = 
log2 12 HAU/50μL and >12 HAU/50μL). This may have been due to the sensitivity of the 
assay, quality of feather sample taken (actively growing feathers and diseased feathers as 
opposed to mature feathers) or low level/lack of virus excretion. The data obtained in 
Chapters 2 and 5 indicate that PCR testing for circulating BFDV DNA in blood is far more 
likely to identify infected birds than PCR on feather extract or haemagglutination assays. 
Further to this, quantitative PCR was found far more useful than traditional PCR as it was 
more sensitive and because it could be used to monitor the progression of viraemia. 
 
It is possible that some of the PCR positive results seen in the lovebird study were 
caused by carryover contamination, as the protocol by Bonne et al. (2008) for avoiding 
carryover contamination had not yet been developed and incorporated. However, HI and HA 
are far less sensitive than PCR and therefore positive HI/HA results are likely to be true. Thus 
it is likely that most of the lovebirds tested had had exposure to BFDV at least when they 
tested positive in HI and HA assays. 
 
In this experiment it was found that lovebirds can be PCR positive and HI positive or 
positive for one and not the other (Chapters 2 and 5) and birds can be PCR positive in blood 
and PCR/HA negative in feathers. In diagnostics, the combination of results of each assay 
will determine the prognostic of that bird, as overcoming infection (indicated by PCR and/or 
HA)  seems to be dependent on mounting an immune-response (indicated by HI). This is why 
PCR alone, may be sufficient for determining presence of BFDV, but does not assist in 
determining the fate of a BFDV infected bird. Therefore, clinicians should utilize antibody 
detection as well as antigen detection. Multiple testing with quantitative PCR would also be Chapter 7.General Discussion 
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useful, so as to determine whether the bird will overcome infection. Additionally, the bird’s 
history, age and species are necessary to consider, as these factors are believed to influence 
the ability to overcome infection. 
 
The observations made in Chapter 5 show that circulating BFDV DNA and antibody 
can frequently be detected without detecting HA activity in feathers or evident clinical signs. 
Thus, lack of lesions does not indicate freedom of infection. Methods based on PCR to detect 
BFDV DNA in feathers would be more sensitive and would probably be more successful in 
detecting positive samples. However, processing of feathers for PCR should be considered 
highly susceptible to carry-over contamination, due to feather dander that floats around when 
preparing feather samples for DNA extraction. This is why HA was chosen for detecting 
excretion of BFDV in feathers. Diagnosis of BFDV should rely on more than one assay as 
well as consideration of age, species and the bird’s history. Retesting at a later time is also 
advisable as PCR is not 100% specific and HI/HA are not 100% sensitive. 
 
Pathogenesis studies performed previously (Wylie and Pass 1987; Ritchie et al. 
1991b; Wylie 1991; Raidal 1994) indicate that adult psittacine birds are resistant to 
developing PBFD and that adult and juvenile birds may not exhibit enteritis when undergoing 
BFDV infection. Clinical signs of enteritis were not observed in the experiment in Chapter 5, 
which is consistent with the previous studies. However, feather lesions were observed in non-
vaccinated control corellas but were only mild. The corellas were euthanized 270 days post-
challenge and lesions did not develop past the initial pinching of pin feathers that was seen 2-
4 weeks after challenge.  
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Examination at necropsy discovered that captive raised long-billed corellas retained 
relatively long (more than one year) bursal activity. This has not been reported previously for 
any Cacatua species and is far longer than that reported for Galliforme birds. Presence or 
absence of bursal activity is believed to be significant for the bird’s ability to overcome 
infection. Therefore, knowledge of such lymphoid development within the species is of value 
to understanding the pathogenesis of PBFD as well as other diseases. 
 
Excretion of virus in feathers is an indication of disease progress. A single, non-
vaccinated bird (52A5) had detectable virus excretion in the feathers. This bird was also the 
last to develop a HI detectable BFDV-antibody titer and had the longest lasting viraemia. 
None of the vaccinated birds developed any clinical signs of BFDV. These results show that 
the ability to mount an early immune-response is important in avoiding clinical disease and 
that vaccination provides the protection to do this. The data also shows variation in 
development of clinical disease between individual corellas. This is likely to be due to 
genetic factors of the corellas, as has been previously suggested (Raidal 1994). BFDV is 
known to attach to erythrocytes of some birds (but not all) - a property utilized in HA/HI 
assays. The bluetongue virus has been found to attach to erythrocytes in vitro. Subsequently, 
the virions become sequestered in invaginations of the cell membrane. Further, it is proposed 
that once the virion is invaginated, antibodies are not able to “reach” the virions allowing for 
“covert” dispersal of virus in the body (Brewer and MacLachlan 1992). A similar scenario 
may occur in BFDV infections. Whether BFDV become sequestered in invaginations of the 
cell membrane, is not known. However if it does, it is likely that it is a determining factor for 
the severity of infection and development of clinical disease. If this mechanism does exist in 
BFDV, it may be involved in the anaemia reported in African grey parrots, perhaps the body 
lyzes infected erythrocytes in an attempt to remove virus from the circulation. Alternatively, Chapter 7.General Discussion 
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BFDV has lytic activity towards erythrocytes. Anaemia in BFDV infection has only been 
reported in African grey parrots (Schoemaker et al. 2000). Species differences probably 
amount to why other species have not been reported to become anemic during BFDV 
infection.  
  
  Haematological assessment of experimental BFDV infection was performed on 
vaccinated and non-vaccinated control corellas before and after injection with BFDV to 
investigate whether BFDV causes a lesser or more concentration of circulating leukocytes, 
total serum protein and packed cell volume. This work was carried out because there have 
been clinical reports that suggest that BFDV causes immune-suppression and anaemia in 
African grey parrots (Schoemaker et al. 2000) and immune-suppression in citron crested 
cockatoo (Latimer et al. 1992). However, the literature on this matter is limited and the 
haematology of the long-billed corella has not previously been characterized.  The data 
obtained here indicate that BFDV causes leukopaenia, involving most leukocyte types, in 
both vaccinated and non-vaccinated juvenile corellas as was previously reported in naturally 
infected young African grey parrots (Schoemaker et al. 2000). Although leukopaenia was 
evident in both groups, vaccination did appear to facilitate clearing of systemic virus and 
prevention of clinical disease. This was probably due to the level of circulating antibody to 
BFDV induced by the vaccine. The vaccinated corellas in this experiment were challenged 
with BFDV 2 weeks after the second vaccine administration and had high antibody titres at 
the time. Whether the vaccine would provide sufficient B-cell memory to protect against 
PBFD at a later time point is yet to be investigated.  
 
The recombinant baculovirus system (Stewart et al. 2007) was useful for producing 
recombinant BFDV capsid protein that induced protective BFDV antibody titres and Chapter 7.General Discussion 
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decreased the ability of BFDV to replicate in corellas (Chapter 5) and limited the 
development of PBFD. This is the first study to provide evidence that recombinant BFDV 
capsid protein, produced with a eukaryotic expression system, may be useful for vaccination 
to protect against PBFD and for controlling BFDV infection in a flock of corellas. 
Recombinant protein expression systems based on E. coli are possibly more viable for 
commercial vaccine production due to the speed at which these systems can produce 
recombinant protein (due to rapid cell division and protein expression). Bonne (2004) showed 
that E. coli expressed BFDV capsid protein could seroconvert sheep and induce production of 
antibody that reacted with native virus in IHC sections and with recombinant BFDV capsid in 
denaturizing Western immuno-blot.  However, it is not known whether such recombinant 
protein self assembles into VLP, as was found baculovirus expressed BFDV protein did 
(Stewart et al. 2007).  It is possible that E. coli expressed recombinant protein does not 
assemble into VLP’s, as prokaryotic organisms lack some post translational modification 
systems found in eukaryotes. Assembly of protein into VLP’s is potentially important for 
production of specific antibody, as epitopes can be both linear (the epitope is a region of the 
protein a.a. sequence) or structural (the epitope is a product of amino acid sequence as well as 
primary, secondary and tertiary structures of the protein molecule). Nonetheless, the work by 
Bonne (2004) indicates that this may not be a concern and E. coli could be advantageously 
explored for BFDV vaccine production.  
 
In conclusion; age, species and the genetics of the individual bird may all be factors 
that influence the severity of BFDV infection and the presentation of clinical signs. 
Nonetheless, vaccination was found to reduce the length of viraemia and protect against 
developing clinical signs of PBFD in long-billed corellas. Vaccinated corellas took longer 
before they had circulating BFDV DNA that could be detected by PCR, than non-vaccinated Chapter 7.General Discussion 
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corellas and relatively quickly cleared systemic virus compared to non-vaccinated corellas. 
BFDV infection lessens the WBC of corellas in acute and peracute infection even if the bird 
has protective antibody titres in circulation, prior to challenge. References 
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Appendix 
 
Graphs showing haematological values (PCV, TSP, and total leukocyte; differential 
leukocyte and acidophil counts) for individual birds in this experiment including galahs (G). 
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Elimination of false-positive polymerase chain reaction results resulting from hole punch
carryover contamination
Nicolai Bonne,
1 Phillip Clark, Patrick Shearer, Shane Raidal
Abstract. The collection of biological material (e.g., blood) directly onto filter paper for subsequent use in
laboratory assays such as polymerase chain reaction (PCR), has become a common practice. Dried cells or
fluid on the paper can be readily rehydrated and retrieved into a standard volume of an appropriate elution
buffer but introduces a dilution factor to the sample. The use of a common cutting instrument for excising
a standard-sized piece of paper that contains the material also introduces the potential for transferring
biological material from one sample to subsequent samples, causing false-positive results by PCR. In the
present study, filter-paper–collected blood that contained beak and feather disease virus was used to determine
if viral DNA could be transferred between samples by a hole punch used to excise sequential filter papers. It
was determined that false-positive results could be obtained at least 13 times after a positive sample.
Subsequently, the efficacy of 4 methods of hole punch disinfection, flaming, VirkonS, bleach, and a bleach-
ethanol combination, was assessed. The only effective and practical method to destroy DNA was a method
where the hole punch was agitated in commercial bleach, rinsed in water, the water was displaced with 100%
ethanol and air-dried. This method was simple, cheap, and relatively rapid, and allowed for the use of a single
hole punch for a series of samples, without carryover contamination and consequent false-positive results.
Key words: Beak and feather disease virus; contamination; disinfection; filter paper; hypochlorite;
polymerase chain reaction.
<!?show "fnote_aff1"$^!"content-markup(./author-grp[1]/aff|./author-grp[1]/dept-list)>
Molecular diagnostic methods (e.g., polymerase chain
reaction [PCR]) are widely used for the detection of
etiological agents, including viruses, bacteria, and parasites,
as well as for genotyping of both fauna and flora and in
forensic investigations. PCR allows the detection of DNA
from samples that originally contain a very few copies of
the DNA of interest.1 However, the fidelity of the PCR
reaction relies on avoiding contamination of true-negative
samples by carryover of target material from other samples.
Recently, it has become common practice to apply
biological material to filter paper
a,b for subsequent use in
PCR. The material dried on filter paper is easily stored and
transported, without the need for refrigeration.3,6,11,13,15,16
Typically, such samples are eluted from the sample paper, and
nucleic acid is subsequently isolated from the eluate for use in
PCR. Furthermore, some filter-paper products include
reagents that lyse cell membranes and stabilize nucleic acids,
allowing material to be easily washed and deposited directly
into the PCR reaction.2,13 To access the biological material
for PCR, the material dried on filter paper is commonly
excised by using a hole punch.3,4,6,9,12,13,16,17 This method
allows for expedient processing of samples and provides
a standard volume of filter paper. However, the use of a single
piece of equipment for multiple samples makes the method
vulnerable to carryover of nucleic acid between samples.
The aim of this experiment was to investigate the
potential for contamination of true-negative samples by
carryover of DNA caused by using a hole punch to excise
material from filter paper. Subsequently, a method to
minimize the potential of DNA transfer from a positive
sample to the other samples was developed.
Ethylenediamine tetra-acetic acid (EDTA)-preserved blood
originating from a long-billed corella (Cacatua tenurostris)
previously diagnosed beak and feather disease virus (BFDV)
positive by clinical examination and PCR by the Murdoch
University veterinary diagnostic service,was spotted onto filter
paper
a and dried at room temperature overnight.
To determine whether the hole punch could cause
carryover contamination, a new, unused hole punch
c was
used to excise filter paper.
a In accordance with the DNA
extraction kit
d specifications, 3 circles were excised from
each filter paper. Sequentially, ‘‘material’’ was excised from
From the School of Veterinary and Biomedical Sciences,
Division of Health Sciences, Murdoch University, Murdoch,
Western Australia (Bonne, Clark, Shearer), and the School of
Veterinary and Agricultural Sciences, Charles Sturt University,
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60 Brief Communicationsan unused filter paper (precut control) from a previously
unopened pack, from filter paper with blood from the
infected corella sample (known positive sample), and from
5 unused filter papers (contamination controls 1–5). The
sequence of filter paper excisions is illustrated in Fig. 1. The
excised circles were placed into 1.5-ml microcentrifuge
tubes, and DNA was extracted according to the kit
manufacturer’s instructions.
Four methods of disinfection were assessed to determine
an efficient and practical method of avoiding carryover
contamination between samples in a test panel. These were
1) flaming the hole punch with a Bunsen burner; 2) soaking
the hole punch in 0.5% (w/v) VirkonS
e for 30 min, with
subsequent washing in running tap water for 1 hr; 3)
soaking the hole punch in bleach (42 g/liter sodium
hypochlorite
f) for 20 min, with subsequent washing in
running tap water for 20 min (after the washing step in
methods 2 and 3, the hole punch was dried by removing
excess water with tissue paper and drying at 50uCi n
a heated cabinet); and 4) agitating the hole punch in 100%
bleach
f (approximately 5 sec), rinsing in water (approxi-
mately 5 sec), immersing and agitating in 100% ethanol (5–
10 sec) to displace the water, and finally air-drying.
The dryness of the hole punch after each method of
liquid disinfection was assessed by flicking the instrument
against a clean dry surface and observing for drops. In
methods 2 and 3, the hole punch was dry after approxi-
mately 60 min at 50uC. In method 4 the ethanol evapo-
rated, leaving the hole punch dry within seconds.
For each of the disinfection methods, a new, unused hole
punch was used to excise filter paper. In accordance with
the instructions in the DNA extraction kit, 3 circles were
excised from each filter paper. Sequentially, ‘‘material’’ was
excised from an unused filter paper (precut control) from
a previously unopened pack, from filter paper with blood
from the infected corella sample (known positive sample),
then from an unused filter paper (carryover positive
control), to positively control carryover of a nondisinfected
hole punch. Further, the known positive sample was
excised (without retaining circles) to contaminate the hole
punch before disinfection. After disinfection, unused filter
paper was excised (disinfection control). Finally, to control
for significant disinfectant residue retention (and associated
interference in subsequent applications), a single circle was
excised from the known positive sample (postdisinfection
positive control). The sequence of sample paper excisions is
illustrated in Fig. 2. The excised circles were placed into
1.5-ml microcentrifuge tubes, and the DNA (if any) was
extracted according to the kit manufacturer’s instructions.
To detect DNA that might be present in the samples
prepared above, PCR for detecting a fragment of BFDV
open reading frame V1 was conducted as previously
described21 by using forward primer P2 (59-AACCCTA-
CAGACGGCGAG-39) and reverse primer P4 (59-GTCA-
CAGTCCTCCTTGTACC-39). Reactions consisted of 2 ml
of 25 mM MgCl2,
g 5 mlo f5 3 polymerase buffer,
g 12.8
pmol of each primer, 0.12 ml of Tth polymerase,
g 2 mlo f
DNA extract, and water-for-injection
h added to a final
volume of 25.12 ml. Reactions were subjected to the
following conditions: 95uC for 5 min, then 32 cycles of
95uC for 30 sec, 60uC for 30 sec, 72uC for 1.5 min, and
finally 72uC for 10 min. PCR products were electrophor-
Figure 1. Method used to assess carryover of biological material by a hole punch used to excise a standard sized hole from
filter paper.
Figure 2. Method used to assess disinfection procedures of a hole punch. For assessing methods of decontamination, the points
where the hole punch was disinfected with method 1 (flaming), method 2 (VirkonS), method 3 (bleach), or method 4 (rapid bleach and
ethanol combination) are shown as an asterisk. A postdisinfection positive sample was used to assess the effects of any carryover of
disinfectant that might have interfered with the assay (causing a false-negative result).
Brief Communications 61esed in a 1% agarose gel at 90 V for 30 min, and the results
were visualized by ultraviolet transillumination.
In the sample panel prepared by using a hole punch that
was not disinfected between excision of the various filter
papers, the following results were obtained: PCR of precut
control did not yield any detectable amplification (Fig. 3,
lane 1). The known positive control (lane 2) yielded the
expected strong signal. Contamination controls 1–5 (lanes
3–7) yielded progressively weaker signals at the same
molecular weight as the positive control.
In the sample panels prepared by using a hole punch that
was disinfected between excision of the various filter
papers, the following results were obtained. In method 1
(Bunsen burner), PCR of the precut control did not yield
any detectable amplification. The known positive sample
yielded a strong product at the expected molecular weight.
The carryover positive control yielded a weaker product at
the expected molecular weight for this fragment. PCR of
the disinfection control sample yielded a product at the
molecular weight of the known positive sample but was
significantly weaker than the known positive. Finally, the
postdisinfection positive control yielded the expected
product (data not shown). In method 2 (VirkonS and tap
water) and method 3 (bleach and tap water), the precut
control did not yield any detectable amplification from
PCR. The expected positive result was obtained with the
known positive sample. PCR of the carryover positive
control resulted in a positive signal, weaker than that of the
known positive. The disinfection control did not yield
detectable amplification. Finally, the postdisinfection
positive control yielded a strong signal at the same
molecular weight of the known positive sample. Methods
2 and 3 both caused corrosion of the hole punch (data not
shown). In method 4 (bleach, tap water, ethanol), no
detectable amplification was obtained with PCR of the
precut control (Fig. 4, lane 1). The known positive sample
yielded the expected positive result (lane 2). PCR of the
carryover positive control obtained a product at the
molecular weight of the known positive sample, however,
significantly weaker than the known positive (lane 3). The
disinfection control sample did not yield a detectable signal
(lane 4). Finally, the postdisinfection positive control
resulted in a strong positive signal (lane 5). This method
did not cause visible corrosion of the hole punch.
Many studies used hole punches to excise material dried
on filter paper2–4,7,9,12–14,16,18,20; however, only a few
reports mention any protocols for detecting possible
carryover or detection of false positives in filter-paper–
based PCR methods.9,11 Furthermore, many published
studies overlooked any consideration for the possibility of
such contamination.2,3,7,12,14,18
Quality assurance methods to avoid such contamination
were reported by some investigators.4,9,13,16,17,20 Some labora-
tories report punching holes in blank paper between samples to
remove possible contaminants.17 One study reported ethanol
flaming the hole punch before making an excision,16 and other
studies reported wiping or pressing the hole punch against
ethanol-wetted paper towel,4,13 or a combination of wiping the
hole punch with ethanol and excising blank papers.9
The present study shows that there may be significant
carryover at least 13 excisions after the first excision of
a positive sample. It was concluded that sequential cutting of
fresh blank paper alone is inadequate for cleaning or removing
contaminating material from the hole punch. Furthermore, the
data obtained in the present experiment show that exposing
a contaminated hole punch to a high-temperature Bunsen
flame may not result in elimination of all residual DNA.
Studies on the effects of ethanol for disinfection showed
that, although various concentrations of ethanol may be, in
some cases, effective at reducing infectivity, it does not
destroy nucleic acid effectively.5,8 Thus, it can be concluded
that a hole-punch disinfection procedure that depends on
Figure 3. Agarose gel, illustrating the effect of using a non-
disinfected hole punch to excise filter paper for DNA extraction
and subsequent polymerase chain reaction (PCR) analysis. Lane
MW: Promega 100-bp molecular weight marker. The sample
sources for lanes 1–7 are shown diagrammatically in Fig. 1. Lane 1:
Precut control. Lane 2: Known positive sample. Lanes 3–7:
Contamination controls 1–5. Lane 8: PCR negative control.
Figure 4. Agarose gel of polymerase chain reaction (PCR)
products yielded from filter paper cut with a disinfected hole punch.
Lane MW: Promega 100-bp molecular weight marker. The sample
sources for lanes 1–5 are shown diagrammatically in Fig. 2. Lane 1:
Precut control. Lane 2: Known positive sample. Lane 3: Carryover
positive control. Lane 4: Postdisinfection result (method 4). Lane 5:
Postdisinfection positive control. Lane 6: PCR negative control.
62 Brief Communicationsalcohol will not be sufficient to avoid nucleic-acid carryover
contamination.
The likely possibility of a hole punch carrying contamina-
tion to consecutive samples and associated false-positive
results may have been overlooked by many laboratories, and
some may be using methods that are insufficient to ensure
decontamination. In the present study, a virgin hole punch
was used to determine whether hardware used for processing
dried blood samples on filter paper could serve as a vessel for
carryover. The results obtained in this experiment give
support for this hypothesis, because clean filter paper
processed subsequently to the known positive control resulted
in progressively weaker positive results for as many as 13
punches afterward. This result is not surprising in light of the
ability of the PCR to detect few copies of the target DNA.
The present study demonstrated that the simple, cheap, and
relatively rapid disinfection technique involving bleach, tap
water, and ethanol was the most successful. This method
allowedfortheuseofasingleholepunchforaseriesofsamples,
without carryover and consequent false-positive results.
Forensic scientists and scientists who study ancient DNA
commonly use bleach to eliminate contaminating DNA on
bone samples.10 Furthermore, studies have determined the
effectiveness of bleach for eliminating DNA in PCR
reactions,19 but the present study is the first to demonstrate
its use to decontaminate hole punches used for filter-paper
excision.
The results presented in the present study provide
evidence for the potential of a hole punch to transfer
material between filter-paper dried samples. The possibility
of carryover of material between samples when using a piece
of hardware should be considered by all researchers who
use PCR analysis of biological material and appropriate
methods used to minimize its occurrence.
Sources and manufacturers
a. Whatman no. 3 filter paper, Whatman International Ltd,
Maidstone, England.
b. FTA filter paper, Whatman International Ltd, Maidstone,
England.
c. One hole punch, Officeworks Superstores Pty Ltd, Box Hill,
Vic, Australia.
d. QIAamp DNA blood mini kit, Qiagen Pty Ltd, Doncaster, Vic,
Australia.
e. ANTEC VirkonS, Janos-Hoey Pty Ltd, Forbes, NSW,
Australia.
f. White King, SaraLee Household and Body Care, Pymble,
NSW, Australia.
g. PCR reagents, Fisher Biotech, Wembley, WA, Australia.
h. Water-for-injection BP, AstraZeneca Pty Ltd, North Ryde,
NSW, Australia.
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Beak and feather disease virus (BFDV) is a significant pathogen of wild Australasian and African
psittacine birds. We assessed the immunogenicity of recombinant BFDV capsid (recBFDVcap) to
protect against the development of psittacine beak and feather disease (PBFD). Long-billed
corellas (Cacatua tenuirostris)( n513) received (by injection) 1 ml vaccine containing 10 mg
recBFDVcap on day 0 and 0.4 ml vaccine containing 66.8 mg recBFDVcap on day 11. All
vaccinated corellas and five non-vaccinated control corellas were given 0.4 ml BFDV suspension
[titre5log2 12 haemagglutination units (HAU) 50 ml
”1] intramuscularly and 0.1 ml orally 16 days
after booster vaccination. Blood was collected during the vaccination period and blood and
feathers were collected after BFDV administration. Testing of blood samples included BFDV DNA
detection by PCR and quantitative PCR (qPCR) as well as antibody detection by
haemagglutination inhibition (HI) and on feather samples, BFDV DNA and antigen was detected
by haemagglutination (HA) and qPCR. Four of 97 blood samples collected from vaccinated birds
after virus challenge tested positive by PCR, whereas 17 of 35 samples taken from non-
vaccinated control corellas tested positive. Vaccinated birds did not develop feather lesions, had
only transient PCR-detectable viraemia and had no evidence of persistent infection 270 days
post-challenge using PCR, histopathology and immunohistochemistry. Non-vaccinated control
corellas developed transient feather lesions and had PCR, HI and HA test results consistent with
PBFD. They were BFDV PCR-positive for up to 41 days post-challenge and qPCR demonstrated
reduced virus replication in vaccinated birds compared with non-vaccinated control birds.
INTRODUCTION
Psittacine beak and feather disease (PBFD) is a significant
disease of both wild and captive psittacine birds in many
parts of the world and has serious implications for the
health of pet birds as well as for the conservation of
threatened species (Albertyn et al., 2004; Bert et al., 2005;
McOrist et al., 1984; Rahaus & Wolff, 2003; Raidal et al.,
1993a). Vaccination against PBFD using inactivated virus
purified from the feathers of chronically infected cockatoos
has been shown to protect psittacine birds from developing
PBFD (Raidal & Cross, 1994; Raidal et al., 1993b).
However, the use of beak and feather disease virus
(BFDV)-infected feathers or other tissues as a source of
antigen is potentially hazardous due to an inability to assess
the reliability of BFDV inactivation in vitro. The mainten-
ance of birds infected with BFDV for the production of
vaccine is impractical and expensive and the production
and maintenance of birds infected with BFDV for the sole
purpose of antigen production is ethically questionable.
This has driven research efforts to find alternative methods
for vaccine production. Many traditional cell culture
systems have been tried for amplification of BFDV;
however, these attempts have been unsuccessful (Pass &
Perry, 1985). As an alternative, Stewart et al. (2007)
described the use of a recombinant baculovirus for the
production of the BFDV capsid protein and showed that
the protein had properties similar to those of the native
virus, including morphology, haemagglutinating activity
and ability to react with anti-BFDV antibody.
Vaccine assessments are best done using susceptible or
specific-pathogen-free animals, but these are difficult to
obtain for wildlife species, particularly endangered ones. In
this report, the vaccination and subsequent BFDV
challenge of hand-raised long-billed corellas (Cacatua
tenurostris) collected from the wild by Western Australia
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determine whether recombinant BFDV capsid protein,
expressed using a baculovirus system, could cause ser-
oconversion and prevent BFDV replication and excretion
in susceptible psittacine birds. By documenting the effects
of BFDV-challenge on vaccinated and control birds the
results also provide important information a propos the
pathogenesis of PBFD.
METHODS
Acquisition of BFDV-free birds. The birds used for this
experiment were 18 hand-raised long-billed corella (C. tenurostris)
nestlings collected from the wild by DEC officers. This was
approved under permit by the Animal Ethics Committee of
Murdoch University. The birds were determined to be free of
BFDV infection, as described below, and housed individually or in
sibling groups and hand-reared using a hand-rearing formula
(Roudybush formula 3, Kimani Aviaries) and temperature-con-
trolled, air-filtered incubators. Once the birds reached weaning age,
they were maintained in suspended wire cages or an aviary in a
single climate-controlled quarantined room. Here the birds were
maintained on a diet of commercial parrot pellets (Passwell), fresh
fruit, vegetables and peanuts.
During the hand-rearing period, the birds were screened repeatedly
for evidence of BFDV infection in the peripheral blood by PCR and
once for evidence of pre-existing antibodies to BFDV by haemagglu-
tination inhibition (HI). Blood samples were collected and tested for
BFDV DNA on their first day of captivity and then on days 11, 18 and
25 after arrival. Anti-BFDV HI antibody was tested on blood samples
collected on day 1. The vaccination trial commenced 41 days after the
nestlings arrived in captivity. Sampling continued during the
vaccination and BFDV-challenge periods as described below.
Production of recombinant BFDV capsid protein. The baculo-
virus system used to express the recombinant capsid protein of BFDV
was developed by Stewart et al. (2007) using the Bac to Bac
(Invitrogen) baculovirus expression system. Briefly, PCR-amplified
BFDV ORFC1 (which encodes the capsid protein) was excised from a
pCR2.1 BFDV ORFC1 construct using an EcoRI/SalI double digest,
ligated into the EcoRI/SalI site of the pFastBAC HTa (Invitrogen)
baculovirus transfer vector and transformed into TOP10F9 chemically
competent Escherichia coli (Invitrogen). The orientation of the gene in
pFASTBAC was verified by restriction digestion with BamHI and
sequence analysis. The recombinant bacmid was generated according
to the manufacturer’s protocol (Invitrogen). The pFASTBAC HTa
BFDV ORFC1 construct was transformed into chemically competent
E. coli DH10Bac (Invitrogen) containing the bacmid and helper
vector, where the BFDV ORFC1 was transposed into the bacmid. The
recombinant bacmid containing the BFDV ORFC1 was purified and
transfected using cellfectin (Invitrogen) into SF9 insect cells to
produce recombinant baculovirus (AcMNPV) containing the BFDV
ORFC1 gene under the control of the polyhedrin promoter. The
recombinant baculovirus was amplified until the titre was sufficient
for high-level expression of the protein. For the production of
recombinant BFDV capsid protein used in the vaccination trial, SF9
insect cells were cultured to a density of 2610
6 cells ml
21, infected
with the recombinant baculovirus at an m.o.i. of 0.2 and then
harvested 72 h post-infection. The cultures were then lysed and the
protein purified as described previously (Stewart et al., 2007).
Western immunoblot detection of recombinant protein. The
recombinant BFDV capsid protein was detected by Western
immunoblot, using mouse antihistidine IgG (Serotec, diluted
1:5000) and alkaline-phosphatase-conjugated goat-anti-mouse IgG
(Sigma Aldrich, diluted 1:30000) using previously described
procedures (Stewart et al., 2007).
Quantification of expressed recombinant BFDV capsid protein
for vaccination. The recombinant protein preparation intended for
primary vaccination was quantified by densitometry (Proteomics
International) and the recombinant protein preparation for secondary
vaccination was quantified in our laboratory by the same method.
Briefly, Samples were mixed with SDS loading solution without
reducing agent and boiled for 5 min. Subsequently, the samples were
loaded onto NuPAGE 4–12% polyacrylamide midi-gels (Invitrogen)
with MES electrophoresis buffer and electrophoresed at 200 V for 1 h.
The gels were stained using colloidal Coomassie G250 (PI-Blue
method). The gels were then scanned using a ProEXPRESS 2D
Proteomic Imaging System (Perkin–Elmer). Quantitative band
analysis was carried out using Totallab TL120 (Nonlinear
Dynamics). The total stained material in each gel lane was determined
and the quantity of the recombinant BFDV capsid protein in the
sample was determined from the graph of known ovalbumin
quantities (chicken lysozyme standard). The percentage of recom-
binant protein was measured using volume ratios from the
recombinant BFDV capsid bands, where it was calculated as Rec/
REC BFDV CAPSID (total).
Vaccine preparation. Vaccine doses were prepared immediately
before injection. Equal volumes of the recombinant proteins and
Freund’s incomplete adjuvant (Sigma Aldrich) were mixed to form a
stable primary emulsion using two sterile glass syringes connected
together by a section of 16-gauge cannula.
Vaccination. Thirteen vaccinated corellas were given injections of
1 ml vaccine containing 10 mg recombinant BFDV capsid protein on
day 0 and 0.4 ml vaccine containing 66.8 mg recombinant BFDV
capsid protein on day 11 post primary vaccination. The vaccine was
delivered by pectoral intramuscular injection. Non-vaccinated control
birds (n55) did not receive any injection. The birds were between 65
and 89 days old on the day of primary vaccination.
BFDV inoculum. Virulent BFDV inoculum, was produced by Raidal
et al. (1993a) and had been stored at 280 uC until its use in this
experiment. These stocks had a haemagglutination titre of log2 12
haemagglutination units (HAU) 50 ml
21 before the experiment,
determined using haemagglutination assay (HA) as described by
Raidal et al. (1993c).
BFDV challenge. Vaccinated birds and non-vaccinated control birds
were challenged 16 days after the secondary injection (27 days after
the primary injection) with 0.5 ml BFDV suspension, 0.4 ml of which
was administered by pectoral intramuscular injection and 0.1 ml of
which was administered orally.
Sampling. Blood was collected by jugular venepuncture from each of
the 18 birds on days 0, 11 and 27 after primary vaccination. The
BFDV suspension was administered 27 days after the primary
vaccination (16 days after secondary vaccination). Then, on days
13, 20, 26, 41 and 97 after the birds were challenged with BFDV
suspension (40, 47, 53, 68 and 124 days post primary vaccination), a
blood sample was collected by jugular venepuncture, and a sample of
powder-down or crest feather was collected from each of the birds.
The birds had well-developed plumage, but frequently had developing
powder-down and growing crest feathers emerging on the chest, neck
and head and these were chosen for sampling when they were found.
The blood was spotted onto Whatman filter paper no. 3, allowed to
dry for at least 1 h at room temperature in an area free of
environmental contamination and stored in individual zip-lock bags
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zip-lock bags and stored at 4 uC until used.
PCR, HI and HA assays. Dried blood spots were excised from the
filter paper using a stationary hole puncher (OfficeWorks) according
to the methods previously described by Bonne et al. (2008), deposited
into 1.5 ml Eppendorf tubes and DNA extracted using a QIAamp
DNA Blood Mini kit (Qiagen). PCR for detection of BFDV DNA was
performed as described by Ypelaar et al. (1999). Anti-BFDV HI
antibody detection was performed on dried blood spots as described
by Riddoch et al. (1996) and HA testing was performed on feather
extracts according to the protocol developed by Raidal et al. (1993c).
Quantitative PCR (qPCR). The above-mentioned DNA extracts
were tested by qPCR and this was also performed on DNA extracts of
feather samples. Primers were designed based on conserved regions of
known BFDV sequences (Wishart & Fortin, 2001). Primers P5 (59-
GGACGCAAAATGAAGGAAG-39) and P6 (59-TAGCGAGAGG-
TTATGCAAGC-39) (GeneWorks) were designed to amplify an
81 bp fragment of ORF V1. Magnesium chloride concentrations
and annealing temperatures were optimized using an Eppendorf
Mastercycler Gradient thermocycler. The optimized PCRs consisted
of 2 mM MgCl2,5ml5 6 polymerization buffer containing dNTPs,
3.34 mM SYTO9 fluorescent dye (Invitrogen), 12.8 pmol each primer
and 0.1 U Tth Plus DNA polymerase, in ultrapure water in a total
volume of 23 ml (all reagents Fischer Biotec, except SYTO9), plus 2 ml
extracted DNA. Reactions were carried out in a Corbett Rotor-Gene
3000 (Corbett Research) real-time thermocycler. Cycling conditions
consisted of an initial denaturation at 95 uC for 5 min, then 40 cycles
of 95 uC for 20 s, 58 uC for 30 s and 72 uC for 20 s, followed by a
final extension step at 72 uC for 10 min. Known-copy-number DNA
standards were included in each run for quantification of viral load.
The cycle threshold (Ct) values obtained for these standards were
plotted against time to construct a standard curve using the software
supplied with the Rotor-Gene. The Ct of each of the samples was then
compared against the graph to estimate the viral load. Melt curve
analysis was performed after each run
Extraction of DNA from feathers. Viral DNA was extracted from
feathers using the methods described by Ypelaar et al. (1999). Five
millimetre feather calamus was cut on a sterile surface and placed into
a microcentrifuge tube (Eppendorf). To this, 200 ml 70% (v/v)
ethanol was added and the tube vortexed briefly, the ethanol was
removed and 200 ml sterile distilled water were then added and the
tube vortexed again. The sterile water was removed and 500 ml lysis
buffer [50 mM KCl, 10 mM Tris/HCl (pH 8.0), 2.5 mM MgCl2,
0.005% (v/v) Tween 20, 0.005% (v/v) Nonidet P40] containing
250 mg proteinase K ml
21 (Qiagen) was added. The feather in lysis
buffer was incubated at 37 uC for 1–2 h, before being heated to 95 uC
for 10 min. The solution was centrifuged and DNA was extracted
from the supernatant with the Qiagen blood mini kit, using the blood
and body fluid spin protocol.
Crude DNA extracts of feather eluates prepared for HA testing were
also made. Feathers were incubated with 100 ml PBS at 60 uC for 1 h
in a microcentrifuge tube (Eppendorf). The solution was centrifuged
briefly after incubation and 10 ml supernatant transferred to another
microcentrifuge tube and then boiled for 10 min.
Statistical analysis. One-way ANOVA with Tukey’s multiple
comparison post test was performed using SigmaPlot 9.01 for
Windows (Stystat Software) to test for significant differences in
mean HI titres between the two groups (vaccinated and non-
vaccinated) and between time points within each group.
Clinical examinations. Clinical examinations were performed
weekly and the birds were inspected for evidence of individual
developing feathers with thickening of the feather sheath, feather
constrictions and other clinical signs consistent with PBFD,
previously described by others (Jacobson et al., 1986; Jergens et al.,
1988; McOrist et al., 1984; Pass & Perry, 1984).
Necropsy and pathological examinations. All birds were killed
and necropsied 270 days post BFDV challenge. At this time blood and
tissue samples were collected for serology, virus detection and
histopathology. Feather samples were collected for HA and PCR
assay. Liver was collected and stored at 220 uC for PCR and blood
was collected for HI antibody and PCR.
Tissue samples collected post mortem included skin and coelomic
visceral organs, which were fixed in buffered formalin for 24 h and
then processed by routine histology methods, stained with haema-
toxylin and eosin and examined by light microscopy.
Immunohistochemistry (IHC) using primary monoclonal antibody
(Shearer et al., 2008a) to recombinant BFDV capsid protein and a
horseradish peroxidase (HRP)-conjugated secondary antibody were
performed on tissue sections as described by Shearer et al. (2008b).
RESULTS
PCR
Samples collected from the birds during the hand-rearing
period, the day of primary and secondary vaccination and
the day of live BFDV challenge were all negative for BFDV
DNA by PCR. Thirteen days post-challenge with BFDV, all
five non-vaccinated control birds had become PCR-
positive for BFDV DNA and none of the vaccinated birds
had detectable BFDV DNA. Similarly, at 20 days post-
challenge, all non-vaccinated control birds were still
positive, and still none of the vaccinated birds had PCR-
detectable BFDV DNA. In contrast, at 26 days post-
challenge one vaccinated bird had become positive and
four non-vaccinated control birds remained positive.
Forty-one days post-challenge, three non-vaccinated con-
trol birds tested PCR positive and three vaccinated birds
had positive results (Fig. 1). Ninety-seven days post-
challenge all birds were PCR negative. Table 1 summarizes
the PCR results from the day of challenge until the end of
the experiment.
qPCR
The assay successfully detected BFDV DNA in the blood of
all control (non-vaccinated) corellas (Fig. 2a). In non-
vaccinated control birds the viral load±SEM was estimated
at 1358473±1113226 copies ml
21 (range 14478–
5768973 copies ml
21) at 2 weeks post-challenge and rose
to a peak of 4850482±4775008 copies ml
21 (range 1709–
23949983 copies ml
21) by 4 weeks post-challenge before
dropping to 575486±551069 copies ml
21 (range 823–
2779419 copies ml
21) at 6 weeks post-challenge. Transient
low-level viraemia of between 58 and 4057 copies ml
21 was
detected in six vaccinated birds at various time points, but
all birds were seropositive at the times when viral DNA was
present in blood samples. The viral load in blood samples
of vaccinated birds followed a similar pattern to that of the
N. Bonne and others
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increasing in a curvilinear fashion from 58 copies ml
21 at
2 weeks post-challenge to a peak of 1177±723 copies ml
21
(range 209–4057 copies ml
21) by 6 weeks post-challenge
(Fig. 2a). Specific peaks were present in the melt curves of
BFDV-positive samples between 82 and 84.5 uC.
The assay also detected BFDV DNA in feather preparations
(Fig. 2b). The mean viral load±SEM in feather extracts of
control birds was estimated at 8831±4662 (range 262–
20 639 copies ml
21) at 2 weeks post-challenge, rose to a
peak of 852500308±681941583 copies ml
21 (range 2591–
3409766576 copies ml
21) at 4 weeks post-challenge, then
decreased to 380734071±380729701 copies ml
21 (range
430–1903652876 copies ml
21) by 6 weeks post-challenge.
Virus was detectable by HA in the feather samples of only
one control bird at 4 and 6 weeks post-challenge, which
were also the samples that had the greatest amount of viral
DNA present. Viral DNA was present in the feather extracts
of three vaccinated birds 2 weeks post-challenge, six
vaccinated birds at 4 weeks post-challenge and 10 vacci-
nated birds 6 weeks post-challenge. However, none of the
three birds with viral DNA in feather extracts at 2 weeks
post-challenge had detectable viral DNA in the equivalent
blood sample. At 4 and 6 weeks post-challenge, only one
out of six and four out of ten birds, respectively, had
detectable amounts of viral DNA in the equivalent blood
sample (between 193 and 420451 copies ml
21). The
samples which were positive for qPCR of feather extracts
but negative for blood samples were considered to be false
positives.
Serology
Screening the birds for anti-BFDV antibody after arrival
did not detect any HI-positive serum. The development of
antibodies to BFDV during the vaccination and challenge
period, as determined by HI, is illustrated in Fig. 1 and
summarized in Table 2.
Detection of virus excretion by HA
Excretion of virus from feathers could not be detected in
any samples from vaccinated birds using HA. Of five non-
vaccinated control birds, one bird tested positive by HA for
excretion of virus in feathers. This bird was HA negative on
Fig. 1. Comparison of vaccinated (n513) and
non-vaccinated (n55) corellas showing sero-
conversion after vaccination and post BFDV
challenge. Serum HI antibody titres as
mean±SD serum log2 HI titres for each group
and the number of seropositive birds are
shown for each time point. The individual
feather HA and serum HI antibody results for
one non-vaccinated control bird (52A5) are
shown as bars along with the time points
(asterisks) when this bird was PCR-positive.
Table 1. Summary of PCR results for vaccinated and non-
vaccinated control birds from 0 to 270 days post-challenge
Days post-
challenge
Vaccinated birds Non-vaccinated
control birds
Number
of positive
birds
Number
of negative
birds
Number
of positive
birds
Number
of negative
birds
00 1 3 0 5
13 0 13 5 0
20 0 13 5 0
26 1 12 4 1
41 3 10 3 2
97 0 13 0 5
270 0 13 0 5
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post-challenge) and day 68 (41 days post-challenge) this
bird had a HA titre of log2 12 HAU 50 ml
21 and .log2 12
HAU 50 ml
21, respectively. This bird’s HA and HI
developments are illustrated in Fig. 1.
Statistical analysis
The Tukey’s multiple comparison post test did not find any
significant difference between group mean HI titres at each
time point after challenge. However, vaccinated birds had
significantly different HI antibody titres on day 27
compared with day 68 (P,0.01). Similarly, there were
statistically significant differences between vaccinated birds
on day 27 compared with day 124 (P,0.01); vaccinated
birds on day 27 compared with non-vaccinated control
birds on day 124 (P,0.01); vaccinated birds on day 40
compared with day 68 (P,0.01); vaccinated birds on day
40 compared with day 124 (P,0.01); vaccinated birds on
day 40 compared with non-vaccinated control birds on day
53 (P,0.05); vaccinated birds on day 40 compared with
day 124 (P,0.001); vaccinated birds on day 47 compared
with non-vaccinated control birds on day 124 (P,0.05);
and non-vaccinated control birds on day 40 compared with
non-vaccinated control birds on day 124 (P,0.05).
Clinical and post-mortem observations
Non-vaccinated control birds developed feather sheath
thickening and dysplasia of varying severity in individual
developing powder-down and crest feathers 2–4 weeks
post-challenge. This included pinching-off of the devel-
oping calamus, which is a pathognomonic sign for PBFD.
No other clinical signs were observed in non-vaccinated
control birds or vaccinated birds.
Compared with a geometric mean HI antibody titre of log2
4.48 (combined results) at 97 days post-BFDV challenge, at
270 days post-challenge the geometric mean HI antibody
Fig. 2. Mean viral load in (a) blood and (b) feather preparations of
control and vaccinated birds after challenge with beak and feather
disease virus (BFDV). Peak viral load was greater in feather
preparations than in blood samples for both groups of birds. Bars
indicate SEM.
Table 2. Mean log2 HI titres±SD versus days post-challenge
n: The number of birds that had detectable HI titre in that group. The vaccinated birds received the primary vaccine
dose on day 0 and secondary dose on day 11. The live BFDV suspension was administered to all vaccinated and non-
vaccinated control birds on day 27.
Days post-challenge Vaccinated birds Non-vaccinated control birds
Mean log2 HI titre SD n Mean log2 HI titre SD n
0 nil nil 13 nil nil 3
11 3.00 – 1 nil nil 5
27 2.67 1.12 9 nil nil 5
40 2.50 1.43 10 2.75 1.50 4
47 3.46 1.51 13 5.00 0.82 4
53 4.38 1.26 13 5.25 1.26 4
68 5.00 1.00 13 4.40 1.95 5
124 5.00 1.15 13 6.00 1.22 5
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liver-PCR-negative. All birds appeared clinically normal
with no evidence of gross or histological lesions detected in
skin or visceral organs. There was a range in size of the
bursa of Fabricius, but in the majority the bursa was
approximately of equal size to the spleen and both of these
organs contained evidence of normal lymphoid follicles at
different stages of development or involution and there was
no evidence of intracytoplasmic BFDV inclusions. Also,
there was no evidence of intracytoplasmic BFDV antigen in
any tissues from IHC.
DISCUSSION
The results obtained in the current study indicate that the use
of recombinant BFDV capsid protein is a potentially viable
option for vaccination to promote an adaptive immune
response to BFDV. All vaccinated corellas developed HI
antibody titres after vaccination and did not develop clinical
signs of PBFD after BFDV challenge. In contrast, non-
vaccinated control corellas developed evidence of mildfeather
lesions in developing powder-down and growing crest
feathers consistent with clinical PBFD after BFDV challenge.
The frequency of PCR- and HA-positive time points was
less in vaccinated birds compared with non-vaccinated
control birds. Vaccinated birds were never PCR-positive in
blood at more than one time point and did not have
detectable HA feather excretion, whereas non-vaccinated
control birds remained PCR-positive for more than
3 weeks and HA feather excretion was detected twice.
Excretion of virus in feathers is strongly associated with the
presence of disease (Raidal et al., 1993c; Khalesi et al.,
2005) and viraemia, detected by PCR on blood, was evident
in non-vaccinated control birds and only transient
viraemia could be detected in vaccinated birds.
The qPCR results indicated that there was reduced virus
replication in vaccinated corellas compared with non-vacci-
nated control corellas. The qPCR assay detected viral DNA in
birds that tested negative by the standard PCR and demon-
s t r a t e dt h a tt h ev i r a ll o a di nb o t hv a c c i n a t e da n dc o n t r o lb i r d s
increased for the first 4 weeks after challenge. That this
occurred despite vaccinated birds having detectable anti-BFDV
antibodies before being challenged indicates that vaccination
does not prevent viral replication. This is a common scenario
with other vaccines (Opriessnig et al., 2006) and is not
surprising in this case. This evidence of viral replication may
not have been detected if a standard PCR assay alone had been
used. Given that vaccination does not prevent viral replication,
it is likely that the chicks of vaccinated birds will still be
susceptible to transient infection and virus replication in the
presence of maternal antibodies, as occurs with porcine
circovirus type 2 and chicken anemia virus (Brentano et al.,
2005; Larochelle et al., 2000). This has implications for the
management of the disease in infected flocks.
As in the earlier vaccination and challenge experiment by
Raidal (1994), where vaccinated sulphur-crested cockatoos
(Cacatua galerita) remained clinically normal after chal-
lenge and developed high HI titres, in the current
experiment, none of the vaccinated corellas developed
clinical signs of PBFD and all developed HI titres, albeit of
a lesser magnitude than those observed by Raidal (1994). In
contrast to the study by Raidal (1994), where non-
vaccinated control birds developed acute PBFD, the non-
vaccinated control birds showed only mild clinical signs,
and only one bird was found to have BFDV excretion in the
feathers. These differences between the two experiments
could be due to either the storage of the inoculums, shown
by HA titration to have resulted in a 2 log2 decrease in viral
titre, or to the lesser amount of inoculum delivered to each
bird in the current experiment (approximately half of that
used by Raidal, 1994). In the current literature, there is
debate about the existence of species-specific or species-
adapted genotypes of BFDV (Bassami et al., 2001; Khalesi
et al., 2005; Phenix et al., 2001; Raue et al., 2004; Ritchie et
al., 2003). Thus the species of bird may also affect the
susceptibility to infection. However, in pathogenesis
studies by Raidal (1994), 18 adult galahs (Eolophus
roseicapillus), three nestling galahs and six nestling
sulphur-crested cockatoos (6–7 weeks of age) were chal-
lenged with the previously mentioned inoculum. Only one
adult galah had clinical signs indicative of PBFD, whereas
the nestling galahs had a gradual onset of PBFD clinical
signs and the nestling sulphur crested-cockatoos developed
acute PBFD within 4 weeks and died.
The results also provide important information concerning
the pathogenesis of PBFD as the PCR data show that not all
BFDV-infected birds develop fulminant disease. Whilst
non-vaccinated control birds developed mild clinical signs,
only one bird (non-vaccinated control) had HA excretion
in the feathers. This bird had test results typical of PBFD.
Thus the results obtained here and those by Raidal (1994)
are similar, even though Raidal (1994) observed a higher
frequency and more severe clinical disease in non-
vaccinated birds. One explanation for this is that the
chicks used in the current paper received a lesser challenge
dose of BFDV inoculum, but it is more likely to be due to
their older age when challenged. It is well accepted that
there is an age-related susceptibility to BFDV. In the
present experiment it was very important to first confirm
that the chicks were truly negative for BFDV infection and
this required repeated PCR testing. This is the reason why
they were first vaccinated at 65–89 days of age and not
earlier. Indeed the results indicate that, at this age, corella
fledglings may well be naturally resistant to developing
PBFD but not to BFDV infection. This is supported by
observations made in pathogenesis and epidemiological
studies by Raidal (1994), where galah and sulphur-crested
cockatoo chicks developed acute PBFD, whereas adult
birds of these species remained clinically normal.
In the present experiment, vaccination with recombinant
BFDV capsid protein elicited an immune response that
could be detected by HI assay. The observation of mild
clinical signs and detection of consistent viraemia by PCR
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inoculum was infective and disease-causing, even after
approximately 15 years of storage. Detection of only
occasional transient viraemia in vaccinated birds, as
opposed to the extended period of viraemia in non-
vaccinated control birds, provides evidence that vaccina-
tion may be useful for preventing persistent viraemia and
virus shedding, but not necessarily in completely prevent-
ing BFDV replication.
The small decline in HI antibody data between days 97 and
270 post BFDV-challenge indicates that anti-BFDV HI
antibody persists in immune birds and may well do so for
many years. Epidemiological data supports this observation
(Raidal et al., 1993b). An annual rate of decline of log2 0.22
can be calculated from the data, because between these two
time points we are confident that antibody titres were not
being maintained by ongoing immune stimulation. The
birds were held as a closed flock and no evidence of
persistent BFDV infection or excretion was detected in
blood samples collected on day 97 and blood, feathers and
liver collected at post-mortem on day 270 post-challenge.
At this time point they were all at least 1 year old and all,
including the control birds, had normal lymphoid tissue in
the bursa of Fabricius and spleen.
These results are significant for understanding the patho-
genesis of PBFD, since it has been previously hypothesized
that infected birds might have a long latency period of up to
2 years, whereby they remain clinically normal until the
progression of the disease is accelerated following stress, or
when moulting is commenced. It is also well accepted that
birds with acute or chronic PBFD lesions suffer from a
compromised immune system with the presence of char-
acteristic intracytoplasmicviral inclusions readilyidentifiable
in the bursa and the presence of chronically persistent viral
excretion. As far as we are aware this is the first report that
demonstrates the relatively long retention (greater than
1 year) of bursal activity in any Cacatua species. The
involution of the bursa of Fabricius in chickens occurs much
earlierthanthisand itiscompletelyatrophied by24 weeksof
age (Naukkarinen & Sorvari, 1984). Given the data presented
inthispresentpaperitseemslikelythatthebursa ofFabricius
of C. tenuirostris retains significant function as a peripheral
lymphoid organ until at least 1 year of age. It may be that
primary immunosuppression is first required to permit
establishment of chronic BFDV infection and excretion and
the pathogenesis of chronic feather and lymphoid lesions, at
least in fledgling corellas up to the age of 2 years.
The present paper provides evidence that baculovirus-
expressed recombinant BFDV capsid protein is immuno-
genic in C. tenurostris fledglings and may be a suitable
candidate vaccine to prevent PBFD in psittacine birds.
Further work is needed to determine an optimal vaccination
regime to protect nestling birds, which are presumably more
susceptible to infection. This would include determining the
optimum antigen dosage per vaccination, the amount of
time between primary and secondary vaccinations, the
appropriate ages of birds that could be vaccinated, the
positive and negative effects of passive transfer of maternal
antibody, the choice and effect of a suitable adjuvant, and
the safety of various routes of administration.
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Abstract The hematological characteristics of juvenile
long-billed corellas (Cacatua tenurostris), with or without
prior administration of a psittacine beak and feather disease
vaccine, were studied for 97 days after experimental
infection with beak and feather disease virus (BFDV). It
was found that the pre-challenge hematological values were
similar betweenvaccinatedandnon-vaccinatedcorellas. Most
pre-challenge parameters were comparable to previously
reported values of other cockatoos and psittacine birds.
Significant differences were seen in both groups when
comparing pre-challenge values with post-challenge values
for total and differential leukocyte concentrations, but packed
cell volume and total serum protein were not significantly
affected by BFDV challenge.
Keywords BFDV.PBFD.Psittacinehematology
Introduction
Clinical hematology is a valuable tool for the diagnosis of
disease in birds (Hawkey and Samour 1988). However,
there is less available knowledge of avian hematology than
for mammals. Relatively few species of birds have had their
hematological characteristics determined. Furthermore, as
many factors may influence these characteristics, such as
stress related to capture, caging, social interactions, environ-
mental conditions, moult, disease, temperature, season,
growth rate, diurnal rhythm, gender, diet, and age, published
reference values only provide broad guidelines for the
determination of ill health (Campbell and Ellis 2007; Clubb
et al. 1991).
Hematological values have been reported for few of the
more than 330 species (Forshaw 1989) of psittacine birds.
Characterized species include: white cockatoo (Cacatua
alba), Goffin’s cockatoo (Cacatua goffini), black cockatoo
(Calyptorhynchus funereus), yellow Amazon (Ara ara-
rauna), blue-fronted Amazon (Amazona aestiva), orange-
winged Amazon (Amazona amazonica), festive Amazon
(Amazona festiva), vinaceous Amazon (Amazona vinacea),
Cuban Amazon (Amazona leukocephala), scarlet macaw
(Ara macao), green-winged macaw (Ara chloroptera),
military macaw (Ara militaris), golden conure (Aratinga
guarouba), Patagonian conure (Cyanoliseus patagonus),
palm cockatoo (Probosciger aterrimus), African grey parrot
(Psittacus erithacus), hyacinth macaw (Anodorhynchus
hyacinthinus), red lory (Eos bornea), African grey timneh
(Psittacus erithacus timneh), yellow-fronted Amazon
(Amazona ochrocephala ochrocephala), double yellow-
headed Amazon (Amazona oratrix), yellow-naped Amazon
(Amazona auropalliata), mealy Amazon (Amazona farinosa
farinosa), sulfur-crested cockatoos (Cacatua sulfurea
sulfurea, C. s. abbotti, C. s. citrinocristata), greater sulfur-
crested cockatoo (Cacatua galerita triton), Moluccan cock-
atoo (Cacatua moluccensis), red-and-blue lory (Eos histrio),
violet-necked lory (Eos squamata), blue-streaked lory (Eos
reticulate), and black-winged lory (Eos cyanogenia)( L u m e i j
and Overduin 1990;P o l oe ta l .1998; Scope et al. 2000). In
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Birds affected by psittacine beak and feather disease
have been reported to commonly succumb due to secondary
infections after infection with the virus and subsequent
immunosuppressive effects (Latimer et al. 1990; Latimer et
al. 1992; Schoemaker et al. 2000). However, only one study
has reported any hematological effects, whereby 14 African
grey parrots naturally infected with BFDV that had severe
leukopenia and anemia or pancytopenia, despite an absence
of feather and beak abnormalities (Schoemaker et al. 2000).
Another study of two juvenile African grey parrots
naturally infected with BFDV (Doneley 2003)f o u n d
splenic and hepatic erythrophagocytosis, multi-focal necrosis
in the spleen associated with eosinophilic intranuclear
inclusion bodies, and numerous large, basophilic, amorphous
intracytoplasmic inclusion bodies in the bursa of Fabricius.
These birds were also diagnosed with PBFD induced
immunosuppressionandsecondaryviral andfungalinfections,
althoughtherewasnoexplanationofhowthesecondarynature
was determined.
To date, there have been no reports on the hematological
aspects of healthy long-billed corella. This study reports the
hematological characteristics of vaccinated and non-vaccinated
long-billed corellas, before and after challenge with live
BFDV.
Materials and methods
The birds used in this experiment were all part of a
vaccination trial to determine the efficacy of recombinant
BFDV capsid protein vaccine to protect against PBFD
(Bonne et al. 2009). Briefly, 18 nestling long-billed corellas
had been collected from the wild and repeatedly screened
for BFDVover a period of 9 weeks while being hand reared.
Thirteen corellas (herein termed “vaccinated corellas”)w e r e
injected with a recombinant BFDV capsid protein vaccine
(27 and 16 days before challenge) and five corellas were
designated ‘controls’ (herein termed “non-vaccinated control
corellas”) .T h ec o r e l l a sr a n g e df r o m1 0 2t o1 1 9d a y so fa g e
on day 0 of this study.
Blood was collected by jugular venipuncture before
BFDV challenge and then at 13, 20, 26, 41, and 97 days
post-challenge. The samples were all collected in the
morning on each of the days to avoid differences due to
diurnal changes. The bloods were preserved in commercial
0.2 ml EDTA tubes (Becton-Dickinson, Rutherford, NJ,
USA) and analyzed within4ho fcollection.
The analytes measured included packed cell volume
(PCV), total serum protein (TSP), total leukocyte concen-
tration (leu), and differential leukocyte concentrations. The
PCV was measured after centrifugation (Clements Micro
hematocrit centrifuge, 15,000 rpm) of whole blood in 75 μl
glass capillary tubes (Hirschmann Laborgeräte) for 5 min.
Following PCV measurement, the TSP was determined
using the plasma by refractometry (Reichert TSreader, NY,
USA). Acidophil concentration was determined, after
quantitative addition of eosin stain (0.1 g eosin, 10 ml
acetone, and 100 ml distilled water) to whole blood, in
a hemocytometer (Kova chambers, Hycor Biomedical,
Australia) according to the manufacturer’s recommendations.
The coefficient of variation (CV) of the acidophil count was
determined by performing ten counts on the same sample.
Differential leukocyte counts (100 cells) were performed on
modified Wright’s stained (Bayer Healthcare, Siemens,
Australia) blood films. The total leukocyte and differential
leukocyte concentrations were then calculated according to
previously described methods (Campbell 1994).
The mean±standard deviation (SD) of each parameter
for each group at each time point was calculated and one-
way ANOVA with Tukey’s multiple comparison post test
was performed using GraphPad Prism version 4.02 for
Windows (GraphPad Software, San Diego, CA, USA;
http://www.graphpad.com) to test for significant difference
between means.
Results
The results are given in Table 1 and 2. Before administra-
tion of the BFDV challenge dose, vaccinated corellas and
non-vaccinated control corellas had TSP (mean±SD) of
36.64±2.80 and 38.40±3.44 g l
−1 (P>0.05), respectively.
Subsequent time points within each group and between
groups were not found to be significantly different
(P>0.05).
Prior to challenge with the BFDV inoculum, vaccinated
and non-vaccinated control corellas had a PCV (mean±SD)
of 0.49±0.03 and 0.50±0.02 l l
−1, respectively, and were
not significantly different to each other (P>0.05). Subsequent
time points within each group and between groups were not
found to be significantly different (P>0.05).
Before challenge with the BFDV inoculum, vaccinated
and non-vaccinated control corellas had a mean total
leukocyte concentration of 15.54±5.35×10
9 and 16.60±
10.20×10
9 l
−1, respectively, and was not significantly
different to each other (P>0.05). The least mean total
leukocyte concentration for vaccinated corellas was 0.70±
0.41×10
9 l
−1 13 days after BFDV administration and for
non-vaccinated control birds 1.38±0.76×10
9 l
−1 26 days
after BFDV administration. In the vaccinated group, the
mean total leukocyte concentration was found to be
significantly different at each subsequent time point when
compared to day 0 (P<0.001). Similarly, in the non-
Comp Clin Patholvaccinated control group, the mean total leukocyte concen-
tration was found to differ significantly between day 0 and
days 13, 20, 26, 41 (all P<0.001), and day 97 (P<0.01;
Fig. 1).
Specific corella leukocytes were identified as seen in
Fig. 2 and the morphology of these cells coincided well with
the morphological descriptions of psittacine leukocytes
found in the literature (Campbell and Ellis 2007).
Vaccinated and non-vaccinated control corellas had a
mean heterophil concentration of 3.96±2.14×10
9 and 3.57±
1.91×10
9 l
−1, respectively, before BFDV challenge. There
was no significant difference in mean heterophil concen-
tration between vaccinated and non-vaccinated control
corellas on day 0 (P>0.05). The least mean heterophil
concentration for vaccinated corellas was on day 13 and for
non-vaccinated control corellas on day 26. At the time
points subsequent to day 0, there was no significant
difference between each group (P>0.05). However, the
mean heterophil concentration for vaccinated corellas was
significantly less at all subsequent time points compared to
the day 0 heterophil concentration (P<0.001). Similarly,
non-vaccinated control corellas had a significant decrease
in heterophil concentration at the time points subsequent to
day 0 (days 13 and 26, P<0.001; days 20, 41, and 97,
P<0.01; Fig. 3).
Vaccinated and non-vaccinated control corellas had
mean lymphocyte concentrations (10.43±3.65×10
9 and
10.06±6.96×10
9 l
−1, respectively) that were not signifi-
cantly different to each other before BFDV challenge
(P>0.05). The least mean lymphocyte concentration for
vaccinated corellas was on day 13 (0.37±0.25×10
9 l
−1) and
for non-vaccinated control corellas on day 26 (0.97±0.58×
10
9 l
−1). At subsequent time points, vaccinated corella
mean lymphocyte concentration was significantly less than
day 0 (days 13, 20, 26, and 97, P<0.001; day 41, P<0.01).
Similarly, the mean lymphocyte concentration for non-
vaccinated control corellas was decreased (days 13, 26, and
41, P<0.01; days 20 and 97, P<0.05; Fig. 4).
The mean monocyte concentration of vaccinated and
non-vaccinated control corellas before BFDV challenge
was 1.24±0.91×10
9 and 0.81±1.11×10
9 l
−1, respectively.
There was no significant difference (P>0.05) in the mean
Table 1 Hematological values (mean±SD) obtained for vaccinated corellas before and up to 97 days after BFDV infection
Days
post-challenge
0 13 20 26 41 97 Unit
TSP 36.64±0.85(11)a 38.60±1.70(10)a 38.38±1.04(13)a 39.00±0.93(13)a 40.38±1.04(13)a 41.82±1.37(11)a g l
−1
PCV 0.49±0.03(11)a 0.47±0.04(8)a 0.47±0.03(13)a 0.47±0.06(13)a 0.48±0.03(13)a 0.49±0.03(12)a l l
−1
Leu 15.54±5.35(11)a 0.70±0.41(9)b 2.41±2.17(12)b 4.00±6.14(12)b 5.74±5.22(13)b 2.83±2.70(13)b ×10
9 l
−1
Het 3.96±2.14(11)a 0.25±016(9)b 0.81 ±1.13(12)b 0.89±1.22(12)b 1.21±0.79(13)b 0.47±0.37(13)b ×10
9 l
−1
Lym 10.43±3.65(11)a 0.37±0.25(9)b 1.49±1.16(12)b 3.03±4.90(12)b 4.36±4.56(13)b 2.18±2.24(13)b ×10
9 l
−1
Mon 1.24±0.91(11)a 0.05±0.03(9)b 0.08±0.07(11)b 0.04±0.04(11)b 0.11±0.05(10)b 0.11±0.15(13)b ×10
9 l
−1
Eos 0.33±0.25(9)a 0.03±0.02(8)b 0.04±0.02(7)b 0.09±0.09(5)a,b 0.12±0.06(5)a,b 0.07±0.08(9)a,b ×10
9 l
−1
Bas 0.20±0.06(7)a 0.01±0.01(5)a 0.03±0.02(7)a 0.02±0.01(3)a 0.06±0.04(7)a 0.03±0.04(5)a ×10
9 l
−1
SD standard deviation, TSP total serum protein, PCV packed cell volume, Leu total leukocyte concentration, Het heterophils, Lym lymphocytes,
Mon monocytes, Eos eosinophils, Bas basophils. N is given in brackets. a, b, c the values for the parameters are significantly different (P<0.05)
when the letters are different
Table 2 Hematological values (mean±SD) obtained for non-vaccinated control corellas before and up to 97 days after BFDV infection
Days post-challenge 0 13 20 26 41 97 Unit
TSP 38.40±1.54(5)a 41.6±3.06(5)a 39.50±3.07(4)a 38.40±1.29(5)a 42.00±1.92(5)a 41.80±0.80(5)a g l
−1
PCV 0.50±0.02(5)a 0.48±0.06(5)a 0.46±0.03(5)a 0.47±0.04(5)a 0.48±0.05(5)a 0.46±0.05(5)a l l
−1
Leu 16.60±10.2(5)a 1.52±2.20(5)b 2.33±1.37(4)b 1.38±0.76(5)b 2.71±2.84(5)b 3.94±2.97(5)b ×10
9 l
−1
Het 3.57±1.91(5)a 0.37±0.38(5)b 0.51±0.34(4)b 0.31±0.31(5)b 0.49±0.37(5)b 0.73±0.53(5)b ×10
9 l
−1
Lym 10.06±6.96(5)a 1.01±1.62(5)b 1.44±1.11(4)b 0.97±0.58(5)b 1.33±1.09(5)b 2.84±2.28(5)b ×10
9 l
−1
Mon 0.81±1.11(5)a 0.10±0.16(5)a 0.14±0.05(3)a 0.04±0.03(5)a 0.01±0.01(3)a 0.12±0.17(5)a ×10
9 l
−1
Eos 0.26(1) 0.01±0.004(3)a 0.09±0.04(2)a 0.02±0.01(3)a 0.10±0.16(4)a 0.17±0.27(5)a ×10
9 l
−1
Bas 0.32±0.29(5)a 0.05±0.08(4)b 0.03±0.02(2)a,b 0.01±0.001(2)b,c 0.08±0.08(3)a,b,c 0.15(1) ×10
9 l
−1
SD standard deviation, TSP total serum protein, PCV packed cell volume, Leu total leukocyte concentration, Het heterophils, Lym lymphocytes,
Mon monocytes, Eos eosinophils, Bas basophils. N is given in brackets. a, b, c the values for the parameters are significantly different (P<0.05)
when the letters are different
Comp Clin Patholmonocyte concentration between the two groups prior to
BFDV challenge. The least mean monocyte concentration
was 0.04±0.04×10
9 l
−1, 26 days after BFDV challenge for
vaccinated corellas and 0.01±0.01×10
9 l
−1 on day 41 after
challenge for non-vaccinated control birds. The Tukey’s
multiple comparison test showed that the mean monocyte
concentration of vaccinated corellas was significantly less
(P<0.001) at all time points after challenge compared with
the pre-challenge mean concentration. Similarly, non-
vaccinated control corella means were significantly less
after challenge (days 13, 26, and 97, P<0.001 and days 20
and 41, P<0.01; Fig. 5).
Prior to BFDV challenge, the mean eosinophil concen-
tration in vaccinated corellas was 0.33±0.25×10
9 and
0.26×10
9 l
−1 (n=1) in non-vaccinated control corellas and
was not found to be significantly different (P>0.05)
between the two groups. In both vaccinated and non-
vaccinated control corellas, the least mean eosinophil
concentration (0.03±0.02 and 0.01±0.004×10
9 l
−1, respec-
tively) was on day 13 after BFDV challenge. The mean
eosinophil concentration was significantly less in vaccinated
corellas on days 13 (P<0.01), 20, and 97 (P<0.05) but not
on days 26 and 41 (P>0.05). In non-vaccinated control
corellas, there were no significant differences in mean
eosinophil concentration before and after challenge
(P>0.05).
Pre-challenge mean basophil concentration was not
significantly different between vaccinated (0.20±0.06×
10
9 l
−1) and non-vaccinated control corellas (0.32±0.29×
10
9 l
−1)( P>0.05). Thirteen days after BFDV challenge,
non-vaccinated control corellas’ mean basophil concentration
(0.05±0.08×10
9 l
−1) had decreased significantly (P<0.05).
In non-vaccinated control corellas, the least mean basophil
concentration was on day 26 (0.01±0.00×10
9 l
−1) which
was found to be significantly less (P<0.05) than day 0, but
not significantly different to day 13. The CV was calculated
to be 36.84% for acidophil counts.
Discussion
Hematological values have been reported for a number of
species of psittacine birds (Lumeij and Overduin 1990;
Polo et al. 1998; Scope et al. 2000). However, to the
authors’ knowledge, there are no published values available
for long-billed corella. As there have been few reports
considering hematological aspects of BFDV infection and
because they may vary significantly from the intervals in
Fig. 1 Mean total leukocyte concentration (cells×10
9 l
−1)±SD vs.
days post-challenge
Fig. 2 Leukocytes from
peripheral blood of a corella
included in this study.
a Heterophil. b Lymphocyte. c
Monocyte. d Basophil.
e Eosinophil. f Thrombocyte
(thrombocytes were not
included in total leukocyte/
acidophil counts). The
morphology of these cells
coincided well with the
morphological descriptions of
psittacine leukocytes found in
the literature (Campbell and
Ellis 2007)
Comp Clin Patholyounger and older corellas, as was previously found in
several cockatoo species, we wanted to investigate the
changes that might occur during BFDV infection of young
long-billed corellas (102 to 119 days) (Clubb et al. 1991).
The mean TSP values obtained in this study are
comparable to TSP values reported by others for species
of cockatoo (Campbell 2000; Lumeij and Overduin 1990;
Polo et al. 1998). The differences in TSP between groups
were insignificant. Only small fluctuations in the mean TSP
between time points were seen in each group and these
likely represent biological variation such as changes of the
birds’ hydration. In contrast, Jacobson et al. (1986) found
that BFDV-infected south-east Asian cockatoos had very
low serum protein concentrations.
The PCV values obtained for birds in this experiment
were similar to that reported previously for species of white
cockatoos and black cockatoos (Campbell 2000; Lumeij
and Overduin 1990; Polo et al. 1998) and there was no
significant change in the mean PCV within each group
throughout the experiment. Previously, severe anemia has
been reported in young African grey parrots with peracute
PBFD (Schoemaker et al. 2000). In the current study, there
was no evidence to support that this may occur in young
long-billed corella. This may reflect a species difference in
susceptibility to the virus, with African grey parrots
documented to be more severely affected by BFDV than
most other species (Doneley 2003; McOrist et al. 1984;
Schoemaker et al. 2000).
The mean total leukocyte concentrations measured for
the vaccinated and non-vaccinated control corellas before
BFDV challenge in this experiment were within the ranges
published by others for various psittacine birds (Campbell
2000; Lumeij and Overduin 1990; Polo et al. 1998). In both
vaccinated and non-vaccinated control groups, there was a
significant decrease in total leukocyte concentration 13 days
after challenge and remained at this level throughout the
course of the experiment. This shows evidence that BFDV
infection may cause leukopenia in young long-billed
corellas as was found in young African grey parrots
(Schoemaker et al. 2000). Furthermore, there was no
evidence for vaccination providing protection against
leukopenia following BFDV infection.
Before BFDV challenge, both the vaccinated and non-
vaccinated control corellas had mean heterophil concen-
trations that were less than published values for other
species of cockatoos (Campbell 2000; Lumeij and Overduin
1990;P o l oe ta l .1998). This may reflect a species difference
or differences in environmental and management factors
(Campbell and Ellis 2007). Both vaccinated and non-
vaccinated control corellas had a similar change in heterophil
concentration after challenge. The results at 13 days post-
challenge were significantly less than the pre-infection
values. The heterophil concentration was not restored to
pre-infection levelsby the end of the experiment, even though
PCRcouldnot detectviremia atthisstage (Bonneetal.2009).
The bone marrow (BM) is a primary site of heterophil
production in post-hatch birds (Campbell and Ellis 2007).
The heteropenia observed in this study may have been
caused by virus entering BM and interfering with granulo-
poiesis. Cytologic evaluation of the BM would be necessary
in order to determine the cause of heteropenia.
Fig. 3 Mean heterophil concentration (cells×10
9 l
−1)±SD vs. days
post-challenge
Fig. 4 Mean lymphocyte concentration (cells×10
9 l
−1)±SD vs. days
post-challenge
Fig. 5 Mean monocyte concentration (cells×10
9 l
−1)±SD vs. days
post-challenge
Comp Clin PatholThe mean lymphocyte concentrations before challenge
for both groups were considerably greater than those
reported for other species of cockatoo (Campbell 2000;
Lumeij and Overduin 1990; Polo et al. 1998). Additionally,
the lymphocyte concentrations were significantly less
13 days after challenge than before challenge. The three
subsequent time points (days 20, 26, and 41) showed an
increase in lymphocyte concentration in vaccinated corellas
before decreasing again at the final time point; however, the
differences were not significant for time points subsequent
to day 13. Non-vaccinated control corellas also had some
fluctuation between subsequent time points after 13 days
post-challenge but were not significant. At 26 and 41 days
post-challenge, vaccinated corellas had mean lymphocyte
values that were comparable to those reported for healthy
psittacine birds (Campbell 2000; Lumeij and Overduin
1990; Polo et al. 1998), but non-vaccinated control corellas
were less and did not reach comparable levels until 97 days
post-challenge. By the end of the experiment, both
vaccinated and non-vaccinated control corellas had mean
lymphocyte concentrations that were below the pre-infection
values. The difference between the pre-infection lymphocyte
concentrations observed in this study to previously reported
normal values for psittacine birds may be due to the age of
the birds or species. Animals vaccinated with modified live
virus vaccine to protect against distemper virus commonly
suffer immunosuppression associated with leukopenia and
lymphopenia after vaccination (Williams et al. 1996). Other
vaccines may stimulate lymphocyte proliferation (Ghaffari et
al. 2001). In the current study, there was no difference in
lymphocyte concentration between vaccinated and non-
vaccinated control corellas before live virus challenge. After
challenge, both groups had significantly less circulating
lymphocytes.
Both vaccinated and non-vaccinated control corellas
had mean monocyte concentrations at the start of the
experiment that were comparable to other cockatoos and
psittacine birds (Campbell 2000; Lumeij and Overduin 1990;
Polo et al. 1998). Thirteen days after challenge, there was a
significant decrease in the monocyte concentration of
vaccinated corellas.
The observed mean eosinophil concentrations were
greater than those reported for other psittacine birds
(Campbell 2000; Lumeij and Overduin 1990; Polo et al.
1998). Thirteen days post-challenge, the mean eosinophil
concentration of vaccinated corellas had decreased signif-
icantly. At this time point, three non-vaccinated control
corellas had a mean eosinophil concentration of 0.01±
0.004×10
9 l
−1; however, statistical analysis could not be
performed to test for significant difference to pre-challenge
eosinophil concentration, as eosinophils could only be
detected in one non-vaccinated control corella before
challenge. Fluctuations in the eosinophil concentrations
throughout the experiment were noted and on the final day,
vaccinated corella mean eosinophil concentration was
significantly less than before challenge (P<0.05). In non-
vaccinated control corellas, the final mean eosinophil
concentration was 0.17±0.27×10
9 l
−1 and could not be
claimed to be significantly different to the pre-challenge
value.
There was no significant difference in mean basophil
concentration between the two groups before challenge and
the basophil concentrations were similar to that reported for
other psittacine birds (Campbell 2000; Lumeij and Overduin
1990;P o l oe ta l .1998). The mean basophil concentration of
non-vaccinated control corellas was significantly (P<0.05)
reduced 13 days after challenge, but vaccinated corellas were
not significantly different at this time point. No significant
change was found in either group after this. This data
provides evidence that vaccinated corellas may suffer less
reduction in circulating basophil concentration than non-
vaccinated control corellas in acute BFDV infection.
Schoemaker et al. (2000) reported leukopenia, anemia,
and pancytopenia in African grey parrots with peracute
PBFD. In the current experiment, there was no evidence for
anemia. This could be due to several factors: the severity of
infection, species of bird, and virus genotype. The African
grey parrots (Schoemaker et al. 2000) and the corellas in
the current study were of similar ages and it is therefore
unlikely that age was an influencing factor. There was little
difference in leukocyte concentrations between vaccinated
and non-vaccinated control corellas, both before and after
challenge. A marked reduction in leukocyte concentrations
was observed in both groups after challenge, except
basophils in vaccinated corellas. Packed cell volume and
serum protein concentration did not change significantly
between measured time points in either group, although
both have been reported previously to change significantly
in African grey parrots (Schoemaker et al. 2000) and south-
east Asian cockatoos (Jacobson et al. 1986). The reason for
changes in circulating leukocyte concentrations in this study
is not clear. Migration of circulating cells into tissues,
leukocyte lysing activity of virus, and possibility of the virus
entering BM and suppressing leukocyte production are all
possible reasons. Until changes in BM of BFDV-infected
birds have been investigated, the reason for leukopenia will
remain unknown.
In summary, young non-infected long-billed corellas
have similar hematological intervals to other related
psittacine species although circulating lymphocytes may
be more prevalent; experimentally BFDV-infected corellas
(both vaccinated and non-vaccinated) may suffer leukopenia;
involving all leukocyte types, vaccinated corellas may have a
slight advantage (less reduction of basophils) over non-
vaccinated control corellas and PCVand TSP did not change
significantly in either group during BFDV infection.
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